data_2eqq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eqq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 22.0 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.642 -0.503 . . . . 2.1200000000000001 109.642 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.58 117.0 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 1.29 111.012 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 17.55 25.22 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.042 -0.599 . . . . 0.67000000000000004 112.859 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.561 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 78.7 m-85 -120.7 119.53 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.877 0.695 . . . . 0.87 112.877 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.911 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 21.4 mmt -84.26 171.94 12.29 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.807 -1.088 . . . . 2.7999999999999998 108.414 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 20.4 mtp180 -147.2 148.08 31.13 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.293 0.568 . . . . 3.7200000000000002 111.526 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 75.7 p -92.72 168.83 11.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.016 -0.993 . . . . 1.22 110.203 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.3 Cg_exo -59.28 -21.29 59.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.682 2.255 . . . . 1.23 112.764 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.58 41.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.116 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.21 25.17 6.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.545 -0.836 . . . . 0.47999999999999998 112.748 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 74.1 mtp180 -87.16 121.55 29.77 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.309 -0.156 . . . . 4.4900000000000002 110.725 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 13' ' ' ARG . 62.4 m -88.0 134.74 33.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.09 0.471 . . . . 0.80000000000000004 110.206 174.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 160.24 25.75 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.891 -0.781 . . . . 2.98 108.891 174.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -34.34 146.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.11 3.207 . . . . 0.91000000000000003 113.23 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.911 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 1.3500000000000001 110.929 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.683 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 17.6 t . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.34 -0.985 . . . . 2.1200000000000001 108.34 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.45 109.46 1.02 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.79 0.328 . . . . 1.29 110.616 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.18 4.64 38.24 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.67000000000000004 111.832 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.2 m-85 -124.28 121.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.097 0.475 . . . . 0.87 111.043 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -100.07 -179.72 4.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.295 -1.002 . . . . 2.7999999999999998 108.295 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 21.0 mmm-85 -124.93 139.83 53.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.162 0.506 . . . . 3.7200000000000002 111.403 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.412 ' HG1' ' CG ' ' A' ' 16' ' ' ASP . 32.3 p -79.18 168.47 26.58 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.089 -0.959 . . . . 1.22 109.644 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.38 -28.73 88.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.137 1.891 . . . . 1.23 111.336 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.482 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 3.0 p-10 -83.82 -5.27 59.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.255 -0.884 . . . . 1.95 111.355 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 36.04 7.94 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.636 -0.792 . . . . 0.47999999999999998 114.416 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.0 mtp180 -93.99 139.39 31.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.522 0.661 . . . . 4.4900000000000002 111.397 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -87.52 96.14 10.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.877 -0.786 . . . . 0.80000000000000004 108.877 171.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -130.7 161.43 61.13 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.653 -0.499 . . . . 2.98 109.653 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.544 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.8 Cg_exo -33.87 147.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.619 3.546 . . . . 0.91000000000000003 114.257 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.629 0.728 . . . . 1.3500000000000001 110.384 171.706 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.236 0.395 0 CA-C-O 121.318 0.58 . . . . 2.1200000000000001 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.3 128.96 37.97 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.412 -0.813 . . . . 1.29 111.666 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 6.15 58.21 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.063 -0.971 . . . . 0.67000000000000004 111.759 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 84.8 m-85 -121.52 139.66 53.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.515 0.674 . . . . 0.87 112.732 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.607 ' HG2' HG23 ' A' ' 22' ' ' THR . 93.3 mmm -129.47 142.94 50.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.667 -1.151 . . . . 2.7999999999999998 108.682 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.601 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -97.36 138.62 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.002 0.429 . . . . 3.7200000000000002 109.909 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.5 p -79.09 -175.93 0.64 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.675 -0.693 . . . . 1.22 110.208 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 63.9 Cg_exo -55.86 -15.88 14.35 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.317 2.011 . . . . 1.23 112.915 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.81 4.64 40.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 1.95 110.738 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.45 24.38 75.13 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.143 -0.551 . . . . 0.47999999999999998 113.022 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 92.5 mtt180 -91.68 116.24 28.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.618 -0.512 . . . . 4.4900000000000002 109.618 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.601 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 30.6 p -88.31 100.5 13.06 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.239 1.019 . . . . 0.80000000000000004 111.398 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.735 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -108.41 175.07 2.12 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 113.678 -1.601 . . . . 2.98 107.246 171.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -43.03 152.78 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.248 2.632 . . . . 0.91000000000000003 113.307 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.607 HG23 ' HG2' ' A' ' 12' ' ' MET . 6.1 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.489 0.662 . . . . 1.3500000000000001 110.221 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.62 -0.511 . . . . 2.1200000000000001 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.06 127.65 19.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.462 . . . . 1.29 111.116 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.21 7.27 60.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.67000000000000004 112.88 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.41 132.0 42.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.503 0.557 . . . . 0.87 112.503 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptp -104.03 -170.35 1.76 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.427 -1.323 . . . . 2.7999999999999998 107.427 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.3 mtp85 -143.1 150.92 40.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.124 -0.63 . . . . 3.7200000000000002 112.381 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.762 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 38.1 p -82.34 171.68 11.32 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.25 -0.886 . . . . 1.22 109.616 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.762 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -55.75 -26.11 54.93 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.903 2.402 . . . . 1.23 112.491 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.54 -24.48 42.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 1.95 110.669 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.22 8.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.377 -0.916 . . . . 0.47999999999999998 112.949 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.7 mpt_? -80.48 129.87 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.541 -0.388 . . . . 4.4900000000000002 110.559 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.0 m -78.52 90.77 4.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.904 0.859 . . . . 0.80000000000000004 110.289 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -103.45 135.33 19.4 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 113.627 -1.624 . . . . 2.98 108.047 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -43.03 152.28 0.22 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.162 2.575 . . . . 0.91000000000000003 113.781 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.325 -0.478 0 CA-C-O 121.511 0.672 . . . . 1.3500000000000001 110.359 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.825 0.345 . . . . 2.1200000000000001 110.784 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.05 122.38 14.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.37 0.605 . . . . 1.29 110.548 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.97 12.34 27.94 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.508 -0.769 . . . . 0.67000000000000004 111.401 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.35 125.13 42.98 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.346 0.593 . . . . 0.87 111.794 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ptp -90.62 171.91 9.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.963 -1.017 . . . . 2.7999999999999998 108.711 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -138.16 148.45 44.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.275 0.559 . . . . 3.7200000000000002 112.1 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.781 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.7 p -84.76 173.66 6.87 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.068 -0.969 . . . . 1.22 109.896 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.781 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 22.3 Cg_endo -61.1 -12.29 22.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.571 2.181 . . . . 1.23 112.311 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.35 -21.64 45.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.913 -0.585 . . . . 1.95 109.954 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.45 27.14 33.67 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.031 -0.828 . . . . 0.47999999999999998 111.031 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.8 134.9 38.2 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.792 -0.448 . . . . 4.4900000000000002 109.792 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.3 m -80.79 130.78 35.25 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.774 0.671 . . . . 0.80000000000000004 111.424 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.83 151.91 66.83 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.073 -1.084 . . . . 2.98 108.073 171.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.26 152.89 18.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 121.929 1.753 . . . . 0.91000000000000003 112.286 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.638 0.733 . . . . 1.3500000000000001 110.332 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.748 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 110.162 -0.31 . . . . 2.1200000000000001 110.162 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.607 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -38.54 -66.9 0.23 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.731 1.011 . . . . 1.29 113.731 -171.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 49.49 1.49 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.131 -1.033 . . . . 0.67000000000000004 112.899 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.748 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 67.0 m-85 -125.03 118.66 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.735 0.779 . . . . 0.87 112.369 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.744 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 24.5 mmt -82.69 172.26 13.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.716 -1.129 . . . . 2.7999999999999998 108.831 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -124.65 139.38 53.91 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.559 -0.457 . . . . 3.7200000000000002 110.151 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.832 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 35.8 p -79.22 176.89 3.27 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.516 -0.766 . . . . 1.22 109.703 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.832 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.0 Cg_endo -52.7 -29.83 43.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.434 2.089 . . . . 1.23 112.207 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 5.2 m-20 -79.74 -22.26 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.576 . . . . 1.95 110.921 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.33 13.74 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.363 -0.695 . . . . 0.47999999999999998 111.363 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -78.59 132.13 37.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.727 -0.842 . . . . 4.4900000000000002 108.727 174.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.89 102.93 11.99 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.598 -0.728 . . . . 0.80000000000000004 110.616 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -128.11 155.21 78.35 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 108.997 -0.742 . . . . 2.98 108.997 177.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 35.1 Cg_exo -31.48 144.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.813 3.675 . . . . 0.91000000000000003 113.751 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.744 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 3.5 p . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 109.013 -0.736 . . . . 1.3500000000000001 109.013 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 11' ' ' TYR . 16.0 m . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 120.866 0.365 . . . . 2.1200000000000001 111.305 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.11 108.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.414 -0.812 . . . . 1.29 112.421 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.26 34.33 26.49 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.767 -0.651 . . . . 0.67000000000000004 113.737 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' A' ' 8' ' ' VAL . 85.9 m-85 -134.01 121.7 21.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.763 0.653 . . . . 0.87 112.763 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -90.44 177.97 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.668 -1.234 . . . . 2.7999999999999998 107.668 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 13' ' ' ARG . 13.1 mtp180 -143.71 155.55 44.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.325 0.861 . . . . 3.7200000000000002 113.325 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -95.54 166.57 14.38 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 114.318 -1.31 . . . . 1.22 110.039 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.07 -28.59 84.09 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.799 2.333 . . . . 1.23 112.606 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.675 ' OD1' ' HD3' ' A' ' 18' ' ' ARG . 2.3 p30 -79.57 -14.17 59.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.519 -0.764 . . . . 1.95 111.921 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.63 11.65 37.49 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.72 -0.753 . . . . 0.47999999999999998 113.868 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.675 ' HD3' ' OD1' ' A' ' 16' ' ' ASP . 11.4 mpt_? -79.89 142.42 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.355 0.577 . . . . 4.4900000000000002 110.36 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.5 m -100.12 117.5 34.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.308 0.575 . . . . 0.80000000000000004 110.933 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -113.06 153.58 45.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.748 -1.204 . . . . 2.98 107.748 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.69 163.53 6.98 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 121.691 1.594 . . . . 0.91000000000000003 112.305 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.844 -0.616 . . . . 1.3500000000000001 111.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 20.3 t . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.666 0.269 . . . . 2.1200000000000001 110.512 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.45 126.24 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 1.29 110.947 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.08 3.5 48.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.793 -0.717 . . . . 0.67000000000000004 111.986 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.8 m-85 -118.27 119.64 35.25 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.288 0.566 . . . . 0.87 111.95 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.421 ' HE2' ' HB2' ' A' ' 12' ' ' MET . 4.6 ppp? -100.59 158.88 15.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.058 -1.46 . . . . 2.7999999999999998 107.058 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm-85 -123.3 150.32 43.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.716 1.006 . . . . 3.7200000000000002 113.716 -164.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 25.4 p -89.79 170.24 10.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 114.356 -1.293 . . . . 1.22 111.204 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 16.5 Cg_exo -66.57 -13.84 41.55 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.008 2.472 . . . . 1.23 110.951 173.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.32 -25.05 42.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.577 -1.192 . . . . 1.95 110.13 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.82 28.57 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.613 -0.721 . . . . 0.47999999999999998 112.079 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -95.41 143.51 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.114 0.483 . . . . 4.4900000000000002 112.152 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -80.79 118.33 22.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.971 -1.013 . . . . 0.80000000000000004 109.935 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -132.53 159.77 71.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.741 -0.837 . . . . 2.98 108.741 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.29 160.31 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.208 1.939 . . . . 0.91000000000000003 112.025 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.35 0.595 . . . . 1.3500000000000001 110.859 172.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.682 HG23 ' H ' ' A' ' 9' ' ' ALA . 4.1 p . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.98 0.419 . . . . 2.1200000000000001 111.151 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.682 ' H ' HG23 ' A' ' 8' ' ' VAL . . . -57.15 134.52 55.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.09 0.471 . . . . 1.29 111.264 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' HG22 ' A' ' 22' ' ' THR . . . 93.88 6.89 61.7 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.673 -0.775 . . . . 0.67000000000000004 111.77 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -128.92 118.08 22.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.385 0.513 . . . . 0.87 112.385 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.3 ptm -89.56 164.04 14.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.164 -1.05 . . . . 2.7999999999999998 108.164 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.82 147.9 43.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.139 -0.624 . . . . 3.7200000000000002 111.39 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.419 ' HG1' ' HB3' ' A' ' 16' ' ' ASP . 71.4 p -79.46 173.24 8.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.419 -0.81 . . . . 1.22 108.89 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.3 -14.28 33.41 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.057 1.838 . . . . 1.23 111.19 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' HB3' ' HG1' ' A' ' 14' ' ' THR . 12.1 t70 -90.95 -10.27 43.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 1.95 110.196 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.94 28.42 58.8 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.154 -0.778 . . . . 0.47999999999999998 111.154 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -79.7 127.03 31.69 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.41 -0.959 . . . . 4.4900000000000002 108.41 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 m -80.18 101.57 8.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.379 0.609 . . . . 0.80000000000000004 110.849 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HE3' ' HG3' ' A' ' 12' ' ' MET . 54.3 pttt -114.74 159.89 35.49 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 108.108 -1.071 . . . . 2.98 108.108 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.601 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.3 Cg_exo -54.46 172.95 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.259 1.972 . . . . 0.91000000000000003 113.034 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.511 HG22 ' HA2' ' A' ' 10' ' ' GLY . 2.9 p . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 121.322 0.582 . . . . 1.3500000000000001 111.293 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.643 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 4.1 t . . . . . 0 C--O 1.233 0.207 0 N-CA-C 108.497 -0.927 . . . . 2.1200000000000001 108.497 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.487 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -61.76 106.13 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.057 0.456 . . . . 1.29 110.823 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.16 26.68 9.99 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.962 -0.637 . . . . 0.67000000000000004 112.52 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.643 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 58.1 m-85 -128.03 130.82 48.9 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.87 111.917 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.4 ptp -96.78 174.62 6.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.946 -1.025 . . . . 2.7999999999999998 108.778 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.6 mtp180 -133.5 143.43 48.78 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.989 0.424 . . . . 3.7200000000000002 110.42 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 21.9 p -79.78 170.32 16.43 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.728 -0.669 . . . . 1.22 109.244 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 21.4 Cg_endo -62.82 -7.09 10.42 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.547 2.164 . . . . 1.23 111.312 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.18 -18.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.475 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 19.52 39.79 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.562 . . . . 0.47999999999999998 112.606 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 79.7 ttt180 -93.83 130.08 39.98 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.353 -0.24 . . . . 4.4900000000000002 110.353 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -83.58 121.42 27.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.262 0.553 . . . . 0.80000000000000004 111.267 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HE2' HG23 ' A' ' 14' ' ' THR . 48.8 mtmt -124.08 160.63 51.28 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.111 -1.07 . . . . 2.98 108.111 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.78 169.06 1.41 Allowed 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.179 1.919 . . . . 0.91000000000000003 111.262 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.5 0.667 . . . . 1.3500000000000001 110.107 174.55 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.595 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.2 t . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 109.638 -0.504 . . . . 2.1200000000000001 109.638 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.97 118.92 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 1.29 111.087 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.65 39.55 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.593 -0.813 . . . . 0.67000000000000004 112.132 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 72.8 m-85 -119.98 128.62 53.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 0.87 112.148 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.1 ptm -104.92 166.03 10.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.566 -1.272 . . . . 2.7999999999999998 107.566 175.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 14.1 mtp180 -135.75 160.78 37.49 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.04 -0.664 . . . . 3.7200000000000002 112.124 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 57.7 p -104.38 172.68 3.92 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.171 -0.922 . . . . 1.22 109.56 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 33.5 Cg_exo -59.32 -18.92 47.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.704 2.269 . . . . 1.23 112.888 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 3.9 m-20 -79.24 -10.07 59.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.753 -0.462 . . . . 1.95 109.753 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.16 22.47 54.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.157 -0.544 . . . . 0.47999999999999998 111.81 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 98.8 mtt180 -85.66 126.61 34.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.714 -0.243 . . . . 4.4900000000000002 110.738 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.6 m -93.19 117.19 29.78 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.723 0.64 . . . . 0.80000000000000004 111.044 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 31.7 pttt -130.28 167.42 20.94 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.182 -1.044 . . . . 2.98 108.182 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 12' ' ' MET . 77.4 Cg_exo -50.89 163.06 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.019 1.813 . . . . 0.91000000000000003 111.783 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.638 0.607 . . . . 1.3500000000000001 112.638 177.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 40.5 t . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.154 -0.684 . . . . 2.1200000000000001 109.154 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.74 117.13 4.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.842 0.353 . . . . 1.29 110.931 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 18.47 20.56 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.963 -0.637 . . . . 0.67000000000000004 111.85 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 69.0 m-85 -128.92 124.46 35.22 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.806 0.813 . . . . 0.87 112.079 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.415 ' C ' ' HD3' ' A' ' 13' ' ' ARG . 26.1 ptm -90.73 164.3 14.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.652 -1.158 . . . . 2.7999999999999998 108.832 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -125.32 141.0 52.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.336 -0.546 . . . . 3.7200000000000002 110.935 -176.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 p -79.32 176.73 3.43 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.379 -0.828 . . . . 1.22 110.332 175.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 14.7 Cg_endo -57.1 -19.15 31.99 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.884 2.389 . . . . 1.23 113.169 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 24.0 p30 -104.7 3.34 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.861 0.363 . . . . 1.95 111.082 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.78 37.35 34.31 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.47999999999999998 113.556 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 24.4 mmt180 -90.12 136.66 32.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.366 -0.605 . . . . 4.4900000000000002 109.366 171.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.7 m -91.87 129.29 37.86 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.989 -0.55 . . . . 0.80000000000000004 111.487 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -147.27 156.56 46.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.503 -0.925 . . . . 2.98 108.503 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -38.5 145.86 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.623 2.882 . . . . 0.91000000000000003 113.32 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.635 0.731 . . . . 1.3500000000000001 111.106 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 15.3 t . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.946 -0.39 . . . . 2.1200000000000001 109.946 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 113.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.942 0.401 . . . . 1.29 111.456 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.95 12.83 19.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.03 -0.605 . . . . 0.67000000000000004 111.659 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.416 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.6 m-85 -129.75 143.15 50.68 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.406 0.622 . . . . 0.87 112.376 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 12' ' ' MET . 4.4 ppp? -122.35 165.61 16.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.486 -1.234 . . . . 2.7999999999999998 107.758 171.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 12.8 mtp85 -131.37 151.84 51.16 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.833 0.679 . . . . 3.7200000000000002 112.833 -171.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.823 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.9 p -79.78 176.62 3.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.93 -1.032 . . . . 1.22 110.045 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.823 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.1 Cg_endo -54.21 -22.33 25.61 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.707 2.272 . . . . 1.23 112.161 172.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 -35.11 46.47 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.926 -0.579 . . . . 1.95 109.824 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.78 15.93 15.41 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.54 -0.754 . . . . 0.47999999999999998 111.504 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 72.0 mtp180 -79.55 130.24 35.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.957 -0.386 . . . . 4.4900000000000002 109.957 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.83 107.41 18.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.291 0.567 . . . . 0.80000000000000004 111.934 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -104.33 157.06 34.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.444 -0.947 . . . . 2.98 108.444 171.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -57.08 150.42 56.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 121.789 1.659 . . . . 0.91000000000000003 111.964 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 115.647 -0.706 . . . . 1.3500000000000001 110.557 176.472 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 11' ' ' TYR . 14.7 m . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 110.304 -0.258 . . . . 2.1200000000000001 110.304 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.77 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.202 0.525 . . . . 1.29 111.909 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.99 36.2 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.326 -0.852 . . . . 0.67000000000000004 112.211 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.641 ' CD1' HG22 ' A' ' 8' ' ' VAL . 18.8 m-85 -127.24 146.54 50.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.536 0.684 . . . . 0.87 112.765 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.569 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.4 ppp? -114.48 168.65 9.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.864 -1.062 . . . . 2.7999999999999998 108.927 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -133.91 146.13 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.402 -0.519 . . . . 3.7200000000000002 110.932 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.3 p -79.87 178.73 2.17 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.9 -0.591 . . . . 1.22 109.477 173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 19.4 Cg_endo -58.42 -19.52 44.12 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.016 1.811 . . . . 1.23 111.948 173.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.764 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -79.23 -22.24 45.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.072 177.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.18 33.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.807 -0.711 . . . . 0.47999999999999998 111.488 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.764 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 81.1 mtp180 -86.03 125.16 33.21 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.361 -0.607 . . . . 4.4900000000000002 109.361 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.47 115.65 25.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.21 -0.45 . . . . 0.80000000000000004 112.063 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.79 ' HE2' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -113.13 157.53 40.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.659 -1.237 . . . . 2.98 107.659 167.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.02 173.91 1.59 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.866 1.711 . . . . 0.91000000000000003 111.891 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 1.3500000000000001 111.03 178.024 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 109.234 -0.654 . . . . 2.1200000000000001 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.35 133.68 55.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.311 . . . . 1.29 111.301 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 1.41 63.36 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.769 -0.729 . . . . 0.67000000000000004 111.302 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.97 123.02 39.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.414 0.626 . . . . 0.87 111.743 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -108.72 165.02 11.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.188 -1.041 . . . . 2.7999999999999998 108.188 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -112.54 148.49 34.4 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.392 -0.523 . . . . 3.7200000000000002 111.774 -171.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.7 p -79.46 174.02 6.78 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.413 -0.812 . . . . 1.22 108.875 170.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 53.1 Cg_exo -55.81 -21.31 32.27 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.12 1.88 . . . . 1.23 112.405 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -22.3 37.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 1.95 110.421 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.76 26.94 11.97 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.47999999999999998 112.022 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 77.1 mtp180 -79.07 127.32 31.85 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.094 -0.335 . . . . 4.4900000000000002 110.094 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -79.17 95.13 5.52 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 123.824 0.702 . . . . 0.80000000000000004 110.154 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.49 165.38 14.53 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.041 -1.096 . . . . 2.98 108.041 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 161.29 2.94 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.926 1.751 . . . . 0.91000000000000003 111.791 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 110.155 173.393 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.67 HG11 ' H ' ' A' ' 9' ' ' ALA . 2.1 t . . . . . 0 C--O 1.238 0.495 0 CA-C-O 120.67 0.271 . . . . 2.1200000000000001 110.494 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.67 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -57.07 130.28 45.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 110.031 -0.359 . . . . 1.29 110.031 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.51 7.91 44.53 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.619 -0.8 . . . . 0.67000000000000004 112.023 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -122.27 131.85 54.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.187 0.81 . . . . 0.87 113.187 176.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.792 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 85.5 mmm -83.51 148.9 26.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.776 -1.194 . . . . 2.7999999999999998 107.776 166.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -129.67 139.87 51.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.524 0.678 . . . . 3.7200000000000002 111.551 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -92.58 168.46 12.53 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.101 -0.954 . . . . 1.22 110.042 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.95 -28.21 48.36 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.798 2.332 . . . . 1.23 113.251 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -82.21 -10.1 59.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.759 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.74 55.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.77 -0.729 . . . . 0.47999999999999998 112.609 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -79.71 149.55 31.15 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.761 0.315 . . . . 4.4900000000000002 110.632 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -105.38 135.61 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.80000000000000004 111.735 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -139.7 143.85 36.71 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 108.237 -1.023 . . . . 2.98 108.237 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -49.7 145.38 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.135 1.89 . . . . 0.91000000000000003 111.879 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.792 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.4 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.816 . . . . 1.3500000000000001 109.991 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 11.4 t . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.697 0.284 . . . . 2.1200000000000001 110.643 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.29 55.96 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.875 0.369 . . . . 1.29 110.664 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.31 12.04 61.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.721 -0.752 . . . . 0.67000000000000004 111.722 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.447 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.6 m-85 -124.81 135.24 52.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.445 0.641 . . . . 0.87 112.193 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.92 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 91.1 mmm -101.65 -179.66 4.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.686 -1.143 . . . . 2.7999999999999998 108.639 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -129.69 143.89 51.03 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.807 -0.357 . . . . 3.7200000000000002 110.24 174.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.833 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.6 p -79.48 176.18 4.0 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.29 -0.868 . . . . 1.22 109.633 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.833 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.1 Cg_endo -55.5 -25.98 51.88 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.757 2.304 . . . . 1.23 112.833 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 7.7 p-10 -95.6 -3.59 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.242 -0.435 . . . . 1.95 111.127 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 32.52 12.61 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.072 -0.585 . . . . 0.47999999999999998 113.863 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.6 mtp180 -82.73 130.43 35.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.182 0.491 . . . . 4.4900000000000002 109.777 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -79.03 86.6 4.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.313 0.578 . . . . 0.80000000000000004 110.298 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -95.45 163.01 22.61 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 108.901 -0.777 . . . . 2.98 108.901 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -40.52 151.43 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.843 2.362 . . . . 0.91000000000000003 112.274 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.92 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 5.9 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.812 0.815 . . . . 1.3500000000000001 109.336 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.5 t . . . . . 0 C--O 1.237 0.418 0 N-CA-C 110.063 -0.347 . . . . 2.1200000000000001 110.063 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.53 113.95 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.462 . . . . 1.29 111.375 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.19 18.6 19.03 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 0.67000000000000004 112.38 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.503 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 92.0 m-85 -127.82 130.69 49.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.87 112.37 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.473 ' HE1' ' O ' ' A' ' 21' ' ' PRO . 19.2 ptt? -103.34 162.81 12.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.689 -1.141 . . . . 2.7999999999999998 108.215 172.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.91 154.14 44.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.483 -0.487 . . . . 3.7200000000000002 112.188 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.2 p -85.59 176.54 3.55 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.346 -0.843 . . . . 1.22 109.824 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 50.6 Cg_exo -55.55 -31.04 77.09 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.364 2.043 . . . . 1.23 111.893 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 -31.4 39.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.692 -0.686 . . . . 1.95 110.622 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.73 22.16 6.46 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.526 -0.845 . . . . 0.47999999999999998 112.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -79.76 129.93 34.9 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.513 -0.551 . . . . 4.4900000000000002 109.513 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -91.52 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.416 0.627 . . . . 0.80000000000000004 111.993 -173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -111.01 147.12 35.89 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.034 -0.985 . . . . 2.98 108.912 173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' O ' ' HE1' ' A' ' 12' ' ' MET . 7.1 Cg_exo -41.12 142.09 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.3 2.667 . . . . 0.91000000000000003 112.774 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.589 0.709 . . . . 1.3500000000000001 110.405 175.607 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 11' ' ' TYR . 7.1 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 109.674 -0.491 . . . . 2.1200000000000001 109.674 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.64 119.96 2.39 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.102 0.778 . . . . 1.29 113.102 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.79 13.35 58.12 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.67000000000000004 113.004 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.511 ' CD1' HG13 ' A' ' 8' ' ' VAL . 15.9 m-85 -124.98 135.48 52.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.341 0.591 . . . . 0.87 112.128 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 82.9 mtp -99.02 176.56 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.024 . . . . 2.7999999999999998 108.815 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.19 140.11 45.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 3.7200000000000002 109.813 173.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.621 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.5 p -80.43 176.79 3.45 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.475 -0.784 . . . . 1.22 109.771 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.8 Cg_exo -50.52 -34.49 42.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.487 2.125 . . . . 1.23 113.45 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -79.95 -5.48 55.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.339 0.59 . . . . 1.95 111.047 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.54 32.63 30.18 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.978 -0.556 . . . . 0.47999999999999998 112.44 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 19.3 mmm180 -88.88 120.91 30.71 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.609 -0.348 . . . . 4.4900000000000002 110.411 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' MET . 86.1 m -80.03 128.42 33.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.879 -0.601 . . . . 0.80000000000000004 111.122 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 14.6 ptpt -153.0 160.84 30.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 2.98 109.102 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 11.7 Cg_exo -39.17 149.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.621 2.88 . . . . 0.91000000000000003 113.267 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.644 ' HA ' ' HG3' ' A' ' 12' ' ' MET . 11.4 p . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.111 0.481 . . . . 1.3500000000000001 112.282 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.249 0.547 . . . . 2.1200000000000001 111.856 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.54 120.89 10.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.279 -0.873 . . . . 1.29 111.847 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 22' ' ' THR . . . 98.66 16.08 32.46 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.016 -0.993 . . . . 0.67000000000000004 112.102 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.97 114.62 17.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.525 0.935 . . . . 0.87 113.525 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.4 ' HE1' ' HB2' ' A' ' 12' ' ' MET . 5.0 ppp? -89.72 156.35 18.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.972 -1.122 . . . . 2.7999999999999998 107.972 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -132.78 140.5 48.05 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.565 -0.454 . . . . 3.7200000000000002 111.044 -171.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 45.6 p -86.58 168.97 16.32 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.919 -0.582 . . . . 1.22 109.952 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 44.9 Cg_exo -58.67 -19.7 47.04 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.558 2.172 . . . . 1.23 112.941 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.48 -12.12 59.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 1.95 110.834 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.5 30.72 26.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.055 -0.593 . . . . 0.47999999999999998 111.638 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -92.59 122.21 34.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 4.4900000000000002 109.709 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.7 m -91.05 107.68 19.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.572 0.701 . . . . 0.80000000000000004 111.272 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -108.84 163.47 16.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.79 -1.095 . . . . 2.98 108.525 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.99 161.7 1.37 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.265 1.977 . . . . 0.91000000000000003 111.519 171.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 10' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 121.307 0.575 . . . . 1.3500000000000001 110.496 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.435 ' H2 ' ' CD ' ' A' ' 1' ' ' GLU . 2.4 mp0 . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.097 0.475 . . . . 12.08 110.434 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -92.62 96.87 10.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 9.8599999999999994 110.983 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -118.94 -65.74 1.14 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.669 -0.696 . . . . 9.6799999999999997 109.609 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -88.71 12.27 15.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.435 0.636 . . . . 7.25 110.041 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.08 -60.78 4.65 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.609 -0.723 . . . . 4.9400000000000004 111.552 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.38 -145.32 18.32 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.343 -0.703 . . . . 3.4500000000000002 111.343 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 1.9 t -142.91 -171.38 3.44 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.838 -0.801 . . . . 1.6399999999999999 108.838 176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 22.0 t -59.68 151.16 5.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 109.642 -0.503 . . . . 2.1200000000000001 109.642 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.58 117.0 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 1.29 111.012 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 17.55 25.22 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.042 -0.599 . . . . 0.67000000000000004 112.859 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.561 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 78.7 m-85 -120.7 119.53 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.877 0.695 . . . . 0.87 112.877 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.911 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 21.4 mmt -84.26 171.94 12.29 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.807 -1.088 . . . . 2.7999999999999998 108.414 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 20.4 mtp180 -147.2 148.08 31.13 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.293 0.568 . . . . 3.7200000000000002 111.526 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 75.7 p -92.72 168.83 11.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.016 -0.993 . . . . 1.22 110.203 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.3 Cg_exo -59.28 -21.29 59.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.682 2.255 . . . . 1.23 112.764 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.58 41.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.116 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.21 25.17 6.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.545 -0.836 . . . . 0.47999999999999998 112.748 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 74.1 mtp180 -87.16 121.55 29.77 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.309 -0.156 . . . . 4.4900000000000002 110.725 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 13' ' ' ARG . 62.4 m -88.0 134.74 33.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.09 0.471 . . . . 0.80000000000000004 110.206 174.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -160.57 160.24 25.75 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.891 -0.781 . . . . 2.98 108.891 174.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.91 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 23.5 Cg_exo -34.34 146.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.11 3.207 . . . . 0.91000000000000003 113.23 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.911 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p -59.04 -29.99 67.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 1.3500000000000001 110.929 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -90.06 -155.86 0.39 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 1.51 109.337 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' HB2' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -79.45 126.09 30.4 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.075 0.464 . . . . 4.6399999999999997 110.167 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.91 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -63.8 -63.41 1.17 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.384 0.611 . . . . 7.4699999999999998 109.382 -178.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -161.15 -55.65 0.05 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.899 -1.519 . . . . 4.3600000000000003 106.899 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 pt -93.09 55.87 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.465 -1.243 . . . . 7.1200000000000001 109.238 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.565 ' HA ' ' HB2' ' A' ' 24' ' ' TYR . 70.2 p . . . . . 0 C--O 1.244 0.806 0 CA-C-N 114.561 -1.2 . . . . 7.2300000000000004 112.446 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.801 0.334 . . . . 12.08 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -140.73 173.02 11.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.245 -0.65 . . . . 9.8599999999999994 109.245 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -115.74 146.18 42.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.877 0.37 . . . . 9.6799999999999997 110.685 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.86 122.44 24.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.075 -0.511 . . . . 7.25 111.036 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -115.69 54.41 0.58 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.965 -0.636 . . . . 4.9400000000000004 112.079 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 -28.49 67.39 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.921 -0.657 . . . . 3.4500000000000002 111.702 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 t -142.45 -92.3 0.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.366 -0.605 . . . . 1.6399999999999999 109.366 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.683 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 17.6 t -92.5 162.69 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.34 -0.985 . . . . 2.1200000000000001 108.34 169.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.45 109.46 1.02 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.79 0.328 . . . . 1.29 110.616 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.18 4.64 38.24 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.67000000000000004 111.832 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.2 m-85 -124.28 121.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.097 0.475 . . . . 0.87 111.043 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -100.07 -179.72 4.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.295 -1.002 . . . . 2.7999999999999998 108.295 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 21.0 mmm-85 -124.93 139.83 53.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.162 0.506 . . . . 3.7200000000000002 111.403 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.412 ' HG1' ' CG ' ' A' ' 16' ' ' ASP . 32.3 p -79.18 168.47 26.58 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.089 -0.959 . . . . 1.22 109.644 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.38 -28.73 88.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.137 1.891 . . . . 1.23 111.336 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.482 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 3.0 p-10 -83.82 -5.27 59.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.255 -0.884 . . . . 1.95 111.355 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 36.04 7.94 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.636 -0.792 . . . . 0.47999999999999998 114.416 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.0 mtp180 -93.99 139.39 31.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.522 0.661 . . . . 4.4900000000000002 111.397 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -87.52 96.14 10.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.877 -0.786 . . . . 0.80000000000000004 108.877 171.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -130.7 161.43 61.13 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.653 -0.499 . . . . 2.98 109.653 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.8 Cg_exo -33.87 147.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.619 3.546 . . . . 0.91000000000000003 114.257 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -56.01 -32.48 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.629 0.728 . . . . 1.3500000000000001 110.384 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 27.1 p90 -94.35 -170.12 2.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.029 -0.987 . . . . 1.51 110.073 175.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.502 ' O ' ' HD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -78.36 148.99 33.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.042 -0.527 . . . . 4.6399999999999997 110.227 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -71.22 43.11 0.08 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.846 -0.616 . . . . 7.4699999999999998 112.013 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 24' ' ' TYR . 5.1 tt -112.41 97.02 6.33 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.209 -1.034 . . . . 4.3600000000000003 108.209 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.97 133.47 29.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.865 -0.607 . . . . 7.1200000000000001 110.907 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.581 -0.723 . . . . 7.2300000000000004 110.017 175.78 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.818 0.342 . . . . 12.08 111.31 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -101.78 115.0 29.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.639 -0.71 . . . . 9.8599999999999994 109.183 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -84.12 153.33 23.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.421 . . . . 9.6799999999999997 111.541 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -90.51 20.32 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.782 -0.645 . . . . 7.25 110.392 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.42 38.89 3.15 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.929 -0.653 . . . . 4.9400000000000004 113.004 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.65 -54.91 2.93 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.178 -0.534 . . . . 3.4500000000000002 113.278 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -131.23 -177.38 4.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 122.57 0.348 . . . . 1.6399999999999999 110.627 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m -86.4 -175.68 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 121.318 0.58 . . . . 2.1200000000000001 112.49 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.3 128.96 37.97 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.412 -0.813 . . . . 1.29 111.666 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 6.15 58.21 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.063 -0.971 . . . . 0.67000000000000004 111.759 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 84.8 m-85 -121.52 139.66 53.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.515 0.674 . . . . 0.87 112.732 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.607 ' HG2' HG23 ' A' ' 22' ' ' THR . 93.3 mmm -129.47 142.94 50.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.667 -1.151 . . . . 2.7999999999999998 108.682 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.601 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -97.36 138.62 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.002 0.429 . . . . 3.7200000000000002 109.909 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.5 p -79.09 -175.93 0.64 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.675 -0.693 . . . . 1.22 110.208 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 63.9 Cg_exo -55.86 -15.88 14.35 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.317 2.011 . . . . 1.23 112.915 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.81 4.64 40.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 1.95 110.738 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.45 24.38 75.13 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.143 -0.551 . . . . 0.47999999999999998 113.022 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 92.5 mtt180 -91.68 116.24 28.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.618 -0.512 . . . . 4.4900000000000002 109.618 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.601 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 30.6 p -88.31 100.5 13.06 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.239 1.019 . . . . 0.80000000000000004 111.398 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.735 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -108.41 175.07 2.12 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 113.678 -1.601 . . . . 2.98 107.246 171.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -43.03 152.78 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.248 2.632 . . . . 0.91000000000000003 113.307 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.607 HG23 ' HG2' ' A' ' 12' ' ' MET . 6.1 p -57.82 -37.95 74.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.489 0.662 . . . . 1.3500000000000001 110.221 174.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 21.6 p90 -88.08 -159.35 0.53 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.061 . . . . 1.51 110.195 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.553 ' O ' ' HD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -77.54 147.43 35.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.357 -0.537 . . . . 4.6399999999999997 109.873 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -59.58 112.15 1.68 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.932 0.396 . . . . 7.4699999999999998 110.883 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -107.71 106.43 16.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.857 -0.794 . . . . 4.3600000000000003 108.857 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.96 148.68 5.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.911 -0.586 . . . . 7.1200000000000001 110.102 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.391 -0.814 . . . . 7.2300000000000004 110.44 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.773 0.32 . . . . 12.08 110.584 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.29 153.44 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.305 -0.407 . . . . 9.8599999999999994 110.524 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -129.42 176.78 7.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.804 -0.635 . . . . 9.6799999999999997 109.612 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -78.63 -36.12 44.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 7.25 110.867 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.17 -39.27 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.663 -0.575 . . . . 4.9400000000000004 111.663 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.56 -44.82 1.92 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.865 -0.683 . . . . 3.4500000000000002 112.703 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.785 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 17.1 t -100.24 -156.05 0.54 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.695 -0.483 . . . . 1.6399999999999999 109.695 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t -64.75 154.66 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.62 -0.511 . . . . 2.1200000000000001 109.62 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.06 127.65 19.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.462 . . . . 1.29 111.116 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.21 7.27 60.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.67000000000000004 112.88 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.41 132.0 42.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.503 0.557 . . . . 0.87 112.503 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptp -104.03 -170.35 1.76 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.427 -1.323 . . . . 2.7999999999999998 107.427 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.785 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 2.3 mtp85 -143.1 150.92 40.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.124 -0.63 . . . . 3.7200000000000002 112.381 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.762 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 38.1 p -82.34 171.68 11.32 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.25 -0.886 . . . . 1.22 109.616 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.762 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -55.75 -26.11 54.93 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.903 2.402 . . . . 1.23 112.491 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.54 -24.48 42.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 1.95 110.669 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.22 8.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.377 -0.916 . . . . 0.47999999999999998 112.949 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.7 mpt_? -80.48 129.87 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.541 -0.388 . . . . 4.4900000000000002 110.559 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.0 m -78.52 90.77 4.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.904 0.859 . . . . 0.80000000000000004 110.289 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -103.45 135.33 19.4 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 113.627 -1.624 . . . . 2.98 108.047 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -43.03 152.28 0.22 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.162 2.575 . . . . 0.91000000000000003 113.781 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -57.77 -31.31 66.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.511 0.672 . . . . 1.3500000000000001 110.359 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -98.76 -177.6 3.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 1.51 110.622 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 2.6 p90 -79.04 135.17 36.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.344 -0.389 . . . . 4.6399999999999997 110.158 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -56.62 114.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.095 -0.502 . . . . 7.4699999999999998 110.427 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -126.91 149.7 49.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.173 -0.467 . . . . 4.3600000000000003 110.244 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.494 ' C ' ' HG1' ' A' ' 28' ' ' THR . 43.2 mt -115.73 -77.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.532 -0.914 . . . . 7.1200000000000001 108.532 176.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HG1' ' C ' ' A' ' 27' ' ' ILE . 3.5 m . . . . . 0 C--O 1.245 0.848 0 N-CA-C 108.493 -0.929 . . . . 7.2300000000000004 108.493 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.608 -0.516 . . . . 12.08 109.608 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.41 -28.19 21.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.451 -0.944 . . . . 9.8599999999999994 108.451 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -89.9 166.48 13.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.035 -0.984 . . . . 9.6799999999999997 109.004 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.1 p -74.17 -64.26 1.05 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.17 0.509 . . . . 7.25 110.655 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.93 122.72 0.74 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.778 -0.725 . . . . 4.9400000000000004 111.851 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.77 -47.36 3.78 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.712 -0.756 . . . . 3.4500000000000002 111.602 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m -126.15 164.29 21.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.064 -0.347 . . . . 1.6399999999999999 110.064 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.15 156.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.825 0.345 . . . . 2.1200000000000001 110.784 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.05 122.38 14.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.37 0.605 . . . . 1.29 110.548 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.97 12.34 27.94 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.508 -0.769 . . . . 0.67000000000000004 111.401 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.35 125.13 42.98 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.346 0.593 . . . . 0.87 111.794 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ptp -90.62 171.91 9.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.963 -1.017 . . . . 2.7999999999999998 108.711 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -138.16 148.45 44.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.275 0.559 . . . . 3.7200000000000002 112.1 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.781 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.7 p -84.76 173.66 6.87 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.068 -0.969 . . . . 1.22 109.896 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.781 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 22.3 Cg_endo -61.1 -12.29 22.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.571 2.181 . . . . 1.23 112.311 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.35 -21.64 45.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.913 -0.585 . . . . 1.95 109.954 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.45 27.14 33.67 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.031 -0.828 . . . . 0.47999999999999998 111.031 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.8 134.9 38.2 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.792 -0.448 . . . . 4.4900000000000002 109.792 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.3 m -80.79 130.78 35.25 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.774 0.671 . . . . 0.80000000000000004 111.424 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.83 151.91 66.83 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.073 -1.084 . . . . 2.98 108.073 171.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HD2' ' HG2' ' A' ' 25' ' ' GLN . 76.2 Cg_exo -53.26 152.89 18.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 121.929 1.753 . . . . 0.91000000000000003 112.286 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.39 -38.38 83.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.638 0.733 . . . . 1.3500000000000001 110.332 175.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.744 ' HE2' ' HB2' ' A' ' 26' ' ' LEU . 30.1 p90 -93.16 -171.79 2.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.819 -1.082 . . . . 1.51 108.749 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -78.71 130.54 35.93 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.92 -0.312 . . . . 4.6399999999999997 110.774 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.623 ' HG2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 mt-30 -43.14 113.01 0.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.922 0.764 . . . . 7.4699999999999998 111.106 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.744 ' HB2' ' HE2' ' A' ' 23' ' ' PHE . 0.2 OUTLIER -90.53 107.08 18.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.713 -0.676 . . . . 4.3600000000000003 111.278 -168.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.16 -68.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.841 -0.618 . . . . 7.1200000000000001 109.739 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.245 -0.884 . . . . 7.2300000000000004 109.536 177.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.706 0.289 . . . . 12.08 110.744 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -101.86 -52.58 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 9.8599999999999994 110.681 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -79.21 12.27 2.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 9.6799999999999997 111.163 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.6 t -89.93 -8.61 51.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 7.25 109.923 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.35 64.43 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.838 -0.696 . . . . 4.9400000000000004 111.814 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.99 86.82 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.663 -0.779 . . . . 3.4500000000000002 112.199 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 13' ' ' ARG . 84.9 m -80.67 -179.24 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.948 0.404 . . . . 1.6399999999999999 110.655 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.748 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 t -71.02 168.51 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.06 -0.518 . . . . 2.1200000000000001 110.162 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.607 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -38.54 -66.9 0.23 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.731 1.011 . . . . 1.29 113.731 -171.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 49.49 1.49 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.131 -1.033 . . . . 0.67000000000000004 112.899 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.748 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 67.0 m-85 -125.03 118.66 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.735 0.779 . . . . 0.87 112.369 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.744 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 24.5 mmt -82.69 172.26 13.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.716 -1.129 . . . . 2.7999999999999998 108.831 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HG3' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -124.65 139.38 53.91 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.559 -0.457 . . . . 3.7200000000000002 110.151 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.832 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 35.8 p -79.22 176.89 3.27 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.516 -0.766 . . . . 1.22 109.703 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.832 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.0 Cg_endo -52.7 -29.83 43.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.434 2.089 . . . . 1.23 112.207 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 5.2 m-20 -79.74 -22.26 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.576 . . . . 1.95 110.921 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.33 13.74 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.363 -0.695 . . . . 0.47999999999999998 111.363 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -78.59 132.13 37.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.727 -0.842 . . . . 4.4900000000000002 108.727 174.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.89 102.93 11.99 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.598 -0.728 . . . . 0.80000000000000004 110.616 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -128.11 155.21 78.35 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 108.997 -0.742 . . . . 2.98 108.997 177.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 35.1 Cg_exo -31.48 144.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.813 3.675 . . . . 0.91000000000000003 113.751 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.744 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 3.5 p -56.33 -36.62 68.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.013 -0.736 . . . . 1.3500000000000001 109.013 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -85.46 -148.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.449 -1.25 . . . . 1.51 109.923 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -100.16 134.08 43.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.152 0.501 . . . . 4.6399999999999997 111.032 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 tp-100 -56.58 115.52 2.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.404 -0.817 . . . . 7.4699999999999998 110.778 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.14 156.04 30.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.981 -0.554 . . . . 4.3600000000000003 110.379 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.89 138.14 34.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.456 -0.338 . . . . 7.1200000000000001 110.289 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.722 -0.656 . . . . 7.2300000000000004 110.331 178.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.146 -0.316 . . . . 12.08 110.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -114.14 152.58 30.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 9.8599999999999994 110.147 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.28 157.63 28.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.24 -0.436 . . . . 9.6799999999999997 110.273 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 m -87.22 32.81 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.228 -0.442 . . . . 7.25 111.738 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.49 -45.63 1.03 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 4.9400000000000004 112.038 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.66 -47.52 0.7 Allowed Glycine 0 C--O 1.226 -0.361 0 N-CA-C 111.489 -0.644 . . . . 3.4500000000000002 111.489 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.557 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 8.1 t -117.13 -161.34 0.81 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.673 -0.862 . . . . 1.6399999999999999 108.673 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 11' ' ' TYR . 16.0 m -77.25 -172.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.866 0.365 . . . . 2.1200000000000001 111.305 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.11 108.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.414 -0.812 . . . . 1.29 112.421 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.26 34.33 26.49 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.767 -0.651 . . . . 0.67000000000000004 113.737 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 85.9 m-85 -134.01 121.7 21.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.763 0.653 . . . . 0.87 112.763 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -90.44 177.97 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.668 -1.234 . . . . 2.7999999999999998 107.668 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.557 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 13.1 mtp180 -143.71 155.55 44.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.325 0.861 . . . . 3.7200000000000002 113.325 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -95.54 166.57 14.38 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 114.318 -1.31 . . . . 1.22 110.039 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.07 -28.59 84.09 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.799 2.333 . . . . 1.23 112.606 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.675 ' OD1' ' HD3' ' A' ' 18' ' ' ARG . 2.3 p30 -79.57 -14.17 59.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.519 -0.764 . . . . 1.95 111.921 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.63 11.65 37.49 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.72 -0.753 . . . . 0.47999999999999998 113.868 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.675 ' HD3' ' OD1' ' A' ' 16' ' ' ASP . 11.4 mpt_? -79.89 142.42 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.355 0.577 . . . . 4.4900000000000002 110.36 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.5 m -100.12 117.5 34.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.308 0.575 . . . . 0.80000000000000004 110.933 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -113.06 153.58 45.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.748 -1.204 . . . . 2.98 107.748 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' PHE . 51.4 Cg_exo -56.69 163.53 6.98 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 121.691 1.594 . . . . 0.91000000000000003 112.305 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 2.22 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.844 -0.616 . . . . 1.3500000000000001 111.822 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HD2' ' H ' ' A' ' 25' ' ' GLN . 49.6 p90 -153.93 166.2 33.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.513 -0.921 . . . . 1.51 108.513 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -146.59 64.64 1.19 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.515 0.674 . . . . 4.6399999999999997 109.914 169.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.5 ' H ' ' HD2' ' A' ' 23' ' ' PHE . 38.3 mt-30 -90.63 103.18 15.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.447 -0.797 . . . . 7.4699999999999998 109.478 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.869 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -88.12 23.02 2.23 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.504 -0.771 . . . . 4.3600000000000003 110.316 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.15 112.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.223 -0.898 . . . . 7.1200000000000001 109.572 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.381 -0.819 . . . . 7.2300000000000004 110.755 -177.393 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.593 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 6.1 pt-20 . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.496 0.189 . . . . 12.08 110.952 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.593 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 48.0 t30 -93.66 121.79 35.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.045 -0.354 . . . . 9.8599999999999994 110.045 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -159.91 144.95 15.14 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.599 -0.889 . . . . 9.6799999999999997 108.599 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -70.21 91.57 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.241 -0.652 . . . . 7.25 109.241 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.5 -38.25 2.32 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.827 -0.702 . . . . 4.9400000000000004 111.866 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.78 -87.07 0.41 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.811 -0.709 . . . . 3.4500000000000002 112.09 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.513 ' SG ' ' HD3' ' A' ' 13' ' ' ARG . 75.5 m -92.03 173.48 7.82 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.162 -0.31 . . . . 1.6399999999999999 110.162 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 20.3 t -71.21 158.43 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.331 -0.395 . . . . 2.1200000000000001 110.512 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.45 126.24 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 1.29 110.947 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.08 3.5 48.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.793 -0.717 . . . . 0.67000000000000004 111.986 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.8 m-85 -118.27 119.64 35.25 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.288 0.566 . . . . 0.87 111.95 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.421 ' HE2' ' HB2' ' A' ' 12' ' ' MET . 4.6 ppp? -100.59 158.88 15.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.058 -1.46 . . . . 2.7999999999999998 107.058 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.513 ' HD3' ' SG ' ' A' ' 7' ' ' CYS . 55.2 mtm-85 -123.3 150.32 43.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.716 1.006 . . . . 3.7200000000000002 113.716 -164.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 25.4 p -89.79 170.24 10.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 114.356 -1.293 . . . . 1.22 111.204 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 16.5 Cg_exo -66.57 -13.84 41.55 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.008 2.472 . . . . 1.23 110.951 173.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.32 -25.05 42.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.577 -1.192 . . . . 1.95 110.13 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.82 28.57 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.613 -0.721 . . . . 0.47999999999999998 112.079 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -95.41 143.51 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.114 0.483 . . . . 4.4900000000000002 112.152 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -80.79 118.33 22.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.971 -1.013 . . . . 0.80000000000000004 109.935 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -132.53 159.77 71.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.741 -0.837 . . . . 2.98 108.741 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.29 160.31 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.208 1.939 . . . . 0.91000000000000003 112.025 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -51.94 -38.47 56.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.35 0.595 . . . . 1.3500000000000001 110.859 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -92.11 -172.38 3.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.661 -0.699 . . . . 1.51 110.468 174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -79.18 133.0 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 4.6399999999999997 110.826 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -65.3 110.78 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.488 -0.778 . . . . 7.4699999999999998 110.077 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.87 123.4 27.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 4.3600000000000003 109.849 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.75 25.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.417 0.627 . . . . 7.1200000000000001 110.837 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.494 -0.765 . . . . 7.2300000000000004 109.924 179.205 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.416 ' H3 ' ' CD ' ' A' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.826 0.346 . . . . 12.08 110.624 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -85.07 116.39 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.416 -0.587 . . . . 9.8599999999999994 109.416 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.69 159.99 20.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.931 0.396 . . . . 9.6799999999999997 111.438 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -74.17 83.29 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 7.25 110.633 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.12 -114.4 1.47 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.025 -0.83 . . . . 4.9400000000000004 111.025 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.38 58.27 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.461 -0.876 . . . . 3.4500000000000002 112.753 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.76 127.48 32.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.311 -0.625 . . . . 1.6399999999999999 109.311 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.682 HG23 ' H ' ' A' ' 9' ' ' ALA . 4.1 p -82.65 -179.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.151 -0.477 . . . . 2.1200000000000001 111.151 -169.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.682 ' H ' HG23 ' A' ' 8' ' ' VAL . . . -57.15 134.52 55.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.09 0.471 . . . . 1.29 111.264 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' HG22 ' A' ' 22' ' ' THR . . . 93.88 6.89 61.7 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.673 -0.775 . . . . 0.67000000000000004 111.77 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -128.92 118.08 22.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.385 0.513 . . . . 0.87 112.385 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.3 ptm -89.56 164.04 14.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.164 -1.05 . . . . 2.7999999999999998 108.164 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.82 147.9 43.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.139 -0.624 . . . . 3.7200000000000002 111.39 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.419 ' HG1' ' HB3' ' A' ' 16' ' ' ASP . 71.4 p -79.46 173.24 8.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.419 -0.81 . . . . 1.22 108.89 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.3 -14.28 33.41 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.057 1.838 . . . . 1.23 111.19 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' HB3' ' HG1' ' A' ' 14' ' ' THR . 12.1 t70 -90.95 -10.27 43.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 1.95 110.196 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.94 28.42 58.8 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.154 -0.778 . . . . 0.47999999999999998 111.154 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -79.7 127.03 31.69 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.41 -0.959 . . . . 4.4900000000000002 108.41 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 m -80.18 101.57 8.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.379 0.609 . . . . 0.80000000000000004 110.849 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HE3' ' HG3' ' A' ' 12' ' ' MET . 54.3 pttt -114.74 159.89 35.49 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 108.108 -1.071 . . . . 2.98 108.108 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.601 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.3 Cg_exo -54.46 172.95 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.259 1.972 . . . . 0.91000000000000003 113.034 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.511 HG22 ' HA2' ' A' ' 10' ' ' GLY . 2.9 p -56.55 -18.68 12.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.322 0.582 . . . . 1.3500000000000001 111.293 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -121.38 -171.89 2.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 1.51 109.473 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.512 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 2.0 p90 -78.33 130.51 36.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.891 0.377 . . . . 4.6399999999999997 110.133 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.69 101.42 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.904 -0.589 . . . . 7.4699999999999998 110.799 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.24 115.85 21.5 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.21 -0.663 . . . . 4.3600000000000003 109.21 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.14 -62.27 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.307 -0.406 . . . . 7.1200000000000001 110.71 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.744 -0.646 . . . . 7.2300000000000004 110.157 179.754 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.403 ' H3 ' ' CD ' ' A' ' 1' ' ' GLU . 6.0 mp0 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.795 0.331 . . . . 12.08 110.541 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -108.68 144.27 36.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 9.8599999999999994 110.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -131.11 15.41 5.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 9.6799999999999997 110.597 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -62.68 -46.98 85.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.615 -0.72 . . . . 7.25 111.232 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.59 66.21 0.49 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.95 -0.643 . . . . 4.9400000000000004 111.677 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.75 -93.97 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.801 -0.714 . . . . 3.4500000000000002 111.58 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.8 t -102.56 -104.21 0.27 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.228 -0.656 . . . . 1.6399999999999999 109.228 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.643 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 4.1 t -91.58 170.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.497 -0.927 . . . . 2.1200000000000001 108.497 170.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.487 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -61.76 106.13 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.057 0.456 . . . . 1.29 110.823 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.16 26.68 9.99 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.962 -0.637 . . . . 0.67000000000000004 112.52 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.643 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 58.1 m-85 -128.03 130.82 48.9 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.87 111.917 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.4 ptp -96.78 174.62 6.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.946 -1.025 . . . . 2.7999999999999998 108.778 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.6 mtp180 -133.5 143.43 48.78 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.989 0.424 . . . . 3.7200000000000002 110.42 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 21.9 p -79.78 170.32 16.43 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.728 -0.669 . . . . 1.22 109.244 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 21.4 Cg_endo -62.82 -7.09 10.42 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.547 2.164 . . . . 1.23 111.312 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.18 -18.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.475 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 19.52 39.79 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.562 . . . . 0.47999999999999998 112.606 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 79.7 ttt180 -93.83 130.08 39.98 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.353 -0.24 . . . . 4.4900000000000002 110.353 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -83.58 121.42 27.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.262 0.553 . . . . 0.80000000000000004 111.267 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HE2' HG23 ' A' ' 14' ' ' THR . 48.8 mtmt -124.08 160.63 51.28 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.111 -1.07 . . . . 2.98 108.111 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.78 169.06 1.41 Allowed 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.179 1.919 . . . . 0.91000000000000003 111.262 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -64.59 -17.5 64.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.5 0.667 . . . . 1.3500000000000001 110.107 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.67 ' CE1' ' HB2' ' A' ' 25' ' ' GLN . 23.5 p90 -117.65 178.01 4.55 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.776 -1.102 . . . . 1.51 109.322 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -79.19 -26.99 42.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.96 0.726 . . . . 4.6399999999999997 112.96 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.67 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 28.6 mt-30 -50.88 107.9 0.2 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.658 0.742 . . . . 7.4699999999999998 112.14 -168.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' O ' HD11 ' A' ' 26' ' ' LEU . 1.2 pp -87.12 146.8 25.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.471 -1.241 . . . . 4.3600000000000003 111.062 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.9 -52.52 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.187 0.518 . . . . 7.1200000000000001 109.699 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.598 -0.715 . . . . 7.2300000000000004 109.84 177.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.346 0.593 . . . . 12.08 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.0 -59.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.833 -0.622 . . . . 9.8599999999999994 110.368 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.93 -26.4 40.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 9.6799999999999997 110.038 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.0 m -78.92 103.36 8.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.43 -0.805 . . . . 7.25 110.768 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.41 -71.13 2.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.253 -0.498 . . . . 4.9400000000000004 112.636 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.08 -143.51 16.52 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.405 -0.678 . . . . 3.4500000000000002 111.405 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.803 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 2.8 t -114.78 -156.26 0.6 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.701 -0.481 . . . . 1.6399999999999999 109.701 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.595 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.2 t -64.57 151.94 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.638 -0.504 . . . . 2.1200000000000001 109.638 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.97 118.92 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 1.29 111.087 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.65 39.55 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.593 -0.813 . . . . 0.67000000000000004 112.132 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 72.8 m-85 -119.98 128.62 53.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 0.87 112.148 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.1 ptm -104.92 166.03 10.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.566 -1.272 . . . . 2.7999999999999998 107.566 175.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.803 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 14.1 mtp180 -135.75 160.78 37.49 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.04 -0.664 . . . . 3.7200000000000002 112.124 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 57.7 p -104.38 172.68 3.92 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.171 -0.922 . . . . 1.22 109.56 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 33.5 Cg_exo -59.32 -18.92 47.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.704 2.269 . . . . 1.23 112.888 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 3.9 m-20 -79.24 -10.07 59.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.753 -0.462 . . . . 1.95 109.753 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.16 22.47 54.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.157 -0.544 . . . . 0.47999999999999998 111.81 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 98.8 mtt180 -85.66 126.61 34.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.714 -0.243 . . . . 4.4900000000000002 110.738 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.6 m -93.19 117.19 29.78 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.723 0.64 . . . . 0.80000000000000004 111.044 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 31.7 pttt -130.28 167.42 20.94 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.182 -1.044 . . . . 2.98 108.182 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 23' ' ' PHE . 77.4 Cg_exo -50.89 163.06 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.019 1.813 . . . . 0.91000000000000003 111.783 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -67.71 27.98 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.638 0.607 . . . . 1.3500000000000001 112.638 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.56 ' H ' ' C ' ' A' ' 21' ' ' PRO . 24.9 p90 -157.68 -155.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.939 -0.763 . . . . 1.51 108.939 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.521 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -93.03 123.38 36.24 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.853 0.358 . . . . 4.6399999999999997 110.675 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 122.86 19.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.567 -0.531 . . . . 7.4699999999999998 109.567 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 26' ' ' LEU . 1.7 tm? -79.0 102.27 8.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.456 -0.572 . . . . 4.3600000000000003 109.456 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.74 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.607 -0.516 . . . . 7.1200000000000001 109.607 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.416 -0.802 . . . . 7.2300000000000004 110.177 179.576 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.731 -0.47 . . . . 12.08 109.731 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -92.41 -62.77 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.41 . . . . 9.8599999999999994 111.024 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -95.08 138.16 33.16 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.127 -0.488 . . . . 9.6799999999999997 110.021 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 p -82.29 -1.21 48.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 7.25 111.608 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.48 -62.36 4.33 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.88 -0.676 . . . . 4.9400000000000004 112.114 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.25 -167.57 25.71 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.786 -0.721 . . . . 3.4500000000000002 112.162 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.601 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 8.9 t -106.11 -155.11 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.06 -0.718 . . . . 1.6399999999999999 109.06 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 40.5 t -60.61 145.32 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.154 -0.684 . . . . 2.1200000000000001 109.154 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.74 117.13 4.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.842 0.353 . . . . 1.29 110.931 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 18.47 20.56 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.963 -0.637 . . . . 0.67000000000000004 111.85 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 69.0 m-85 -128.92 124.46 35.22 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.806 0.813 . . . . 0.87 112.079 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.415 ' C ' ' HD3' ' A' ' 13' ' ' ARG . 26.1 ptm -90.73 164.3 14.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.652 -1.158 . . . . 2.7999999999999998 108.832 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.601 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -125.32 141.0 52.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.336 -0.546 . . . . 3.7200000000000002 110.935 -176.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 p -79.32 176.73 3.43 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.379 -0.828 . . . . 1.22 110.332 175.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 14.7 Cg_endo -57.1 -19.15 31.99 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.884 2.389 . . . . 1.23 113.169 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 24.0 p30 -104.7 3.34 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.861 0.363 . . . . 1.95 111.082 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.78 37.35 34.31 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.47999999999999998 113.556 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 24.4 mmt180 -90.12 136.66 32.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.366 -0.605 . . . . 4.4900000000000002 109.366 171.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.7 m -91.87 129.29 37.86 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.989 -0.55 . . . . 0.80000000000000004 111.487 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -147.27 156.56 46.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.503 -0.925 . . . . 2.98 108.503 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 6.4 Cg_exo -38.5 145.86 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.623 2.882 . . . . 0.91000000000000003 113.32 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.64 6.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.635 0.731 . . . . 1.3500000000000001 111.106 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.61 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 54.6 p90 -150.27 -179.52 7.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.771 -1.104 . . . . 1.51 108.033 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -159.07 67.97 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.633 0.73 . . . . 4.6399999999999997 109.612 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 14.8 mm100 -85.85 -25.81 26.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.911 -1.041 . . . . 7.4699999999999998 109.814 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 26' ' ' LEU . 1.5 pp -82.6 114.14 20.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.363 -0.835 . . . . 4.3600000000000003 110.945 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.78 13.51 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 7.1200000000000001 109.659 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.246 0.903 0 CA-C-N 114.715 -1.13 . . . . 7.2300000000000004 109.593 -179.35 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.816 -0.438 . . . . 12.08 109.816 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -129.4 134.6 47.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 9.8599999999999994 110.314 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -103.98 124.94 49.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.921 -0.581 . . . . 9.6799999999999997 110.594 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m -65.35 -57.44 8.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 7.25 110.083 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.84 20.06 4.12 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.683 -0.77 . . . . 4.9400000000000004 111.204 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.83 6.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.91 -0.662 . . . . 3.4500000000000002 111.782 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.881 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 7.7 t -125.0 -153.99 0.59 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.409 -0.589 . . . . 1.6399999999999999 109.409 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 15.3 t -64.52 158.2 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.946 -0.39 . . . . 2.1200000000000001 109.946 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 113.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.942 0.401 . . . . 1.29 111.456 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.95 12.83 19.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.03 -0.605 . . . . 0.67000000000000004 111.659 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 97.6 m-85 -129.75 143.15 50.68 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.406 0.622 . . . . 0.87 112.376 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 12' ' ' MET . 4.4 ppp? -122.35 165.61 16.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.486 -1.234 . . . . 2.7999999999999998 107.758 171.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.881 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 12.8 mtp85 -131.37 151.84 51.16 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.833 0.679 . . . . 3.7200000000000002 112.833 -171.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.823 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.9 p -79.78 176.62 3.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.93 -1.032 . . . . 1.22 110.045 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.823 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.1 Cg_endo -54.21 -22.33 25.61 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.707 2.272 . . . . 1.23 112.161 172.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 -35.11 46.47 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.926 -0.579 . . . . 1.95 109.824 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.78 15.93 15.41 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.54 -0.754 . . . . 0.47999999999999998 111.504 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 72.0 mtp180 -79.55 130.24 35.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.957 -0.386 . . . . 4.4900000000000002 109.957 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.83 107.41 18.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.291 0.567 . . . . 0.80000000000000004 111.934 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -104.33 157.06 34.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.444 -0.947 . . . . 2.98 108.444 171.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -57.08 150.42 56.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 121.789 1.659 . . . . 0.91000000000000003 111.964 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -52.18 -50.15 62.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.647 -0.706 . . . . 1.3500000000000001 110.557 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.506 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 2.8 p90 -97.0 175.73 6.22 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.059 -0.973 . . . . 1.51 109.399 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -79.61 120.32 23.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.654 -0.498 . . . . 4.6399999999999997 109.654 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -61.57 111.34 1.78 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 7.4699999999999998 110.969 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tt -83.7 102.66 12.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.862 -0.792 . . . . 4.3600000000000003 108.862 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.7 pt -95.08 -25.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 7.1200000000000001 111.738 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.442 -0.79 . . . . 7.2300000000000004 110.174 -179.762 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.764 0.316 . . . . 12.08 110.784 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -86.5 90.46 8.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.21 0.529 . . . . 9.8599999999999994 110.722 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -114.55 11.97 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.634 0.731 . . . . 9.6799999999999997 109.383 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.63 93.0 3.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.177 -0.92 . . . . 7.25 109.904 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.19 -20.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.173 -0.922 . . . . 4.9400000000000004 111.412 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.26 78.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.093 -0.803 . . . . 3.4500000000000002 111.093 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -97.93 -162.16 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.522 -0.918 . . . . 1.6399999999999999 108.522 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 11' ' ' TYR . 14.7 m -69.78 156.91 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.433 -0.507 . . . . 2.1200000000000001 110.304 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.77 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.202 0.525 . . . . 1.29 111.909 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.99 36.2 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.326 -0.852 . . . . 0.67000000000000004 112.211 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.641 ' CD1' HG22 ' A' ' 8' ' ' VAL . 18.8 m-85 -127.24 146.54 50.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.536 0.684 . . . . 0.87 112.765 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.569 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.4 ppp? -114.48 168.65 9.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.864 -1.062 . . . . 2.7999999999999998 108.927 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -133.91 146.13 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.402 -0.519 . . . . 3.7200000000000002 110.932 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.3 p -79.87 178.73 2.17 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.9 -0.591 . . . . 1.22 109.477 173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 19.4 Cg_endo -58.42 -19.52 44.12 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.016 1.811 . . . . 1.23 111.948 173.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.764 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -79.23 -22.24 45.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.072 177.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.18 33.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.807 -0.711 . . . . 0.47999999999999998 111.488 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.764 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 81.1 mtp180 -86.03 125.16 33.21 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.361 -0.607 . . . . 4.4900000000000002 109.361 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.47 115.65 25.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.21 -0.45 . . . . 0.80000000000000004 112.063 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.79 ' HE2' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -113.13 157.53 40.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.659 -1.237 . . . . 2.98 107.659 167.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.02 173.91 1.59 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.866 1.711 . . . . 0.91000000000000003 111.891 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -62.74 -12.67 25.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 1.3500000000000001 111.03 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 37.2 p90 -139.78 171.41 14.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.548 -0.751 . . . . 1.51 109.04 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.75 41.32 0.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.801 0.81 . . . . 4.6399999999999997 109.37 167.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.47 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 15.4 mm100 -90.3 105.9 18.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.796 -1.093 . . . . 7.4699999999999998 110.104 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 pp -129.14 128.05 42.66 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.151 0.5 . . . . 4.3600000000000003 110.042 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.4 mt -106.91 -29.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.165 -0.68 . . . . 7.1200000000000001 109.165 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.243 0.732 0 CA-C-N 115.61 -0.723 . . . . 7.2300000000000004 109.815 176.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.849 0.357 . . . . 12.08 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -99.82 72.03 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 9.8599999999999994 110.883 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -159.81 135.33 8.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.811 -0.811 . . . . 9.6799999999999997 108.811 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 t -88.7 -46.79 8.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 7.25 111.14 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.88 -88.18 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.62 -0.8 . . . . 4.9400000000000004 112.241 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.7 -50.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.993 -0.622 . . . . 3.4500000000000002 111.885 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.4 m -128.42 -169.69 2.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.343 -0.614 . . . . 1.6399999999999999 109.343 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.08 157.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.234 -0.654 . . . . 2.1200000000000001 109.234 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.35 133.68 55.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.311 . . . . 1.29 111.301 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 1.41 63.36 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.769 -0.729 . . . . 0.67000000000000004 111.302 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.97 123.02 39.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.414 0.626 . . . . 0.87 111.743 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -108.72 165.02 11.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.188 -1.041 . . . . 2.7999999999999998 108.188 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -112.54 148.49 34.4 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.392 -0.523 . . . . 3.7200000000000002 111.774 -171.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.7 p -79.46 174.02 6.78 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.413 -0.812 . . . . 1.22 108.875 170.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 53.1 Cg_exo -55.81 -21.31 32.27 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.12 1.88 . . . . 1.23 112.405 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -22.3 37.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 1.95 110.421 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.76 26.94 11.97 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.47999999999999998 112.022 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 77.1 mtp180 -79.07 127.32 31.85 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.094 -0.335 . . . . 4.4900000000000002 110.094 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -79.17 95.13 5.52 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 123.824 0.702 . . . . 0.80000000000000004 110.154 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.49 165.38 14.53 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.041 -1.096 . . . . 2.98 108.041 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 161.29 2.94 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.926 1.751 . . . . 0.91000000000000003 111.791 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 p -54.56 -41.02 69.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 110.155 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 34.0 p90 -92.18 -173.6 3.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.3 -0.863 . . . . 1.51 109.868 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' O ' ' HD1' ' A' ' 23' ' ' PHE . 13.4 p90 -79.91 130.93 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.708 -0.478 . . . . 4.6399999999999997 109.708 178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -61.11 116.97 4.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.14 0.495 . . . . 7.4699999999999998 110.99 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 26' ' ' LEU . 2.7 pp -81.5 135.45 35.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.58 -0.736 . . . . 4.3600000000000003 110.369 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.63 -54.34 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.14 -0.482 . . . . 7.1200000000000001 110.715 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.462 -0.78 . . . . 7.2300000000000004 109.886 177.287 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 110.096 -0.335 . . . . 12.08 110.096 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -114.85 -70.41 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 9.8599999999999994 110.487 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -102.23 -2.83 28.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.221 0.534 . . . . 9.6799999999999997 110.266 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -76.01 -13.23 60.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 7.25 110.73 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 98.73 0.14 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.256 -0.973 . . . . 4.9400000000000004 112.579 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.14 -74.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.576 -1.01 . . . . 3.4500000000000002 110.576 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.633 ' SG ' ' HG2' ' A' ' 13' ' ' ARG . 3.4 m -127.53 126.47 42.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.199 -0.667 . . . . 1.6399999999999999 109.199 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.67 HG11 ' H ' ' A' ' 9' ' ' ALA . 2.1 t -83.4 -179.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 2.1200000000000001 110.494 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.67 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -57.07 130.28 45.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 110.031 -0.359 . . . . 1.29 110.031 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.51 7.91 44.53 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.619 -0.8 . . . . 0.67000000000000004 112.023 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -122.27 131.85 54.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.187 0.81 . . . . 0.87 113.187 176.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.792 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 85.5 mmm -83.51 148.9 26.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.776 -1.194 . . . . 2.7999999999999998 107.776 166.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.633 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 18.6 mtm-85 -129.67 139.87 51.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.524 0.678 . . . . 3.7200000000000002 111.551 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -92.58 168.46 12.53 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.101 -0.954 . . . . 1.22 110.042 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.95 -28.21 48.36 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.798 2.332 . . . . 1.23 113.251 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -82.21 -10.1 59.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.759 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.74 55.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.77 -0.729 . . . . 0.47999999999999998 112.609 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -79.71 149.55 31.15 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.761 0.315 . . . . 4.4900000000000002 110.632 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -105.38 135.61 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.80000000000000004 111.735 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -139.7 143.85 36.71 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 108.237 -1.023 . . . . 2.98 108.237 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.475 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 3.2 Cg_endo -49.7 145.38 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.135 1.89 . . . . 0.91000000000000003 111.879 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.792 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.4 p -64.29 -19.87 65.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.816 . . . . 1.3500000000000001 109.991 174.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.527 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 38.8 p90 -119.88 -169.77 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.596 -1.183 . . . . 1.51 109.289 176.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -159.88 76.99 0.66 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.459 -0.571 . . . . 4.6399999999999997 109.459 163.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.527 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 7.4 tt0 -90.8 85.47 6.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.581 -0.736 . . . . 7.4699999999999998 109.016 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -89.38 168.07 12.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.179 -0.464 . . . . 4.3600000000000003 109.77 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 27' ' ' ILE . 4.5 mp -119.83 142.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.101 -0.333 . . . . 7.1200000000000001 110.101 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.222 -0.894 . . . . 7.2300000000000004 110.82 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.59 0.233 . . . . 12.08 110.557 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -88.42 140.13 29.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 9.8599999999999994 110.502 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 23.86 5.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 9.6799999999999997 110.515 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.1 p -60.06 -45.08 94.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 7.25 111.634 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.66 40.96 0.59 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.323 -0.711 . . . . 4.9400000000000004 111.323 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.97 83.21 0.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.087 -0.577 . . . . 3.4500000000000002 112.354 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.81 177.04 9.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.053 -0.351 . . . . 1.6399999999999999 110.053 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 11.4 t -72.53 158.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 2.1200000000000001 110.643 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.29 55.96 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.875 0.369 . . . . 1.29 110.664 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.31 12.04 61.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.721 -0.752 . . . . 0.67000000000000004 111.722 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.447 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.6 m-85 -124.81 135.24 52.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.445 0.641 . . . . 0.87 112.193 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.92 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 91.1 mmm -101.65 -179.66 4.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.686 -1.143 . . . . 2.7999999999999998 108.639 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -129.69 143.89 51.03 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.807 -0.357 . . . . 3.7200000000000002 110.24 174.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.833 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.6 p -79.48 176.18 4.0 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.29 -0.868 . . . . 1.22 109.633 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.833 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.1 Cg_endo -55.5 -25.98 51.88 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.757 2.304 . . . . 1.23 112.833 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 7.7 p-10 -95.6 -3.59 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.242 -0.435 . . . . 1.95 111.127 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 32.52 12.61 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.072 -0.585 . . . . 0.47999999999999998 113.863 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.6 mtp180 -82.73 130.43 35.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.182 0.491 . . . . 4.4900000000000002 109.777 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -79.03 86.6 4.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.313 0.578 . . . . 0.80000000000000004 110.298 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -95.45 163.01 22.61 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 108.901 -0.777 . . . . 2.98 108.901 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.536 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 14.9 Cg_exo -40.52 151.43 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.843 2.362 . . . . 0.91000000000000003 112.274 167.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.92 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 5.9 t -64.1 -17.99 63.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.812 0.815 . . . . 1.3500000000000001 109.336 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HE1' HD21 ' A' ' 26' ' ' LEU . 24.0 p90 -106.63 -163.42 0.92 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.677 -1.147 . . . . 1.51 109.192 170.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -77.3 138.82 39.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.063 0.459 . . . . 4.6399999999999997 110.468 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 7.8 tt0 -66.72 102.07 0.88 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.563 -0.455 . . . . 7.4699999999999998 109.833 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' HE1' ' A' ' 23' ' ' PHE . 1.6 pt? -87.2 129.12 35.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.285 0.564 . . . . 4.3600000000000003 110.137 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -109.69 -50.39 6.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.088 -0.708 . . . . 7.1200000000000001 109.088 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.248 0.977 0 CA-C-N 115.232 -0.895 . . . . 7.2300000000000004 109.113 173.039 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.634 0.254 . . . . 12.08 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -143.18 -59.31 0.42 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.53 -0.305 . . . . 9.8599999999999994 111.381 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.95 2.24 24.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.892 0.377 . . . . 9.6799999999999997 111.845 -174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.7 p -86.34 -22.55 26.64 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.184 0.516 . . . . 7.25 109.726 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.98 95.64 0.14 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.38 -0.827 . . . . 4.9400000000000004 111.175 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.15 40.86 2.72 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.03 -0.605 . . . . 3.4500000000000002 113.166 -176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -153.29 -162.19 1.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.92 -0.77 . . . . 1.6399999999999999 108.92 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.5 t -63.93 152.83 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.063 -0.347 . . . . 2.1200000000000001 110.063 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.53 113.95 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.462 . . . . 1.29 111.375 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.19 18.6 19.03 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 0.67000000000000004 112.38 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.503 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 92.0 m-85 -127.82 130.69 49.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.87 112.37 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.473 ' HE1' ' O ' ' A' ' 21' ' ' PRO . 19.2 ptt? -103.34 162.81 12.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.689 -1.141 . . . . 2.7999999999999998 108.215 172.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.91 154.14 44.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.483 -0.487 . . . . 3.7200000000000002 112.188 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.2 p -85.59 176.54 3.55 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.346 -0.843 . . . . 1.22 109.824 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 50.6 Cg_exo -55.55 -31.04 77.09 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.364 2.043 . . . . 1.23 111.893 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 -31.4 39.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.692 -0.686 . . . . 1.95 110.622 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.73 22.16 6.46 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.526 -0.845 . . . . 0.47999999999999998 112.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -79.76 129.93 34.9 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.513 -0.551 . . . . 4.4900000000000002 109.513 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -91.52 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.416 0.627 . . . . 0.80000000000000004 111.993 -173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -111.01 147.12 35.89 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.034 -0.985 . . . . 2.98 108.912 173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 7.1 Cg_exo -41.12 142.09 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.3 2.667 . . . . 0.91000000000000003 112.774 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -63.24 -22.66 67.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.589 0.709 . . . . 1.3500000000000001 110.405 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 52.9 p90 -114.74 -177.63 3.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.872 -1.058 . . . . 1.51 109.42 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -157.89 31.42 0.26 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 4.6399999999999997 110.038 170.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -73.22 76.54 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.447 -0.797 . . . . 7.4699999999999998 109.513 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.9 95.75 8.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 4.3600000000000003 110.055 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 28' ' ' THR . 28.3 pt -81.62 -49.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 7.1200000000000001 110.31 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.489 ' N ' HG13 ' A' ' 27' ' ' ILE . 50.7 m . . . . . 0 C--O 1.244 0.809 0 N-CA-C 108.737 -0.838 . . . . 7.2300000000000004 108.737 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 111.564 0.209 . . . . 12.08 111.564 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.54 100.63 10.9 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.547 -0.538 . . . . 9.8599999999999994 109.547 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -83.56 -41.35 18.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.431 . . . . 9.6799999999999997 111.101 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.7 p -81.12 -15.26 56.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.269 0.557 . . . . 7.25 110.819 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.59 73.33 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.418 -0.81 . . . . 4.9400000000000004 111.273 -175.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . -130.22 -131.28 3.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.096 -0.573 . . . . 3.4500000000000002 112.477 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.772 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 7.7 t -116.66 -151.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.569 -0.53 . . . . 1.6399999999999999 109.569 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 11' ' ' TYR . 7.1 p -71.79 152.62 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.674 -0.491 . . . . 2.1200000000000001 109.674 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.64 119.96 2.39 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.102 0.778 . . . . 1.29 113.102 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.79 13.35 58.12 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.67000000000000004 113.004 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.511 ' CD1' HG13 ' A' ' 8' ' ' VAL . 15.9 m-85 -124.98 135.48 52.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.341 0.591 . . . . 0.87 112.128 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 82.9 mtp -99.02 176.56 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.024 . . . . 2.7999999999999998 108.815 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.772 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -135.19 140.11 45.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 3.7200000000000002 109.813 173.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.621 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.5 p -80.43 176.79 3.45 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.475 -0.784 . . . . 1.22 109.771 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.8 Cg_exo -50.52 -34.49 42.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.487 2.125 . . . . 1.23 113.45 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -79.95 -5.48 55.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.339 0.59 . . . . 1.95 111.047 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.54 32.63 30.18 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.978 -0.556 . . . . 0.47999999999999998 112.44 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 19.3 mmm180 -88.88 120.91 30.71 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.609 -0.348 . . . . 4.4900000000000002 110.411 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' MET . 86.1 m -80.03 128.42 33.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.879 -0.601 . . . . 0.80000000000000004 111.122 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 14.6 ptpt -153.0 160.84 30.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 2.98 109.102 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG2' ' O ' ' A' ' 24' ' ' TYR . 11.7 Cg_exo -39.17 149.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.621 2.88 . . . . 0.91000000000000003 113.267 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.644 ' HA ' ' HG3' ' A' ' 12' ' ' MET . 11.4 p -61.49 -6.37 2.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.111 0.481 . . . . 1.3500000000000001 112.282 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' HE2' ' HA ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -113.3 -88.9 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.565 . . . . 1.51 110.88 177.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.544 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -153.94 -89.68 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.014 0.435 . . . . 4.6399999999999997 110.967 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' H ' ' HD1' ' A' ' 24' ' ' TYR . 38.1 mt-30 -93.07 -79.3 0.4 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.776 -0.647 . . . . 7.4699999999999998 111.005 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' HA ' ' HE2' ' A' ' 23' ' ' PHE . 3.3 pp -154.58 163.61 39.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.533 -0.758 . . . . 4.3600000000000003 110.632 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 mm -127.09 -32.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 7.1200000000000001 109.982 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.194 -0.907 . . . . 7.2300000000000004 109.764 173.212 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.808 0.337 . . . . 12.08 110.201 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -133.94 102.4 5.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.177 -0.465 . . . . 9.8599999999999994 110.392 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -80.54 -28.09 37.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 9.6799999999999997 109.245 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -77.61 -35.44 52.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.563 -0.744 . . . . 7.25 110.992 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.07 2.04 38.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.862 -0.685 . . . . 4.9400000000000004 111.745 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.42 -38.08 1.97 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.684 -0.769 . . . . 3.4500000000000002 112.119 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.25 -179.19 6.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 1.6399999999999999 110.242 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.7 m -87.85 -178.22 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 121.249 0.547 . . . . 2.1200000000000001 111.856 -171.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.54 120.89 10.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.279 -0.873 . . . . 1.29 111.847 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 22' ' ' THR . . . 98.66 16.08 32.46 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.016 -0.993 . . . . 0.67000000000000004 112.102 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.97 114.62 17.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.525 0.935 . . . . 0.87 113.525 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.4 ' HE1' ' HB2' ' A' ' 12' ' ' MET . 5.0 ppp? -89.72 156.35 18.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.972 -1.122 . . . . 2.7999999999999998 107.972 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -132.78 140.5 48.05 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.565 -0.454 . . . . 3.7200000000000002 111.044 -171.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 45.6 p -86.58 168.97 16.32 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.919 -0.582 . . . . 1.22 109.952 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 44.9 Cg_exo -58.67 -19.7 47.04 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.558 2.172 . . . . 1.23 112.941 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.48 -12.12 59.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 1.95 110.834 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.5 30.72 26.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.055 -0.593 . . . . 0.47999999999999998 111.638 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -92.59 122.21 34.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 4.4900000000000002 109.709 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.7 m -91.05 107.68 19.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.572 0.701 . . . . 0.80000000000000004 111.272 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -108.84 163.47 16.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.79 -1.095 . . . . 2.98 108.525 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.559 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 87.1 Cg_exo -50.99 161.7 1.37 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.265 1.977 . . . . 0.91000000000000003 111.519 171.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 10' ' ' GLY . 0.7 OUTLIER -57.2 -23.19 46.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.307 0.575 . . . . 1.3500000000000001 110.496 175.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 36.1 p90 -115.44 169.09 9.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.08 -0.964 . . . . 1.51 109.709 171.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -78.63 141.14 38.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.098 -0.501 . . . . 4.6399999999999997 110.782 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.09 92.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.521 -0.763 . . . . 7.4699999999999998 110.181 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tt -97.29 124.16 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 4.3600000000000003 110.26 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 54.3 mt -98.07 -52.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 7.1200000000000001 109.779 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.1 -0.955 . . . . 7.2300000000000004 109.642 -178.846 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 22.0 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.642 -0.503 . . . . 1.46 109.642 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.58 117.0 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.83999999999999997 111.012 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 17.55 25.22 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.042 -0.599 . . . . 0.32000000000000001 112.859 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 78.7 m-85 -120.7 119.53 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.877 0.695 . . . . 0.48999999999999999 112.877 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.937 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 21.4 mmt -84.26 171.94 12.29 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.807 -1.088 . . . . 2.3599999999999999 108.414 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 20.4 mtp180 -147.2 148.08 31.13 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.293 0.568 . . . . 3.0 111.526 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 75.7 p -92.72 168.83 11.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.016 -0.993 . . . . 0.5 110.203 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.3 Cg_exo -59.28 -21.29 59.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.682 2.255 . . . . 0.79000000000000004 112.764 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.58 41.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.116 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.21 25.17 6.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.545 -0.836 . . . . 0.38 112.748 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 74.1 mtp180 -87.16 121.55 29.77 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.309 -0.156 . . . . 3.79 110.725 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 13' ' ' ARG . 62.4 m -88.0 134.74 33.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.09 0.471 . . . . 0.69999999999999996 110.206 174.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -160.57 160.24 25.75 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.891 -0.781 . . . . 2.5 108.891 174.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -34.34 146.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.11 3.207 . . . . 0.59999999999999998 113.23 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.937 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.929 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 17.6 t . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.34 -0.985 . . . . 1.46 108.34 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.45 109.46 1.02 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.79 0.328 . . . . 0.83999999999999997 110.616 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' C ' HG23 ' A' ' 22' ' ' THR . . . 106.18 4.64 38.24 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.32000000000000001 111.832 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.696 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.2 m-85 -124.28 121.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.097 0.475 . . . . 0.48999999999999999 111.043 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -100.07 -179.72 4.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.295 -1.002 . . . . 2.3599999999999999 108.295 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 21.0 mmm-85 -124.93 139.83 53.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.162 0.506 . . . . 3.0 111.403 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 p -79.18 168.47 26.58 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.089 -0.959 . . . . 0.5 109.644 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.38 -28.73 88.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.137 1.891 . . . . 0.79000000000000004 111.336 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 3.0 p-10 -83.82 -5.27 59.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.255 -0.884 . . . . 1.95 111.355 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 36.04 7.94 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.636 -0.792 . . . . 0.38 114.416 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.0 mtp180 -93.99 139.39 31.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.522 0.661 . . . . 3.79 111.397 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -87.52 96.14 10.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.877 -0.786 . . . . 0.69999999999999996 108.877 171.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -130.7 161.43 61.13 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.653 -0.499 . . . . 2.5 109.653 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.554 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.8 Cg_exo -33.87 147.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.619 3.546 . . . . 0.59999999999999998 114.257 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 10' ' ' GLY . 2.9 p . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.629 0.728 . . . . 1.0 110.384 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.236 0.395 0 CA-C-O 121.318 0.58 . . . . 1.46 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.3 128.96 37.97 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.412 -0.813 . . . . 0.83999999999999997 111.666 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 96.88 6.15 58.21 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.063 -0.971 . . . . 0.32000000000000001 111.759 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 84.8 m-85 -121.52 139.66 53.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.515 0.674 . . . . 0.48999999999999999 112.732 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.605 ' HG2' HG22 ' A' ' 22' ' ' THR . 93.3 mmm -129.47 142.94 50.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.667 -1.151 . . . . 2.3599999999999999 108.682 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.639 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -97.36 138.62 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.002 0.429 . . . . 3.0 109.909 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.74 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.5 p -79.09 -175.93 0.64 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.675 -0.693 . . . . 0.5 110.208 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.74 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 63.9 Cg_exo -55.86 -15.88 14.35 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.317 2.011 . . . . 0.79000000000000004 112.915 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.81 4.64 40.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 1.95 110.738 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.45 24.38 75.13 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.143 -0.551 . . . . 0.38 113.022 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 92.5 mtt180 -91.68 116.24 28.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.618 -0.512 . . . . 3.79 109.618 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 30.6 p -88.31 100.5 13.06 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.239 1.019 . . . . 0.69999999999999996 111.398 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.731 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -108.41 175.07 2.12 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 113.678 -1.601 . . . . 2.5 107.246 171.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -43.03 152.78 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.248 2.632 . . . . 0.59999999999999998 113.307 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.605 HG22 ' HG2' ' A' ' 12' ' ' MET . 6.1 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.489 0.662 . . . . 1.0 110.221 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.62 -0.511 . . . . 1.46 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.06 127.65 19.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.462 . . . . 0.83999999999999997 111.116 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.21 7.27 60.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.32000000000000001 112.88 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.41 132.0 42.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.503 0.557 . . . . 0.48999999999999999 112.503 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptp -104.03 -170.35 1.76 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.427 -1.323 . . . . 2.3599999999999999 107.427 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.3 mtp85 -143.1 150.92 40.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.124 -0.63 . . . . 3.0 112.381 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 38.1 p -82.34 171.68 11.32 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.25 -0.886 . . . . 0.5 109.616 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -55.75 -26.11 54.93 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.903 2.402 . . . . 0.79000000000000004 112.491 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.54 -24.48 42.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 1.95 110.669 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.22 8.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.377 -0.916 . . . . 0.38 112.949 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.7 mpt_? -80.48 129.87 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.541 -0.388 . . . . 3.79 110.559 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.0 m -78.52 90.77 4.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.904 0.859 . . . . 0.69999999999999996 110.289 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.45 135.33 19.4 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 113.627 -1.624 . . . . 2.5 108.047 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -43.03 152.28 0.22 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.162 2.575 . . . . 0.59999999999999998 113.781 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.325 -0.478 0 CA-C-O 121.511 0.672 . . . . 1.0 110.359 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.825 0.345 . . . . 1.46 110.784 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.05 122.38 14.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.37 0.605 . . . . 0.83999999999999997 110.548 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.97 12.34 27.94 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.508 -0.769 . . . . 0.32000000000000001 111.401 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.35 125.13 42.98 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.346 0.593 . . . . 0.48999999999999999 111.794 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ptp -90.62 171.91 9.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.963 -1.017 . . . . 2.3599999999999999 108.711 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -138.16 148.45 44.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.275 0.559 . . . . 3.0 112.1 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.793 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.7 p -84.76 173.66 6.87 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.068 -0.969 . . . . 0.5 109.896 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 22.3 Cg_endo -61.1 -12.29 22.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.571 2.181 . . . . 0.79000000000000004 112.311 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.35 -21.64 45.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.913 -0.585 . . . . 1.95 109.954 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.45 27.14 33.67 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.031 -0.828 . . . . 0.38 111.031 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.8 134.9 38.2 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.792 -0.448 . . . . 3.79 109.792 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.3 m -80.79 130.78 35.25 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.774 0.671 . . . . 0.69999999999999996 111.424 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.83 151.91 66.83 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.073 -1.084 . . . . 2.5 108.073 171.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.26 152.89 18.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 121.929 1.753 . . . . 0.59999999999999998 112.286 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.638 0.733 . . . . 1.0 110.332 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.759 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 110.162 -0.31 . . . . 1.46 110.162 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -38.54 -66.9 0.23 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.731 1.011 . . . . 0.83999999999999997 113.731 -171.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 49.49 1.49 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.131 -1.033 . . . . 0.32000000000000001 112.899 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.759 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 67.0 m-85 -125.03 118.66 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.735 0.779 . . . . 0.48999999999999999 112.369 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.777 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 24.5 mmt -82.69 172.26 13.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.716 -1.129 . . . . 2.3599999999999999 108.831 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -124.65 139.38 53.91 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.559 -0.457 . . . . 3.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.817 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 35.8 p -79.22 176.89 3.27 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.703 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.817 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.0 Cg_endo -52.7 -29.83 43.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.434 2.089 . . . . 0.79000000000000004 112.207 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 5.2 m-20 -79.74 -22.26 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.576 . . . . 1.95 110.921 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.33 13.74 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.363 -0.695 . . . . 0.38 111.363 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HD2' ' HB2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -78.59 132.13 37.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.727 -0.842 . . . . 3.79 108.727 174.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.89 102.93 11.99 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.598 -0.728 . . . . 0.69999999999999996 110.616 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -128.11 155.21 78.35 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 108.997 -0.742 . . . . 2.5 108.997 177.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 35.1 Cg_exo -31.48 144.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.813 3.675 . . . . 0.59999999999999998 113.751 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.777 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 3.5 p . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG23 ' CD2' ' A' ' 11' ' ' TYR . 16.0 m . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 120.866 0.365 . . . . 1.46 111.305 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.11 108.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.414 -0.812 . . . . 0.83999999999999997 112.421 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.26 34.33 26.49 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.767 -0.651 . . . . 0.32000000000000001 113.737 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 8' ' ' VAL . 85.9 m-85 -134.01 121.7 21.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.763 0.653 . . . . 0.48999999999999999 112.763 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -90.44 177.97 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.668 -1.234 . . . . 2.3599999999999999 107.668 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 13' ' ' ARG . 13.1 mtp180 -143.71 155.55 44.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.325 0.861 . . . . 3.0 113.325 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -95.54 166.57 14.38 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 114.318 -1.31 . . . . 0.5 110.039 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.07 -28.59 84.09 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.799 2.333 . . . . 0.79000000000000004 112.606 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.686 ' OD1' ' HD3' ' A' ' 18' ' ' ARG . 2.3 p30 -79.57 -14.17 59.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.519 -0.764 . . . . 1.95 111.921 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.63 11.65 37.49 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.72 -0.753 . . . . 0.38 113.868 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.686 ' HD3' ' OD1' ' A' ' 16' ' ' ASP . 11.4 mpt_? -79.89 142.42 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.355 0.577 . . . . 3.79 110.36 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.5 m -100.12 117.5 34.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.308 0.575 . . . . 0.69999999999999996 110.933 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -113.06 153.58 45.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.748 -1.204 . . . . 2.5 107.748 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.69 163.53 6.98 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 121.691 1.594 . . . . 0.59999999999999998 112.305 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 20.3 t . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.666 0.269 . . . . 1.46 110.512 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.45 126.24 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.83999999999999997 110.947 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.08 3.5 48.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.793 -0.717 . . . . 0.32000000000000001 111.986 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.8 m-85 -118.27 119.64 35.25 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.288 0.566 . . . . 0.48999999999999999 111.95 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.59 158.88 15.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.058 -1.46 . . . . 2.3599999999999999 107.058 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm-85 -123.3 150.32 43.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.716 1.006 . . . . 3.0 113.716 -164.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 25.4 p -89.79 170.24 10.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 114.356 -1.293 . . . . 0.5 111.204 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 16.5 Cg_exo -66.57 -13.84 41.55 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.008 2.472 . . . . 0.79000000000000004 110.951 173.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.32 -25.05 42.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.577 -1.192 . . . . 1.95 110.13 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.82 28.57 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.613 -0.721 . . . . 0.38 112.079 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -95.41 143.51 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.114 0.483 . . . . 3.79 112.152 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -80.79 118.33 22.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.971 -1.013 . . . . 0.69999999999999996 109.935 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -132.53 159.77 71.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.741 -0.837 . . . . 2.5 108.741 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.29 160.31 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.208 1.939 . . . . 0.59999999999999998 112.025 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.35 0.595 . . . . 1.0 110.859 172.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 9' ' ' ALA . 4.1 p . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.98 0.419 . . . . 1.46 111.151 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 8' ' ' VAL . . . -57.15 134.52 55.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.09 0.471 . . . . 0.83999999999999997 111.264 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 22' ' ' THR . . . 93.88 6.89 61.7 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 111.77 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -128.92 118.08 22.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.385 0.513 . . . . 0.48999999999999999 112.385 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.3 ptm -89.56 164.04 14.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.164 -1.05 . . . . 2.3599999999999999 108.164 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.82 147.9 43.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.139 -0.624 . . . . 3.0 111.39 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.4 p -79.46 173.24 8.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.419 -0.81 . . . . 0.5 108.89 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.8 Cg_exo -61.3 -14.28 33.41 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.057 1.838 . . . . 0.79000000000000004 111.19 170.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.95 -10.27 43.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 1.95 110.196 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.94 28.42 58.8 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.154 -0.778 . . . . 0.38 111.154 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -79.7 127.03 31.69 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.41 -0.959 . . . . 3.79 108.41 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 m -80.18 101.57 8.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.379 0.609 . . . . 0.69999999999999996 110.849 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HE3' ' HG3' ' A' ' 12' ' ' MET . 54.3 pttt -114.74 159.89 35.49 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 108.108 -1.071 . . . . 2.5 108.108 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.3 Cg_exo -54.46 172.95 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.259 1.972 . . . . 0.59999999999999998 113.034 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.528 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.9 p . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 121.322 0.582 . . . . 1.0 111.293 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.657 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 4.1 t . . . . . 0 C--O 1.233 0.207 0 N-CA-C 108.497 -0.927 . . . . 1.46 108.497 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.76 106.13 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.057 0.456 . . . . 0.83999999999999997 110.823 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.16 26.68 9.99 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.962 -0.637 . . . . 0.32000000000000001 112.52 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.657 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 58.1 m-85 -128.03 130.82 48.9 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.48999999999999999 111.917 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.4 ptp -96.78 174.62 6.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.946 -1.025 . . . . 2.3599999999999999 108.778 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.6 mtp180 -133.5 143.43 48.78 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.989 0.424 . . . . 3.0 110.42 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 21.9 p -79.78 170.32 16.43 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.728 -0.669 . . . . 0.5 109.244 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 21.4 Cg_endo -62.82 -7.09 10.42 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.547 2.164 . . . . 0.79000000000000004 111.312 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.18 -18.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.475 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 19.52 39.79 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.562 . . . . 0.38 112.606 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 79.7 ttt180 -93.83 130.08 39.98 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.353 -0.24 . . . . 3.79 110.353 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -83.58 121.42 27.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.262 0.553 . . . . 0.69999999999999996 111.267 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 14' ' ' THR . 48.8 mtmt -124.08 160.63 51.28 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.111 -1.07 . . . . 2.5 108.111 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.78 169.06 1.41 Allowed 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.179 1.919 . . . . 0.59999999999999998 111.262 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.5 0.667 . . . . 1.0 110.107 174.55 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.2 t . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 109.638 -0.504 . . . . 1.46 109.638 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.97 118.92 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.83999999999999997 111.087 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.65 39.55 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.593 -0.813 . . . . 0.32000000000000001 112.132 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 72.8 m-85 -119.98 128.62 53.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 0.48999999999999999 112.148 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.1 ptm -104.92 166.03 10.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.566 -1.272 . . . . 2.3599999999999999 107.566 175.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 14.1 mtp180 -135.75 160.78 37.49 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.04 -0.664 . . . . 3.0 112.124 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 57.7 p -104.38 172.68 3.92 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.171 -0.922 . . . . 0.5 109.56 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 33.5 Cg_exo -59.32 -18.92 47.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.704 2.269 . . . . 0.79000000000000004 112.888 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 3.9 m-20 -79.24 -10.07 59.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.753 -0.462 . . . . 1.95 109.753 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.16 22.47 54.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.157 -0.544 . . . . 0.38 111.81 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 98.8 mtt180 -85.66 126.61 34.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.714 -0.243 . . . . 3.79 110.738 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.6 m -93.19 117.19 29.78 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.723 0.64 . . . . 0.69999999999999996 111.044 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 31.7 pttt -130.28 167.42 20.94 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.182 -1.044 . . . . 2.5 108.182 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' A' ' 12' ' ' MET . 77.4 Cg_exo -50.89 163.06 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.019 1.813 . . . . 0.59999999999999998 111.783 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 177.144 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 40.5 t . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.154 -0.684 . . . . 1.46 109.154 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.74 117.13 4.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.931 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 18.47 20.56 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.963 -0.637 . . . . 0.32000000000000001 111.85 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 69.0 m-85 -128.92 124.46 35.22 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.806 0.813 . . . . 0.48999999999999999 112.079 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.418 ' C ' ' HD3' ' A' ' 13' ' ' ARG . 26.1 ptm -90.73 164.3 14.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.652 -1.158 . . . . 2.3599999999999999 108.832 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -125.32 141.0 52.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.336 -0.546 . . . . 3.0 110.935 -176.693 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 p -79.32 176.73 3.43 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.379 -0.828 . . . . 0.5 110.332 175.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 14.7 Cg_endo -57.1 -19.15 31.99 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 113.169 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 24.0 p30 -104.7 3.34 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.861 0.363 . . . . 1.95 111.082 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.78 37.35 34.31 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.38 113.556 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 24.4 mmt180 -90.12 136.66 32.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.366 -0.605 . . . . 3.79 109.366 171.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.7 m -91.87 129.29 37.86 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.989 -0.55 . . . . 0.69999999999999996 111.487 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 11.8 ptpt -147.27 156.56 46.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.503 -0.925 . . . . 2.5 108.503 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -38.5 145.86 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.623 2.882 . . . . 0.59999999999999998 113.32 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.635 0.731 . . . . 1.0 111.106 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 15.3 t . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.946 -0.39 . . . . 1.46 109.946 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 113.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.942 0.401 . . . . 0.83999999999999997 111.456 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.95 12.83 19.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.03 -0.605 . . . . 0.32000000000000001 111.659 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.6 m-85 -129.75 143.15 50.68 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.406 0.622 . . . . 0.48999999999999999 112.376 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -122.35 165.61 16.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.486 -1.234 . . . . 2.3599999999999999 107.758 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 12.8 mtp85 -131.37 151.84 51.16 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.833 0.679 . . . . 3.0 112.833 -171.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.9 p -79.78 176.62 3.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.93 -1.032 . . . . 0.5 110.045 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.1 Cg_endo -54.21 -22.33 25.61 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.707 2.272 . . . . 0.79000000000000004 112.161 172.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 -35.11 46.47 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.926 -0.579 . . . . 1.95 109.824 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.78 15.93 15.41 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.54 -0.754 . . . . 0.38 111.504 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 72.0 mtp180 -79.55 130.24 35.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.957 -0.386 . . . . 3.79 109.957 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.83 107.41 18.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.291 0.567 . . . . 0.69999999999999996 111.934 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -104.33 157.06 34.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.444 -0.947 . . . . 2.5 108.444 171.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -57.08 150.42 56.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 121.789 1.659 . . . . 0.59999999999999998 111.964 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.557 176.472 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CD1' ' A' ' 11' ' ' TYR . 14.7 m . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 110.304 -0.258 . . . . 1.46 110.304 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.77 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.202 0.525 . . . . 0.83999999999999997 111.909 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.99 36.2 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.326 -0.852 . . . . 0.32000000000000001 112.211 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CD1' HG23 ' A' ' 8' ' ' VAL . 18.8 m-85 -127.24 146.54 50.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.536 0.684 . . . . 0.48999999999999999 112.765 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.4 ppp? -114.48 168.65 9.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.864 -1.062 . . . . 2.3599999999999999 108.927 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -133.91 146.13 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.402 -0.519 . . . . 3.0 110.932 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.832 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.3 p -79.87 178.73 2.17 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.9 -0.591 . . . . 0.5 109.477 173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.832 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 19.4 Cg_endo -58.42 -19.52 44.12 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.016 1.811 . . . . 0.79000000000000004 111.948 173.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.787 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -79.23 -22.24 45.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.072 177.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.18 33.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.807 -0.711 . . . . 0.38 111.488 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.787 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 81.1 mtp180 -86.03 125.16 33.21 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.361 -0.607 . . . . 3.79 109.361 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.47 115.65 25.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 112.063 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HE2' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -113.13 157.53 40.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.659 -1.237 . . . . 2.5 107.659 167.388 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.02 173.91 1.59 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.866 1.711 . . . . 0.59999999999999998 111.891 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 1.0 111.03 178.024 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 109.234 -0.654 . . . . 1.46 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.35 133.68 55.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.311 . . . . 0.83999999999999997 111.301 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 1.41 63.36 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.769 -0.729 . . . . 0.32000000000000001 111.302 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.97 123.02 39.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.414 0.626 . . . . 0.48999999999999999 111.743 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -108.72 165.02 11.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.188 -1.041 . . . . 2.3599999999999999 108.188 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -112.54 148.49 34.4 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.392 -0.523 . . . . 3.0 111.774 -171.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.7 p -79.46 174.02 6.78 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.5 108.875 170.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 53.1 Cg_exo -55.81 -21.31 32.27 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.12 1.88 . . . . 0.79000000000000004 112.405 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -22.3 37.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 1.95 110.421 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.76 26.94 11.97 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.38 112.022 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 77.1 mtp180 -79.07 127.32 31.85 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.094 -0.335 . . . . 3.79 110.094 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -79.17 95.13 5.52 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 123.824 0.702 . . . . 0.69999999999999996 110.154 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.49 165.38 14.53 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.041 -1.096 . . . . 2.5 108.041 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 161.29 2.94 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.926 1.751 . . . . 0.59999999999999998 111.791 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.572 0.701 . . . . 1.0 110.155 173.393 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.1 t . . . . . 0 C--O 1.238 0.495 0 CA-C-O 120.67 0.271 . . . . 1.46 110.494 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.07 130.28 45.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 110.031 -0.359 . . . . 0.83999999999999997 110.031 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.51 7.91 44.53 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.023 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -122.27 131.85 54.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.187 0.81 . . . . 0.48999999999999999 113.187 176.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 85.5 mmm -83.51 148.9 26.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.776 -1.194 . . . . 2.3599999999999999 107.776 166.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -129.67 139.87 51.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.524 0.678 . . . . 3.0 111.551 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 p -92.58 168.46 12.53 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.101 -0.954 . . . . 0.5 110.042 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 54.2 Cg_exo -53.95 -28.21 48.36 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.798 2.332 . . . . 0.79000000000000004 113.251 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -82.21 -10.1 59.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.759 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.74 55.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.77 -0.729 . . . . 0.38 112.609 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -79.71 149.55 31.15 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.761 0.315 . . . . 3.79 110.632 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -105.38 135.61 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.69999999999999996 111.735 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -139.7 143.85 36.71 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 108.237 -1.023 . . . . 2.5 108.237 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -49.7 145.38 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.135 1.89 . . . . 0.59999999999999998 111.879 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.811 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.4 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.816 . . . . 1.0 109.991 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 11.4 t . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.697 0.284 . . . . 1.46 110.643 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.29 55.96 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.875 0.369 . . . . 0.83999999999999997 110.664 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.31 12.04 61.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.721 -0.752 . . . . 0.32000000000000001 111.722 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.457 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.6 m-85 -124.81 135.24 52.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.445 0.641 . . . . 0.48999999999999999 112.193 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.955 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 91.1 mmm -101.65 -179.66 4.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.686 -1.143 . . . . 2.3599999999999999 108.639 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -129.69 143.89 51.03 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.807 -0.357 . . . . 3.0 110.24 174.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.6 p -79.48 176.18 4.0 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.29 -0.868 . . . . 0.5 109.633 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.1 Cg_endo -55.5 -25.98 51.88 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.757 2.304 . . . . 0.79000000000000004 112.833 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 7.7 p-10 -95.6 -3.59 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.242 -0.435 . . . . 1.95 111.127 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 32.52 12.61 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.072 -0.585 . . . . 0.38 113.863 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.6 mtp180 -82.73 130.43 35.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.182 0.491 . . . . 3.79 109.777 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -79.03 86.6 4.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.313 0.578 . . . . 0.69999999999999996 110.298 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -95.45 163.01 22.61 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 108.901 -0.777 . . . . 2.5 108.901 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -40.52 151.43 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.843 2.362 . . . . 0.59999999999999998 112.274 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.955 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 5.9 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.812 0.815 . . . . 1.0 109.336 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.5 t . . . . . 0 C--O 1.237 0.418 0 N-CA-C 110.063 -0.347 . . . . 1.46 110.063 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.53 113.95 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.462 . . . . 0.83999999999999997 111.375 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.19 18.6 19.03 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 0.32000000000000001 112.38 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 92.0 m-85 -127.82 130.69 49.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.48999999999999999 112.37 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -103.34 162.81 12.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.689 -1.141 . . . . 2.3599999999999999 108.215 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -126.91 154.14 44.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.483 -0.487 . . . . 3.0 112.188 -169.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.617 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.2 p -85.59 176.54 3.55 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.346 -0.843 . . . . 0.5 109.824 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 50.6 Cg_exo -55.55 -31.04 77.09 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.364 2.043 . . . . 0.79000000000000004 111.893 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 -31.4 39.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.692 -0.686 . . . . 1.95 110.622 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.73 22.16 6.46 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.526 -0.845 . . . . 0.38 112.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 56.0 mtp180 -79.76 129.93 34.9 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.513 -0.551 . . . . 3.79 109.513 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -91.52 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.416 0.627 . . . . 0.69999999999999996 111.993 -173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -111.01 147.12 35.89 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.034 -0.985 . . . . 2.5 108.912 173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -41.12 142.09 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.3 2.667 . . . . 0.59999999999999998 112.774 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.589 0.709 . . . . 1.0 110.405 175.607 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 11' ' ' TYR . 7.1 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 109.674 -0.491 . . . . 1.46 109.674 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.64 119.96 2.39 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.102 0.778 . . . . 0.83999999999999997 113.102 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.79 13.35 58.12 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.32000000000000001 113.004 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.525 ' CD1' HG13 ' A' ' 8' ' ' VAL . 15.9 m-85 -124.98 135.48 52.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.341 0.591 . . . . 0.48999999999999999 112.128 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.647 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 82.9 mtp -99.02 176.56 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.024 . . . . 2.3599999999999999 108.815 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.19 140.11 45.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 3.0 109.813 173.007 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.5 p -80.43 176.79 3.45 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.475 -0.784 . . . . 0.5 109.771 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.8 Cg_exo -50.52 -34.49 42.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.487 2.125 . . . . 0.79000000000000004 113.45 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -79.95 -5.48 55.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.339 0.59 . . . . 1.95 111.047 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.54 32.63 30.18 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.978 -0.556 . . . . 0.38 112.44 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 19.3 mmm180 -88.88 120.91 30.71 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.609 -0.348 . . . . 3.79 110.411 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' MET . 86.1 m -80.03 128.42 33.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.879 -0.601 . . . . 0.69999999999999996 111.122 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 14.6 ptpt -153.0 160.84 30.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 2.5 109.102 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 11.7 Cg_exo -39.17 149.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.621 2.88 . . . . 0.59999999999999998 113.267 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HG3' ' A' ' 12' ' ' MET . 11.4 p . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.111 0.481 . . . . 1.0 112.282 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.249 0.547 . . . . 1.46 111.856 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.54 120.89 10.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.279 -0.873 . . . . 0.83999999999999997 111.847 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.08 32.46 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.016 -0.993 . . . . 0.32000000000000001 112.102 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 91.4 m-85 -127.97 114.62 17.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.525 0.935 . . . . 0.48999999999999999 113.525 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.407 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.0 ppp? -89.72 156.35 18.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.972 -1.122 . . . . 2.3599999999999999 107.972 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 4.4 mtm-85 -132.78 140.5 48.05 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.565 -0.454 . . . . 3.0 111.044 -171.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 45.6 p -86.58 168.97 16.32 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.919 -0.582 . . . . 0.5 109.952 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 44.9 Cg_exo -58.67 -19.7 47.04 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.558 2.172 . . . . 0.79000000000000004 112.941 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.48 -12.12 59.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 1.95 110.834 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.5 30.72 26.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.055 -0.593 . . . . 0.38 111.638 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 28.5 ttm180 -92.59 122.21 34.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 3.79 109.709 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.7 m -91.05 107.68 19.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.572 0.701 . . . . 0.69999999999999996 111.272 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HE3' ' SD ' ' A' ' 12' ' ' MET . 55.8 mtmt -108.84 163.47 16.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.79 -1.095 . . . . 2.5 108.525 174.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.99 161.7 1.37 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.265 1.977 . . . . 0.59999999999999998 111.519 171.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 121.307 0.575 . . . . 1.0 110.496 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.097 0.475 . . . . 12.08 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -92.62 96.87 10.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 9.5 110.983 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -118.94 -65.74 1.14 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.669 -0.696 . . . . 8.9900000000000002 109.609 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -88.71 12.27 15.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.435 0.636 . . . . 6.9900000000000002 110.041 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.08 -60.78 4.65 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.609 -0.723 . . . . 4.7800000000000002 111.552 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.38 -145.32 18.32 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.343 -0.703 . . . . 3.1000000000000001 111.343 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 1.9 t -142.91 -171.38 3.44 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.838 -0.801 . . . . 1.51 108.838 176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 22.0 t -59.68 151.16 5.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 109.642 -0.503 . . . . 1.46 109.642 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.58 117.0 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.83999999999999997 111.012 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 17.55 25.22 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.042 -0.599 . . . . 0.32000000000000001 112.859 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 78.7 m-85 -120.7 119.53 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.877 0.695 . . . . 0.48999999999999999 112.877 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.937 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 21.4 mmt -84.26 171.94 12.29 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.807 -1.088 . . . . 2.3599999999999999 108.414 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 20.4 mtp180 -147.2 148.08 31.13 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.293 0.568 . . . . 3.0 111.526 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 75.7 p -92.72 168.83 11.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.016 -0.993 . . . . 0.5 110.203 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.3 Cg_exo -59.28 -21.29 59.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.682 2.255 . . . . 0.79000000000000004 112.764 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.58 41.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.116 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.21 25.17 6.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.545 -0.836 . . . . 0.38 112.748 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 74.1 mtp180 -87.16 121.55 29.77 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.309 -0.156 . . . . 3.79 110.725 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 13' ' ' ARG . 62.4 m -88.0 134.74 33.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.09 0.471 . . . . 0.69999999999999996 110.206 174.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -160.57 160.24 25.75 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.891 -0.781 . . . . 2.5 108.891 174.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.933 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 23.5 Cg_exo -34.34 146.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.11 3.207 . . . . 0.59999999999999998 113.23 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.937 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p -59.04 -29.99 67.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.929 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -90.06 -155.86 0.39 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 1.3500000000000001 109.337 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' HB2' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -79.45 126.09 30.4 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.075 0.464 . . . . 4.3200000000000003 110.167 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.933 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -63.8 -63.41 1.17 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.384 0.611 . . . . 6.7199999999999998 109.382 -178.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -161.15 -55.65 0.05 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.899 -1.519 . . . . 3.8999999999999999 106.899 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 pt -93.09 55.87 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.465 -1.243 . . . . 6.8099999999999996 109.238 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.605 ' HA ' ' HB2' ' A' ' 24' ' ' TYR . 70.2 p . . . . . 0 C--O 1.244 0.806 0 CA-C-N 114.561 -1.2 . . . . 6.8300000000000001 112.446 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.801 0.334 . . . . 12.08 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -140.73 173.02 11.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.245 -0.65 . . . . 9.5 109.245 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -115.74 146.18 42.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.877 0.37 . . . . 8.9900000000000002 110.685 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.86 122.44 24.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.075 -0.511 . . . . 6.9900000000000002 111.036 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -115.69 54.41 0.58 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.965 -0.636 . . . . 4.7800000000000002 112.079 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 -28.49 67.39 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.921 -0.657 . . . . 3.1000000000000001 111.702 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 t -142.45 -92.3 0.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.366 -0.605 . . . . 1.51 109.366 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 17.6 t -92.5 162.69 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.34 -0.985 . . . . 1.46 108.34 169.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.45 109.46 1.02 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.79 0.328 . . . . 0.83999999999999997 110.616 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' C ' HG23 ' A' ' 22' ' ' THR . . . 106.18 4.64 38.24 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.32000000000000001 111.832 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.696 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.2 m-85 -124.28 121.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.097 0.475 . . . . 0.48999999999999999 111.043 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -100.07 -179.72 4.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.295 -1.002 . . . . 2.3599999999999999 108.295 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 21.0 mmm-85 -124.93 139.83 53.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.162 0.506 . . . . 3.0 111.403 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 p -79.18 168.47 26.58 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.089 -0.959 . . . . 0.5 109.644 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.38 -28.73 88.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.137 1.891 . . . . 0.79000000000000004 111.336 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 3.0 p-10 -83.82 -5.27 59.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.255 -0.884 . . . . 1.95 111.355 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 36.04 7.94 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.636 -0.792 . . . . 0.38 114.416 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.0 mtp180 -93.99 139.39 31.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.522 0.661 . . . . 3.79 111.397 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -87.52 96.14 10.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.877 -0.786 . . . . 0.69999999999999996 108.877 171.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -130.7 161.43 61.13 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.653 -0.499 . . . . 2.5 109.653 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.554 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.8 Cg_exo -33.87 147.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.619 3.546 . . . . 0.59999999999999998 114.257 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 10' ' ' GLY . 2.9 p -56.01 -32.48 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.629 0.728 . . . . 1.0 110.384 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 27.1 p90 -94.35 -170.12 2.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.029 -0.987 . . . . 1.3500000000000001 110.073 175.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' O ' ' HD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -78.36 148.99 33.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.042 -0.527 . . . . 4.3200000000000003 110.227 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -71.22 43.11 0.08 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.846 -0.616 . . . . 6.7199999999999998 112.013 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 24' ' ' TYR . 5.1 tt -112.41 97.02 6.33 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.209 -1.034 . . . . 3.8999999999999999 108.209 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.97 133.47 29.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.865 -0.607 . . . . 6.8099999999999996 110.907 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.581 -0.723 . . . . 6.8300000000000001 110.017 175.78 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.818 0.342 . . . . 12.08 111.31 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -101.78 115.0 29.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.639 -0.71 . . . . 9.5 109.183 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -84.12 153.33 23.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.421 . . . . 8.9900000000000002 111.541 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -90.51 20.32 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.782 -0.645 . . . . 6.9900000000000002 110.392 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.42 38.89 3.15 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.929 -0.653 . . . . 4.7800000000000002 113.004 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.65 -54.91 2.93 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.178 -0.534 . . . . 3.1000000000000001 113.278 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -131.23 -177.38 4.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 122.57 0.348 . . . . 1.51 110.627 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m -86.4 -175.68 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 121.318 0.58 . . . . 1.46 112.49 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.3 128.96 37.97 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.412 -0.813 . . . . 0.83999999999999997 111.666 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 96.88 6.15 58.21 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.063 -0.971 . . . . 0.32000000000000001 111.759 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 84.8 m-85 -121.52 139.66 53.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.515 0.674 . . . . 0.48999999999999999 112.732 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.605 ' HG2' HG22 ' A' ' 22' ' ' THR . 93.3 mmm -129.47 142.94 50.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.667 -1.151 . . . . 2.3599999999999999 108.682 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.639 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -97.36 138.62 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.002 0.429 . . . . 3.0 109.909 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.74 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.5 p -79.09 -175.93 0.64 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.675 -0.693 . . . . 0.5 110.208 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.74 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 63.9 Cg_exo -55.86 -15.88 14.35 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.317 2.011 . . . . 0.79000000000000004 112.915 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.81 4.64 40.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 1.95 110.738 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.45 24.38 75.13 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.143 -0.551 . . . . 0.38 113.022 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 92.5 mtt180 -91.68 116.24 28.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.618 -0.512 . . . . 3.79 109.618 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 30.6 p -88.31 100.5 13.06 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.239 1.019 . . . . 0.69999999999999996 111.398 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.731 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -108.41 175.07 2.12 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 113.678 -1.601 . . . . 2.5 107.246 171.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -43.03 152.78 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.248 2.632 . . . . 0.59999999999999998 113.307 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.605 HG22 ' HG2' ' A' ' 12' ' ' MET . 6.1 p -57.82 -37.95 74.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.489 0.662 . . . . 1.0 110.221 174.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 21.6 p90 -88.08 -159.35 0.53 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.061 . . . . 1.3500000000000001 110.195 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.543 ' O ' ' HD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -77.54 147.43 35.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.357 -0.537 . . . . 4.3200000000000003 109.873 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 20' ' ' LYS . 47.7 mt-30 -59.58 112.15 1.68 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.932 0.396 . . . . 6.7199999999999998 110.883 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -107.71 106.43 16.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.857 -0.794 . . . . 3.8999999999999999 108.857 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.96 148.68 5.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.911 -0.586 . . . . 6.8099999999999996 110.102 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.391 -0.814 . . . . 6.8300000000000001 110.44 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.773 0.32 . . . . 12.08 110.584 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.29 153.44 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.305 -0.407 . . . . 9.5 110.524 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -129.42 176.78 7.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.804 -0.635 . . . . 8.9900000000000002 109.612 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -78.63 -36.12 44.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 6.9900000000000002 110.867 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.17 -39.27 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.663 -0.575 . . . . 4.7800000000000002 111.663 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.56 -44.82 1.92 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.865 -0.683 . . . . 3.1000000000000001 112.703 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.811 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 17.1 t -100.24 -156.05 0.54 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.695 -0.483 . . . . 1.51 109.695 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 24.8 t -64.75 154.66 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.62 -0.511 . . . . 1.46 109.62 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.06 127.65 19.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.462 . . . . 0.83999999999999997 111.116 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.21 7.27 60.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.32000000000000001 112.88 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.41 132.0 42.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.503 0.557 . . . . 0.48999999999999999 112.503 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptp -104.03 -170.35 1.76 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.427 -1.323 . . . . 2.3599999999999999 107.427 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.811 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 2.3 mtp85 -143.1 150.92 40.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.124 -0.63 . . . . 3.0 112.381 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 38.1 p -82.34 171.68 11.32 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.25 -0.886 . . . . 0.5 109.616 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -55.75 -26.11 54.93 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.903 2.402 . . . . 0.79000000000000004 112.491 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.54 -24.48 42.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 1.95 110.669 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.22 8.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.377 -0.916 . . . . 0.38 112.949 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.7 mpt_? -80.48 129.87 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.541 -0.388 . . . . 3.79 110.559 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.0 m -78.52 90.77 4.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.904 0.859 . . . . 0.69999999999999996 110.289 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.45 135.33 19.4 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 113.627 -1.624 . . . . 2.5 108.047 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -43.03 152.28 0.22 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.162 2.575 . . . . 0.59999999999999998 113.781 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -57.77 -31.31 66.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.511 0.672 . . . . 1.0 110.359 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -98.76 -177.6 3.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 1.3500000000000001 110.622 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.6 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 2.6 p90 -79.04 135.17 36.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.344 -0.389 . . . . 4.3200000000000003 110.158 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 25' ' ' GLN . 18.7 mt-30 -56.62 114.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.095 -0.502 . . . . 6.7199999999999998 110.427 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -126.91 149.7 49.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.173 -0.467 . . . . 3.8999999999999999 110.244 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.2 mt -115.73 -77.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.532 -0.914 . . . . 6.8099999999999996 108.532 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.245 0.848 0 N-CA-C 108.493 -0.929 . . . . 6.8300000000000001 108.493 170.52 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.608 -0.516 . . . . 12.08 109.608 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.41 -28.19 21.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.451 -0.944 . . . . 9.5 108.451 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -89.9 166.48 13.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.035 -0.984 . . . . 8.9900000000000002 109.004 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.1 p -74.17 -64.26 1.05 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.17 0.509 . . . . 6.9900000000000002 110.655 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.93 122.72 0.74 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.778 -0.725 . . . . 4.7800000000000002 111.851 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.77 -47.36 3.78 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.712 -0.756 . . . . 3.1000000000000001 111.602 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m -126.15 164.29 21.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.064 -0.347 . . . . 1.51 110.064 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.15 156.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.825 0.345 . . . . 1.46 110.784 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.05 122.38 14.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.37 0.605 . . . . 0.83999999999999997 110.548 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.97 12.34 27.94 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.508 -0.769 . . . . 0.32000000000000001 111.401 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.35 125.13 42.98 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.346 0.593 . . . . 0.48999999999999999 111.794 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ptp -90.62 171.91 9.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.963 -1.017 . . . . 2.3599999999999999 108.711 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -138.16 148.45 44.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.275 0.559 . . . . 3.0 112.1 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.793 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.7 p -84.76 173.66 6.87 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.068 -0.969 . . . . 0.5 109.896 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 22.3 Cg_endo -61.1 -12.29 22.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.571 2.181 . . . . 0.79000000000000004 112.311 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.35 -21.64 45.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.913 -0.585 . . . . 1.95 109.954 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.45 27.14 33.67 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.031 -0.828 . . . . 0.38 111.031 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.8 134.9 38.2 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.792 -0.448 . . . . 3.79 109.792 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.3 m -80.79 130.78 35.25 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.774 0.671 . . . . 0.69999999999999996 111.424 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.83 151.91 66.83 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.073 -1.084 . . . . 2.5 108.073 171.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.644 ' HD2' ' HG2' ' A' ' 25' ' ' GLN . 76.2 Cg_exo -53.26 152.89 18.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 121.929 1.753 . . . . 0.59999999999999998 112.286 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.39 -38.38 83.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.638 0.733 . . . . 1.0 110.332 175.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.744 ' HE2' ' HB2' ' A' ' 26' ' ' LEU . 30.1 p90 -93.16 -171.79 2.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.819 -1.082 . . . . 1.3500000000000001 108.749 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -78.71 130.54 35.93 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.92 -0.312 . . . . 4.3200000000000003 110.774 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.644 ' HG2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 mt-30 -43.14 113.01 0.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.922 0.764 . . . . 6.7199999999999998 111.106 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.744 ' HB2' ' HE2' ' A' ' 23' ' ' PHE . 0.2 OUTLIER -90.53 107.08 18.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.713 -0.676 . . . . 3.8999999999999999 111.278 -168.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.16 -68.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.841 -0.618 . . . . 6.8099999999999996 109.739 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.245 -0.884 . . . . 6.8300000000000001 109.536 177.911 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.706 0.289 . . . . 12.08 110.744 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -101.86 -52.58 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 9.5 110.681 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -79.21 12.27 2.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 8.9900000000000002 111.163 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.6 t -89.93 -8.61 51.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 6.9900000000000002 109.923 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.35 64.43 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.838 -0.696 . . . . 4.7800000000000002 111.814 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.99 86.82 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.663 -0.779 . . . . 3.1000000000000001 112.199 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 13' ' ' ARG . 84.9 m -80.67 -179.24 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.948 0.404 . . . . 1.51 110.655 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.759 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 t -71.02 168.51 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.06 -0.518 . . . . 1.46 110.162 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -38.54 -66.9 0.23 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.731 1.011 . . . . 0.83999999999999997 113.731 -171.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 49.49 1.49 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.131 -1.033 . . . . 0.32000000000000001 112.899 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.759 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 67.0 m-85 -125.03 118.66 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.735 0.779 . . . . 0.48999999999999999 112.369 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.777 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 24.5 mmt -82.69 172.26 13.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.716 -1.129 . . . . 2.3599999999999999 108.831 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HG3' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -124.65 139.38 53.91 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.559 -0.457 . . . . 3.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.817 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 35.8 p -79.22 176.89 3.27 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.703 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.817 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.0 Cg_endo -52.7 -29.83 43.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.434 2.089 . . . . 0.79000000000000004 112.207 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 5.2 m-20 -79.74 -22.26 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.576 . . . . 1.95 110.921 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.33 13.74 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.363 -0.695 . . . . 0.38 111.363 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HD2' ' HB2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -78.59 132.13 37.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.727 -0.842 . . . . 3.79 108.727 174.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.89 102.93 11.99 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.598 -0.728 . . . . 0.69999999999999996 110.616 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -128.11 155.21 78.35 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 108.997 -0.742 . . . . 2.5 108.997 177.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 35.1 Cg_exo -31.48 144.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.813 3.675 . . . . 0.59999999999999998 113.751 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.777 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 3.5 p -56.33 -36.62 68.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' H ' ' A' ' 24' ' ' TYR . 25.7 p90 -85.46 -148.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.449 -1.25 . . . . 1.3500000000000001 109.923 170.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' H ' ' HB2' ' A' ' 23' ' ' PHE . 6.8 p90 -100.16 134.08 43.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.152 0.501 . . . . 4.3200000000000003 111.032 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 tp-100 -56.58 115.52 2.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.404 -0.817 . . . . 6.7199999999999998 110.778 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.14 156.04 30.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.981 -0.554 . . . . 3.8999999999999999 110.379 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.89 138.14 34.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.456 -0.338 . . . . 6.8099999999999996 110.289 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.722 -0.656 . . . . 6.8300000000000001 110.331 178.464 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.146 -0.316 . . . . 12.08 110.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -114.14 152.58 30.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 9.5 110.147 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.28 157.63 28.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.24 -0.436 . . . . 8.9900000000000002 110.273 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 m -87.22 32.81 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.228 -0.442 . . . . 6.9900000000000002 111.738 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.49 -45.63 1.03 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 4.7800000000000002 112.038 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.66 -47.52 0.7 Allowed Glycine 0 C--O 1.226 -0.361 0 N-CA-C 111.489 -0.644 . . . . 3.1000000000000001 111.489 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 8.1 t -117.13 -161.34 0.81 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.673 -0.862 . . . . 1.51 108.673 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG23 ' CD2' ' A' ' 11' ' ' TYR . 16.0 m -77.25 -172.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.866 0.365 . . . . 1.46 111.305 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.11 108.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.414 -0.812 . . . . 0.83999999999999997 112.421 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.26 34.33 26.49 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.767 -0.651 . . . . 0.32000000000000001 113.737 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 85.9 m-85 -134.01 121.7 21.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.763 0.653 . . . . 0.48999999999999999 112.763 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -90.44 177.97 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.668 -1.234 . . . . 2.3599999999999999 107.668 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.546 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 13.1 mtp180 -143.71 155.55 44.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.325 0.861 . . . . 3.0 113.325 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -95.54 166.57 14.38 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 114.318 -1.31 . . . . 0.5 110.039 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.07 -28.59 84.09 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.799 2.333 . . . . 0.79000000000000004 112.606 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.686 ' OD1' ' HD3' ' A' ' 18' ' ' ARG . 2.3 p30 -79.57 -14.17 59.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.519 -0.764 . . . . 1.95 111.921 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.63 11.65 37.49 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.72 -0.753 . . . . 0.38 113.868 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.686 ' HD3' ' OD1' ' A' ' 16' ' ' ASP . 11.4 mpt_? -79.89 142.42 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.355 0.577 . . . . 3.79 110.36 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.5 m -100.12 117.5 34.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.308 0.575 . . . . 0.69999999999999996 110.933 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -113.06 153.58 45.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.748 -1.204 . . . . 2.5 107.748 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.69 163.53 6.98 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 121.691 1.594 . . . . 0.59999999999999998 112.305 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 2.22 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.822 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' HD2' ' H ' ' A' ' 25' ' ' GLN . 49.6 p90 -153.93 166.2 33.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.513 -0.921 . . . . 1.3500000000000001 108.513 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -146.59 64.64 1.19 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.515 0.674 . . . . 4.3200000000000003 109.914 169.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.526 ' H ' ' HD2' ' A' ' 23' ' ' PHE . 38.3 mt-30 -90.63 103.18 15.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.447 -0.797 . . . . 6.7199999999999998 109.478 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.954 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -88.12 23.02 2.23 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.504 -0.771 . . . . 3.8999999999999999 110.316 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.15 112.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.223 -0.898 . . . . 6.8099999999999996 109.572 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.381 -0.819 . . . . 6.8300000000000001 110.755 -177.393 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.599 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 6.1 pt-20 . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.496 0.189 . . . . 12.08 110.952 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.599 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 48.0 t30 -93.66 121.79 35.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.045 -0.354 . . . . 9.5 110.045 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -159.91 144.95 15.14 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.599 -0.889 . . . . 8.9900000000000002 108.599 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -70.21 91.57 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.241 -0.652 . . . . 6.9900000000000002 109.241 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.5 -38.25 2.32 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.827 -0.702 . . . . 4.7800000000000002 111.866 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.78 -87.07 0.41 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.811 -0.709 . . . . 3.1000000000000001 112.09 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' SG ' ' HD3' ' A' ' 13' ' ' ARG . 75.5 m -92.03 173.48 7.82 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.162 -0.31 . . . . 1.51 110.162 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 20.3 t -71.21 158.43 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.331 -0.395 . . . . 1.46 110.512 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.45 126.24 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.83999999999999997 110.947 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.08 3.5 48.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.793 -0.717 . . . . 0.32000000000000001 111.986 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.8 m-85 -118.27 119.64 35.25 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.288 0.566 . . . . 0.48999999999999999 111.95 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.59 158.88 15.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.058 -1.46 . . . . 2.3599999999999999 107.058 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HD3' ' SG ' ' A' ' 7' ' ' CYS . 55.2 mtm-85 -123.3 150.32 43.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.716 1.006 . . . . 3.0 113.716 -164.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 25.4 p -89.79 170.24 10.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 114.356 -1.293 . . . . 0.5 111.204 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 16.5 Cg_exo -66.57 -13.84 41.55 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.008 2.472 . . . . 0.79000000000000004 110.951 173.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.32 -25.05 42.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.577 -1.192 . . . . 1.95 110.13 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.82 28.57 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.613 -0.721 . . . . 0.38 112.079 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -95.41 143.51 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.114 0.483 . . . . 3.79 112.152 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -80.79 118.33 22.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.971 -1.013 . . . . 0.69999999999999996 109.935 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -132.53 159.77 71.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.741 -0.837 . . . . 2.5 108.741 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.29 160.31 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.208 1.939 . . . . 0.59999999999999998 112.025 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -51.94 -38.47 56.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.35 0.595 . . . . 1.0 110.859 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -92.11 -172.38 3.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.661 -0.699 . . . . 1.3500000000000001 110.468 174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 4.2 p90 -79.18 133.0 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 4.3200000000000003 110.826 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -65.3 110.78 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.488 -0.778 . . . . 6.7199999999999998 110.077 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.87 123.4 27.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 3.8999999999999999 109.849 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.75 25.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.417 0.627 . . . . 6.8099999999999996 110.837 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.494 -0.765 . . . . 6.8300000000000001 109.924 179.205 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.826 0.346 . . . . 12.08 110.624 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -85.07 116.39 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.416 -0.587 . . . . 9.5 109.416 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.69 159.99 20.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.931 0.396 . . . . 8.9900000000000002 111.438 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -74.17 83.29 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 6.9900000000000002 110.633 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.12 -114.4 1.47 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.025 -0.83 . . . . 4.7800000000000002 111.025 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.38 58.27 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.461 -0.876 . . . . 3.1000000000000001 112.753 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.76 127.48 32.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.311 -0.625 . . . . 1.51 109.311 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 9' ' ' ALA . 4.1 p -82.65 -179.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.151 -0.477 . . . . 1.46 111.151 -169.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 8' ' ' VAL . . . -57.15 134.52 55.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.09 0.471 . . . . 0.83999999999999997 111.264 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 22' ' ' THR . . . 93.88 6.89 61.7 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 111.77 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -128.92 118.08 22.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.385 0.513 . . . . 0.48999999999999999 112.385 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.3 ptm -89.56 164.04 14.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.164 -1.05 . . . . 2.3599999999999999 108.164 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.82 147.9 43.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.139 -0.624 . . . . 3.0 111.39 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.4 p -79.46 173.24 8.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.419 -0.81 . . . . 0.5 108.89 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.8 Cg_exo -61.3 -14.28 33.41 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.057 1.838 . . . . 0.79000000000000004 111.19 170.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.95 -10.27 43.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 1.95 110.196 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.94 28.42 58.8 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.154 -0.778 . . . . 0.38 111.154 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -79.7 127.03 31.69 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.41 -0.959 . . . . 3.79 108.41 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 m -80.18 101.57 8.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.379 0.609 . . . . 0.69999999999999996 110.849 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HE3' ' HG3' ' A' ' 12' ' ' MET . 54.3 pttt -114.74 159.89 35.49 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 108.108 -1.071 . . . . 2.5 108.108 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.3 Cg_exo -54.46 172.95 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.259 1.972 . . . . 0.59999999999999998 113.034 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.528 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.9 p -56.55 -18.68 12.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.322 0.582 . . . . 1.0 111.293 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -121.38 -171.89 2.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 1.3500000000000001 109.473 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.573 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 2.0 p90 -78.33 130.51 36.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.891 0.377 . . . . 4.3200000000000003 110.133 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -64.69 101.42 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.904 -0.589 . . . . 6.7199999999999998 110.799 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.24 115.85 21.5 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.21 -0.663 . . . . 3.8999999999999999 109.21 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.14 -62.27 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.307 -0.406 . . . . 6.8099999999999996 110.71 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.744 -0.646 . . . . 6.8300000000000001 110.157 179.754 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.795 0.331 . . . . 12.08 110.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -108.68 144.27 36.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 9.5 110.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -131.11 15.41 5.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 8.9900000000000002 110.597 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -62.68 -46.98 85.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.615 -0.72 . . . . 6.9900000000000002 111.232 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.59 66.21 0.49 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.95 -0.643 . . . . 4.7800000000000002 111.677 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.75 -93.97 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.801 -0.714 . . . . 3.1000000000000001 111.58 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.8 t -102.56 -104.21 0.27 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.228 -0.656 . . . . 1.51 109.228 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.657 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 4.1 t -91.58 170.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.497 -0.927 . . . . 1.46 108.497 170.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.76 106.13 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.057 0.456 . . . . 0.83999999999999997 110.823 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.16 26.68 9.99 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.962 -0.637 . . . . 0.32000000000000001 112.52 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.657 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 58.1 m-85 -128.03 130.82 48.9 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.48999999999999999 111.917 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.4 ptp -96.78 174.62 6.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.946 -1.025 . . . . 2.3599999999999999 108.778 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.6 mtp180 -133.5 143.43 48.78 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.989 0.424 . . . . 3.0 110.42 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 21.9 p -79.78 170.32 16.43 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.728 -0.669 . . . . 0.5 109.244 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 21.4 Cg_endo -62.82 -7.09 10.42 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.547 2.164 . . . . 0.79000000000000004 111.312 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.18 -18.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.475 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 19.52 39.79 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.562 . . . . 0.38 112.606 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 79.7 ttt180 -93.83 130.08 39.98 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.353 -0.24 . . . . 3.79 110.353 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -83.58 121.42 27.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.262 0.553 . . . . 0.69999999999999996 111.267 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 14' ' ' THR . 48.8 mtmt -124.08 160.63 51.28 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.111 -1.07 . . . . 2.5 108.111 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.78 169.06 1.41 Allowed 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.179 1.919 . . . . 0.59999999999999998 111.262 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -64.59 -17.5 64.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.5 0.667 . . . . 1.0 110.107 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 25' ' ' GLN . 23.5 p90 -117.65 178.01 4.55 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.776 -1.102 . . . . 1.3500000000000001 109.322 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -79.19 -26.99 42.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.96 0.726 . . . . 4.3200000000000003 112.96 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.68 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 79.0 mt-30 -50.88 107.9 0.2 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.658 0.742 . . . . 6.7199999999999998 112.14 -168.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.2 pp -87.12 146.8 25.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.471 -1.241 . . . . 3.8999999999999999 111.062 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.9 -52.52 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.187 0.518 . . . . 6.8099999999999996 109.699 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.598 -0.715 . . . . 6.8300000000000001 109.84 177.984 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.346 0.593 . . . . 12.08 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.0 -59.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.833 -0.622 . . . . 9.5 110.368 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.93 -26.4 40.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 8.9900000000000002 110.038 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.0 m -78.92 103.36 8.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.43 -0.805 . . . . 6.9900000000000002 110.768 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.41 -71.13 2.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.253 -0.498 . . . . 4.7800000000000002 112.636 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.08 -143.51 16.52 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.405 -0.678 . . . . 3.1000000000000001 111.405 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.814 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 2.8 t -114.78 -156.26 0.6 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.701 -0.481 . . . . 1.51 109.701 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.2 t -64.57 151.94 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.638 -0.504 . . . . 1.46 109.638 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.97 118.92 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.83999999999999997 111.087 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.65 39.55 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.593 -0.813 . . . . 0.32000000000000001 112.132 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 72.8 m-85 -119.98 128.62 53.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 0.48999999999999999 112.148 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.1 ptm -104.92 166.03 10.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.566 -1.272 . . . . 2.3599999999999999 107.566 175.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.814 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 14.1 mtp180 -135.75 160.78 37.49 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.04 -0.664 . . . . 3.0 112.124 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 57.7 p -104.38 172.68 3.92 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.171 -0.922 . . . . 0.5 109.56 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 33.5 Cg_exo -59.32 -18.92 47.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.704 2.269 . . . . 0.79000000000000004 112.888 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 3.9 m-20 -79.24 -10.07 59.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.753 -0.462 . . . . 1.95 109.753 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.16 22.47 54.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.157 -0.544 . . . . 0.38 111.81 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 98.8 mtt180 -85.66 126.61 34.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.714 -0.243 . . . . 3.79 110.738 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.6 m -93.19 117.19 29.78 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.723 0.64 . . . . 0.69999999999999996 111.044 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 31.7 pttt -130.28 167.42 20.94 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.182 -1.044 . . . . 2.5 108.182 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 23' ' ' PHE . 77.4 Cg_exo -50.89 163.06 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.019 1.813 . . . . 0.59999999999999998 111.783 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -67.71 27.98 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 21' ' ' PRO . 24.9 p90 -157.68 -155.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.939 -0.763 . . . . 1.3500000000000001 108.939 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -93.03 123.38 36.24 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.853 0.358 . . . . 4.3200000000000003 110.675 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -68.13 122.86 19.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.567 -0.531 . . . . 6.7199999999999998 109.567 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.7 tm? -79.0 102.27 8.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.456 -0.572 . . . . 3.8999999999999999 109.456 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.74 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.607 -0.516 . . . . 6.8099999999999996 109.607 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.416 -0.802 . . . . 6.8300000000000001 110.177 179.576 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.731 -0.47 . . . . 12.08 109.731 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -92.41 -62.77 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.41 . . . . 9.5 111.024 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -95.08 138.16 33.16 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.127 -0.488 . . . . 8.9900000000000002 110.021 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 p -82.29 -1.21 48.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 6.9900000000000002 111.608 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.48 -62.36 4.33 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.88 -0.676 . . . . 4.7800000000000002 112.114 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.25 -167.57 25.71 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.786 -0.721 . . . . 3.1000000000000001 112.162 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.631 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 8.9 t -106.11 -155.11 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.06 -0.718 . . . . 1.51 109.06 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 40.5 t -60.61 145.32 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.154 -0.684 . . . . 1.46 109.154 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.74 117.13 4.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.931 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 18.47 20.56 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.963 -0.637 . . . . 0.32000000000000001 111.85 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 69.0 m-85 -128.92 124.46 35.22 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.806 0.813 . . . . 0.48999999999999999 112.079 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.418 ' C ' ' HD3' ' A' ' 13' ' ' ARG . 26.1 ptm -90.73 164.3 14.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.652 -1.158 . . . . 2.3599999999999999 108.832 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.631 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -125.32 141.0 52.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.336 -0.546 . . . . 3.0 110.935 -176.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 p -79.32 176.73 3.43 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.379 -0.828 . . . . 0.5 110.332 175.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 14.7 Cg_endo -57.1 -19.15 31.99 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 113.169 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 24.0 p30 -104.7 3.34 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.861 0.363 . . . . 1.95 111.082 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.78 37.35 34.31 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.38 113.556 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 24.4 mmt180 -90.12 136.66 32.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.366 -0.605 . . . . 3.79 109.366 171.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.7 m -91.87 129.29 37.86 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.989 -0.55 . . . . 0.69999999999999996 111.487 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 11.8 ptpt -147.27 156.56 46.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.503 -0.925 . . . . 2.5 108.503 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.62 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 6.4 Cg_exo -38.5 145.86 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.623 2.882 . . . . 0.59999999999999998 113.32 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.64 6.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.635 0.731 . . . . 1.0 111.106 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 54.6 p90 -150.27 -179.52 7.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.771 -1.104 . . . . 1.3500000000000001 108.033 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -159.07 67.97 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.633 0.73 . . . . 4.3200000000000003 109.612 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.453 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 79.9 mm-40 -85.85 -25.81 26.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.911 -1.041 . . . . 6.7199999999999998 109.814 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.5 pp -82.6 114.14 20.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.363 -0.835 . . . . 3.8999999999999999 110.945 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.78 13.51 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 6.8099999999999996 109.659 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.246 0.903 0 CA-C-N 114.715 -1.13 . . . . 6.8300000000000001 109.593 -179.35 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.816 -0.438 . . . . 12.08 109.816 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -129.4 134.6 47.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 9.5 110.314 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -103.98 124.94 49.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.921 -0.581 . . . . 8.9900000000000002 110.594 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m -65.35 -57.44 8.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 6.9900000000000002 110.083 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.84 20.06 4.12 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.683 -0.77 . . . . 4.7800000000000002 111.204 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.83 6.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.91 -0.662 . . . . 3.1000000000000001 111.782 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.886 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 7.7 t -125.0 -153.99 0.59 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.409 -0.589 . . . . 1.51 109.409 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 15.3 t -64.52 158.2 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.946 -0.39 . . . . 1.46 109.946 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 113.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.942 0.401 . . . . 0.83999999999999997 111.456 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.95 12.83 19.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.03 -0.605 . . . . 0.32000000000000001 111.659 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 97.6 m-85 -129.75 143.15 50.68 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.406 0.622 . . . . 0.48999999999999999 112.376 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -122.35 165.61 16.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.486 -1.234 . . . . 2.3599999999999999 107.758 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.886 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 12.8 mtp85 -131.37 151.84 51.16 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.833 0.679 . . . . 3.0 112.833 -171.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.9 p -79.78 176.62 3.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.93 -1.032 . . . . 0.5 110.045 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.1 Cg_endo -54.21 -22.33 25.61 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.707 2.272 . . . . 0.79000000000000004 112.161 172.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 -35.11 46.47 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.926 -0.579 . . . . 1.95 109.824 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.78 15.93 15.41 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.54 -0.754 . . . . 0.38 111.504 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 72.0 mtp180 -79.55 130.24 35.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.957 -0.386 . . . . 3.79 109.957 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.83 107.41 18.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.291 0.567 . . . . 0.69999999999999996 111.934 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -104.33 157.06 34.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.444 -0.947 . . . . 2.5 108.444 171.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -57.08 150.42 56.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 121.789 1.659 . . . . 0.59999999999999998 111.964 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -52.18 -50.15 62.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.557 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 2.8 p90 -97.0 175.73 6.22 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.059 -0.973 . . . . 1.3500000000000001 109.399 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -79.61 120.32 23.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.654 -0.498 . . . . 4.3200000000000003 109.654 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -61.57 111.34 1.78 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 6.7199999999999998 110.969 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tt -83.7 102.66 12.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.862 -0.792 . . . . 3.8999999999999999 108.862 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.7 pt -95.08 -25.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 6.8099999999999996 111.738 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.442 -0.79 . . . . 6.8300000000000001 110.174 -179.762 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.764 0.316 . . . . 12.08 110.784 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -86.5 90.46 8.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.21 0.529 . . . . 9.5 110.722 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.418 ' HE1' ' H ' ' A' ' 13' ' ' ARG . 49.2 p90 -114.55 11.97 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.634 0.731 . . . . 8.9900000000000002 109.383 173.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.63 93.0 3.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.177 -0.92 . . . . 6.9900000000000002 109.904 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.19 -20.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.173 -0.922 . . . . 4.7800000000000002 111.412 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.26 78.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.093 -0.803 . . . . 3.1000000000000001 111.093 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -97.93 -162.16 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.522 -0.918 . . . . 1.51 108.522 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CD1' ' A' ' 11' ' ' TYR . 14.7 m -69.78 156.91 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.433 -0.507 . . . . 1.46 110.304 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.77 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.202 0.525 . . . . 0.83999999999999997 111.909 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.99 36.2 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.326 -0.852 . . . . 0.32000000000000001 112.211 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CD1' HG23 ' A' ' 8' ' ' VAL . 18.8 m-85 -127.24 146.54 50.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.536 0.684 . . . . 0.48999999999999999 112.765 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.4 ppp? -114.48 168.65 9.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.864 -1.062 . . . . 2.3599999999999999 108.927 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -133.91 146.13 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.402 -0.519 . . . . 3.0 110.932 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.832 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.3 p -79.87 178.73 2.17 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.9 -0.591 . . . . 0.5 109.477 173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.832 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 19.4 Cg_endo -58.42 -19.52 44.12 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.016 1.811 . . . . 0.79000000000000004 111.948 173.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.787 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -79.23 -22.24 45.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.072 177.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.18 33.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.807 -0.711 . . . . 0.38 111.488 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.787 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 81.1 mtp180 -86.03 125.16 33.21 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.361 -0.607 . . . . 3.79 109.361 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.47 115.65 25.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 112.063 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HE2' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -113.13 157.53 40.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.659 -1.237 . . . . 2.5 107.659 167.388 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.02 173.91 1.59 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.866 1.711 . . . . 0.59999999999999998 111.891 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -62.74 -12.67 25.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 1.0 111.03 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 37.2 p90 -139.78 171.41 14.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.548 -0.751 . . . . 1.3500000000000001 109.04 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.75 41.32 0.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.801 0.81 . . . . 4.3200000000000003 109.37 167.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 86.7 mm-40 -90.3 105.9 18.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.796 -1.093 . . . . 6.7199999999999998 110.104 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 pp -129.14 128.05 42.66 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.151 0.5 . . . . 3.8999999999999999 110.042 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.4 mt -106.91 -29.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.165 -0.68 . . . . 6.8099999999999996 109.165 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.243 0.732 0 CA-C-N 115.61 -0.723 . . . . 6.8300000000000001 109.815 176.983 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.849 0.357 . . . . 12.08 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -99.82 72.03 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 9.5 110.883 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -159.81 135.33 8.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.811 -0.811 . . . . 8.9900000000000002 108.811 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 t -88.7 -46.79 8.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 6.9900000000000002 111.14 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.88 -88.18 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.62 -0.8 . . . . 4.7800000000000002 112.241 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.7 -50.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.993 -0.622 . . . . 3.1000000000000001 111.885 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.4 m -128.42 -169.69 2.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.343 -0.614 . . . . 1.51 109.343 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.08 157.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.234 -0.654 . . . . 1.46 109.234 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.35 133.68 55.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.311 . . . . 0.83999999999999997 111.301 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 1.41 63.36 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.769 -0.729 . . . . 0.32000000000000001 111.302 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.97 123.02 39.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.414 0.626 . . . . 0.48999999999999999 111.743 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -108.72 165.02 11.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.188 -1.041 . . . . 2.3599999999999999 108.188 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -112.54 148.49 34.4 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.392 -0.523 . . . . 3.0 111.774 -171.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.7 p -79.46 174.02 6.78 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.5 108.875 170.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 53.1 Cg_exo -55.81 -21.31 32.27 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.12 1.88 . . . . 0.79000000000000004 112.405 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -22.3 37.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 1.95 110.421 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.76 26.94 11.97 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.38 112.022 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 77.1 mtp180 -79.07 127.32 31.85 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.094 -0.335 . . . . 3.79 110.094 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -79.17 95.13 5.52 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 123.824 0.702 . . . . 0.69999999999999996 110.154 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.49 165.38 14.53 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.041 -1.096 . . . . 2.5 108.041 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 161.29 2.94 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.926 1.751 . . . . 0.59999999999999998 111.791 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 p -54.56 -41.02 69.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.572 0.701 . . . . 1.0 110.155 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 34.0 p90 -92.18 -173.6 3.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.3 -0.863 . . . . 1.3500000000000001 109.868 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' O ' ' HD1' ' A' ' 23' ' ' PHE . 13.4 p90 -79.91 130.93 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.708 -0.478 . . . . 4.3200000000000003 109.708 178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -61.11 116.97 4.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.14 0.495 . . . . 6.7199999999999998 110.99 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 2.7 pp -81.5 135.45 35.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.58 -0.736 . . . . 3.8999999999999999 110.369 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.63 -54.34 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.14 -0.482 . . . . 6.8099999999999996 110.715 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.462 -0.78 . . . . 6.8300000000000001 109.886 177.287 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 110.096 -0.335 . . . . 12.08 110.096 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -114.85 -70.41 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 9.5 110.487 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -102.23 -2.83 28.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.221 0.534 . . . . 8.9900000000000002 110.266 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -76.01 -13.23 60.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 6.9900000000000002 110.73 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 98.73 0.14 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.256 -0.973 . . . . 4.7800000000000002 112.579 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.14 -74.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.576 -1.01 . . . . 3.1000000000000001 110.576 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.642 ' SG ' ' HG2' ' A' ' 13' ' ' ARG . 3.4 m -127.53 126.47 42.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.199 -0.667 . . . . 1.51 109.199 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.1 t -83.4 -179.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 1.46 110.494 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.07 130.28 45.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 110.031 -0.359 . . . . 0.83999999999999997 110.031 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.51 7.91 44.53 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.023 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -122.27 131.85 54.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.187 0.81 . . . . 0.48999999999999999 113.187 176.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 85.5 mmm -83.51 148.9 26.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.776 -1.194 . . . . 2.3599999999999999 107.776 166.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.642 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 18.6 mtm-85 -129.67 139.87 51.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.524 0.678 . . . . 3.0 111.551 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 p -92.58 168.46 12.53 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.101 -0.954 . . . . 0.5 110.042 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 54.2 Cg_exo -53.95 -28.21 48.36 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.798 2.332 . . . . 0.79000000000000004 113.251 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -82.21 -10.1 59.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.759 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.74 55.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.77 -0.729 . . . . 0.38 112.609 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -79.71 149.55 31.15 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.761 0.315 . . . . 3.79 110.632 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -105.38 135.61 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.69999999999999996 111.735 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -139.7 143.85 36.71 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 108.237 -1.023 . . . . 2.5 108.237 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 3.2 Cg_endo -49.7 145.38 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.135 1.89 . . . . 0.59999999999999998 111.879 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.811 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.4 p -64.29 -19.87 65.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.816 . . . . 1.0 109.991 174.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 38.8 p90 -119.88 -169.77 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.596 -1.183 . . . . 1.3500000000000001 109.289 176.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -159.88 76.99 0.66 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.459 -0.571 . . . . 4.3200000000000003 109.459 163.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 48.2 tt0 -90.8 85.47 6.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.581 -0.736 . . . . 6.7199999999999998 109.016 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -89.38 168.07 12.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.179 -0.464 . . . . 3.8999999999999999 109.77 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 27' ' ' ILE . 4.5 mp -119.83 142.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.101 -0.333 . . . . 6.8099999999999996 110.101 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.222 -0.894 . . . . 6.8300000000000001 110.82 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.59 0.233 . . . . 12.08 110.557 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -88.42 140.13 29.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 9.5 110.502 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 23.86 5.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 8.9900000000000002 110.515 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.1 p -60.06 -45.08 94.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 6.9900000000000002 111.634 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.66 40.96 0.59 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.323 -0.711 . . . . 4.7800000000000002 111.323 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.97 83.21 0.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.087 -0.577 . . . . 3.1000000000000001 112.354 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.81 177.04 9.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.053 -0.351 . . . . 1.51 110.053 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 11.4 t -72.53 158.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 1.46 110.643 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.29 55.96 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.875 0.369 . . . . 0.83999999999999997 110.664 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.31 12.04 61.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.721 -0.752 . . . . 0.32000000000000001 111.722 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.457 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.6 m-85 -124.81 135.24 52.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.445 0.641 . . . . 0.48999999999999999 112.193 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.955 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 91.1 mmm -101.65 -179.66 4.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.686 -1.143 . . . . 2.3599999999999999 108.639 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -129.69 143.89 51.03 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.807 -0.357 . . . . 3.0 110.24 174.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.6 p -79.48 176.18 4.0 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.29 -0.868 . . . . 0.5 109.633 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.1 Cg_endo -55.5 -25.98 51.88 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.757 2.304 . . . . 0.79000000000000004 112.833 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 7.7 p-10 -95.6 -3.59 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.242 -0.435 . . . . 1.95 111.127 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 32.52 12.61 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.072 -0.585 . . . . 0.38 113.863 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.6 mtp180 -82.73 130.43 35.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.182 0.491 . . . . 3.79 109.777 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -79.03 86.6 4.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.313 0.578 . . . . 0.69999999999999996 110.298 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -95.45 163.01 22.61 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 108.901 -0.777 . . . . 2.5 108.901 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 14.9 Cg_exo -40.52 151.43 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.843 2.362 . . . . 0.59999999999999998 112.274 167.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.955 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 5.9 t -64.1 -17.99 63.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.812 0.815 . . . . 1.0 109.336 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HE1' HD22 ' A' ' 26' ' ' LEU . 24.0 p90 -106.63 -163.42 0.92 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.677 -1.147 . . . . 1.3500000000000001 109.192 170.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -77.3 138.82 39.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.063 0.459 . . . . 4.3200000000000003 110.468 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.566 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 56.6 tt0 -66.72 102.07 0.88 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.563 -0.455 . . . . 6.7199999999999998 109.833 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD22 ' HE1' ' A' ' 23' ' ' PHE . 1.6 pt? -87.2 129.12 35.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.285 0.564 . . . . 3.8999999999999999 110.137 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -109.69 -50.39 6.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.088 -0.708 . . . . 6.8099999999999996 109.088 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.248 0.977 0 CA-C-N 115.232 -0.895 . . . . 6.8300000000000001 109.113 173.039 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.634 0.254 . . . . 12.08 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -143.18 -59.31 0.42 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.53 -0.305 . . . . 9.5 111.381 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.95 2.24 24.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.892 0.377 . . . . 8.9900000000000002 111.845 -174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.7 p -86.34 -22.55 26.64 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.184 0.516 . . . . 6.9900000000000002 109.726 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.98 95.64 0.14 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.38 -0.827 . . . . 4.7800000000000002 111.175 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.15 40.86 2.72 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.03 -0.605 . . . . 3.1000000000000001 113.166 -176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -153.29 -162.19 1.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.92 -0.77 . . . . 1.51 108.92 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.5 t -63.93 152.83 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.063 -0.347 . . . . 1.46 110.063 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.53 113.95 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.462 . . . . 0.83999999999999997 111.375 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.19 18.6 19.03 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 0.32000000000000001 112.38 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 92.0 m-85 -127.82 130.69 49.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.48999999999999999 112.37 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -103.34 162.81 12.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.689 -1.141 . . . . 2.3599999999999999 108.215 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -126.91 154.14 44.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.483 -0.487 . . . . 3.0 112.188 -169.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.617 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.2 p -85.59 176.54 3.55 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.346 -0.843 . . . . 0.5 109.824 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 50.6 Cg_exo -55.55 -31.04 77.09 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.364 2.043 . . . . 0.79000000000000004 111.893 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 -31.4 39.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.692 -0.686 . . . . 1.95 110.622 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.73 22.16 6.46 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.526 -0.845 . . . . 0.38 112.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 56.0 mtp180 -79.76 129.93 34.9 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.513 -0.551 . . . . 3.79 109.513 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -91.52 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.416 0.627 . . . . 0.69999999999999996 111.993 -173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -111.01 147.12 35.89 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.034 -0.985 . . . . 2.5 108.912 173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.574 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 7.1 Cg_exo -41.12 142.09 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.3 2.667 . . . . 0.59999999999999998 112.774 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -63.24 -22.66 67.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.589 0.709 . . . . 1.0 110.405 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 52.9 p90 -114.74 -177.63 3.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.872 -1.058 . . . . 1.3500000000000001 109.42 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -157.89 31.42 0.26 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 4.3200000000000003 110.038 170.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -73.22 76.54 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.447 -0.797 . . . . 6.7199999999999998 109.513 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.9 95.75 8.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 3.8999999999999999 110.055 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.506 HG13 ' N ' ' A' ' 28' ' ' THR . 28.3 pt -81.62 -49.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 6.8099999999999996 110.31 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.506 ' N ' HG13 ' A' ' 27' ' ' ILE . 50.7 m . . . . . 0 C--O 1.244 0.809 0 N-CA-C 108.737 -0.838 . . . . 6.8300000000000001 108.737 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 111.564 0.209 . . . . 12.08 111.564 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.54 100.63 10.9 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.547 -0.538 . . . . 9.5 109.547 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -83.56 -41.35 18.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.431 . . . . 8.9900000000000002 111.101 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.7 p -81.12 -15.26 56.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.269 0.557 . . . . 6.9900000000000002 110.819 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.59 73.33 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.418 -0.81 . . . . 4.7800000000000002 111.273 -175.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . -130.22 -131.28 3.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.096 -0.573 . . . . 3.1000000000000001 112.477 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.805 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 7.7 t -116.66 -151.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.569 -0.53 . . . . 1.51 109.569 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 11' ' ' TYR . 7.1 p -71.79 152.62 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.674 -0.491 . . . . 1.46 109.674 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.64 119.96 2.39 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.102 0.778 . . . . 0.83999999999999997 113.102 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.79 13.35 58.12 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.32000000000000001 113.004 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' CD1' HG13 ' A' ' 8' ' ' VAL . 15.9 m-85 -124.98 135.48 52.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.341 0.591 . . . . 0.48999999999999999 112.128 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.647 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 82.9 mtp -99.02 176.56 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.024 . . . . 2.3599999999999999 108.815 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.805 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -135.19 140.11 45.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 3.0 109.813 173.007 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.5 p -80.43 176.79 3.45 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.475 -0.784 . . . . 0.5 109.771 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.8 Cg_exo -50.52 -34.49 42.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.487 2.125 . . . . 0.79000000000000004 113.45 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -79.95 -5.48 55.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.339 0.59 . . . . 1.95 111.047 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.54 32.63 30.18 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.978 -0.556 . . . . 0.38 112.44 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 19.3 mmm180 -88.88 120.91 30.71 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.609 -0.348 . . . . 3.79 110.411 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' MET . 86.1 m -80.03 128.42 33.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.879 -0.601 . . . . 0.69999999999999996 111.122 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 14.6 ptpt -153.0 160.84 30.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 2.5 109.102 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 24' ' ' TYR . 11.7 Cg_exo -39.17 149.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.621 2.88 . . . . 0.59999999999999998 113.267 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HG3' ' A' ' 12' ' ' MET . 11.4 p -61.49 -6.37 2.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.111 0.481 . . . . 1.0 112.282 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.547 ' HE2' ' HA ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -113.3 -88.9 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.565 . . . . 1.3500000000000001 110.88 177.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.552 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -153.94 -89.68 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.014 0.435 . . . . 4.3200000000000003 110.967 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.552 ' H ' ' HD1' ' A' ' 24' ' ' TYR . 38.1 mt-30 -93.07 -79.3 0.4 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.776 -0.647 . . . . 6.7199999999999998 111.005 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.547 ' HA ' ' HE2' ' A' ' 23' ' ' PHE . 3.3 pp -154.58 163.61 39.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.533 -0.758 . . . . 3.8999999999999999 110.632 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 mm -127.09 -32.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 6.8099999999999996 109.982 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.194 -0.907 . . . . 6.8300000000000001 109.764 173.212 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.808 0.337 . . . . 12.08 110.201 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -133.94 102.4 5.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.177 -0.465 . . . . 9.5 110.392 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -80.54 -28.09 37.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 8.9900000000000002 109.245 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -77.61 -35.44 52.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.563 -0.744 . . . . 6.9900000000000002 110.992 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.07 2.04 38.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.862 -0.685 . . . . 4.7800000000000002 111.745 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.42 -38.08 1.97 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.684 -0.769 . . . . 3.1000000000000001 112.119 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.25 -179.19 6.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 1.51 110.242 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.7 m -87.85 -178.22 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 121.249 0.547 . . . . 1.46 111.856 -171.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.54 120.89 10.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.279 -0.873 . . . . 0.83999999999999997 111.847 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.08 32.46 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.016 -0.993 . . . . 0.32000000000000001 112.102 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 91.4 m-85 -127.97 114.62 17.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.525 0.935 . . . . 0.48999999999999999 113.525 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.407 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.0 ppp? -89.72 156.35 18.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.972 -1.122 . . . . 2.3599999999999999 107.972 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 4.4 mtm-85 -132.78 140.5 48.05 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.565 -0.454 . . . . 3.0 111.044 -171.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 45.6 p -86.58 168.97 16.32 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.919 -0.582 . . . . 0.5 109.952 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 44.9 Cg_exo -58.67 -19.7 47.04 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.558 2.172 . . . . 0.79000000000000004 112.941 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.48 -12.12 59.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 1.95 110.834 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.5 30.72 26.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.055 -0.593 . . . . 0.38 111.638 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 28.5 ttm180 -92.59 122.21 34.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 3.79 109.709 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.7 m -91.05 107.68 19.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.572 0.701 . . . . 0.69999999999999996 111.272 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HE3' ' SD ' ' A' ' 12' ' ' MET . 55.8 mtmt -108.84 163.47 16.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.79 -1.095 . . . . 2.5 108.525 174.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 87.1 Cg_exo -50.99 161.7 1.37 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.265 1.977 . . . . 0.59999999999999998 111.519 171.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -23.19 46.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.307 0.575 . . . . 1.0 110.496 175.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 36.1 p90 -115.44 169.09 9.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.08 -0.964 . . . . 1.3500000000000001 109.709 171.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -78.63 141.14 38.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.098 -0.501 . . . . 4.3200000000000003 110.782 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.09 92.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.521 -0.763 . . . . 6.7199999999999998 110.181 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tt -97.29 124.16 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 3.8999999999999999 110.26 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 54.3 mt -98.07 -52.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 6.8099999999999996 109.779 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.1 -0.955 . . . . 6.8300000000000001 109.642 -178.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 22.0 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.642 -0.503 . . . . 1.46 109.642 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.58 117.0 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.83999999999999997 111.012 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 17.55 25.22 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.042 -0.599 . . . . 0.32000000000000001 112.859 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 78.7 m-85 -120.7 119.53 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.877 0.695 . . . . 0.48999999999999999 112.877 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.937 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 21.4 mmt -84.26 171.94 12.29 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.807 -1.088 . . . . 2.3599999999999999 108.414 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 20.4 mtp180 -147.2 148.08 31.13 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.293 0.568 . . . . 3.0 111.526 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 75.7 p -92.72 168.83 11.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.016 -0.993 . . . . 0.5 110.203 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.3 Cg_exo -59.28 -21.29 59.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.682 2.255 . . . . 0.79000000000000004 112.764 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.58 41.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.116 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.21 25.17 6.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.545 -0.836 . . . . 0.38 112.748 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 74.1 mtp180 -87.16 121.55 29.77 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.309 -0.156 . . . . 3.79 110.725 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 13' ' ' ARG . 62.4 m -88.0 134.74 33.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.09 0.471 . . . . 0.69999999999999996 110.206 174.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -160.57 160.24 25.75 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.891 -0.781 . . . . 2.5 108.891 174.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -34.34 146.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.11 3.207 . . . . 0.59999999999999998 113.23 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.937 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.929 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 17.6 t . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.34 -0.985 . . . . 1.46 108.34 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.45 109.46 1.02 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.79 0.328 . . . . 0.83999999999999997 110.616 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' C ' HG23 ' A' ' 22' ' ' THR . . . 106.18 4.64 38.24 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.32000000000000001 111.832 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.696 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.2 m-85 -124.28 121.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.097 0.475 . . . . 0.48999999999999999 111.043 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -100.07 -179.72 4.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.295 -1.002 . . . . 2.3599999999999999 108.295 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 21.0 mmm-85 -124.93 139.83 53.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.162 0.506 . . . . 3.0 111.403 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 p -79.18 168.47 26.58 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.089 -0.959 . . . . 0.5 109.644 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.38 -28.73 88.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.137 1.891 . . . . 0.79000000000000004 111.336 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 3.0 p-10 -83.82 -5.27 59.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.255 -0.884 . . . . 1.95 111.355 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 36.04 7.94 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.636 -0.792 . . . . 0.38 114.416 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.0 mtp180 -93.99 139.39 31.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.522 0.661 . . . . 3.79 111.397 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -87.52 96.14 10.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.877 -0.786 . . . . 0.69999999999999996 108.877 171.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -130.7 161.43 61.13 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.653 -0.499 . . . . 2.5 109.653 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.554 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.8 Cg_exo -33.87 147.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.619 3.546 . . . . 0.59999999999999998 114.257 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 10' ' ' GLY . 2.9 p . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.629 0.728 . . . . 1.0 110.384 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.236 0.395 0 CA-C-O 121.318 0.58 . . . . 1.46 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.3 128.96 37.97 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.412 -0.813 . . . . 0.83999999999999997 111.666 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 96.88 6.15 58.21 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.063 -0.971 . . . . 0.32000000000000001 111.759 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 84.8 m-85 -121.52 139.66 53.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.515 0.674 . . . . 0.48999999999999999 112.732 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.605 ' HG2' HG22 ' A' ' 22' ' ' THR . 93.3 mmm -129.47 142.94 50.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.667 -1.151 . . . . 2.3599999999999999 108.682 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.639 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -97.36 138.62 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.002 0.429 . . . . 3.0 109.909 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.74 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.5 p -79.09 -175.93 0.64 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.675 -0.693 . . . . 0.5 110.208 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.74 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 63.9 Cg_exo -55.86 -15.88 14.35 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.317 2.011 . . . . 0.79000000000000004 112.915 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.81 4.64 40.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 1.95 110.738 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.45 24.38 75.13 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.143 -0.551 . . . . 0.38 113.022 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 92.5 mtt180 -91.68 116.24 28.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.618 -0.512 . . . . 3.79 109.618 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 30.6 p -88.31 100.5 13.06 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.239 1.019 . . . . 0.69999999999999996 111.398 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.731 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -108.41 175.07 2.12 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 113.678 -1.601 . . . . 2.5 107.246 171.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -43.03 152.78 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.248 2.632 . . . . 0.59999999999999998 113.307 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.605 HG22 ' HG2' ' A' ' 12' ' ' MET . 6.1 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.489 0.662 . . . . 1.0 110.221 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.62 -0.511 . . . . 1.46 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.06 127.65 19.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.462 . . . . 0.83999999999999997 111.116 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.21 7.27 60.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.32000000000000001 112.88 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.41 132.0 42.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.503 0.557 . . . . 0.48999999999999999 112.503 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptp -104.03 -170.35 1.76 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.427 -1.323 . . . . 2.3599999999999999 107.427 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.3 mtp85 -143.1 150.92 40.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.124 -0.63 . . . . 3.0 112.381 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 38.1 p -82.34 171.68 11.32 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.25 -0.886 . . . . 0.5 109.616 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -55.75 -26.11 54.93 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.903 2.402 . . . . 0.79000000000000004 112.491 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.54 -24.48 42.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 1.95 110.669 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.22 8.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.377 -0.916 . . . . 0.38 112.949 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.7 mpt_? -80.48 129.87 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.541 -0.388 . . . . 3.79 110.559 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.0 m -78.52 90.77 4.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.904 0.859 . . . . 0.69999999999999996 110.289 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.45 135.33 19.4 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 113.627 -1.624 . . . . 2.5 108.047 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -43.03 152.28 0.22 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.162 2.575 . . . . 0.59999999999999998 113.781 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.325 -0.478 0 CA-C-O 121.511 0.672 . . . . 1.0 110.359 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.825 0.345 . . . . 1.46 110.784 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.05 122.38 14.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.37 0.605 . . . . 0.83999999999999997 110.548 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.97 12.34 27.94 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.508 -0.769 . . . . 0.32000000000000001 111.401 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.35 125.13 42.98 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.346 0.593 . . . . 0.48999999999999999 111.794 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ptp -90.62 171.91 9.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.963 -1.017 . . . . 2.3599999999999999 108.711 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -138.16 148.45 44.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.275 0.559 . . . . 3.0 112.1 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.793 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.7 p -84.76 173.66 6.87 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.068 -0.969 . . . . 0.5 109.896 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 22.3 Cg_endo -61.1 -12.29 22.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.571 2.181 . . . . 0.79000000000000004 112.311 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.35 -21.64 45.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.913 -0.585 . . . . 1.95 109.954 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.45 27.14 33.67 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.031 -0.828 . . . . 0.38 111.031 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.8 134.9 38.2 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.792 -0.448 . . . . 3.79 109.792 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.3 m -80.79 130.78 35.25 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.774 0.671 . . . . 0.69999999999999996 111.424 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.83 151.91 66.83 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.073 -1.084 . . . . 2.5 108.073 171.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.26 152.89 18.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 121.929 1.753 . . . . 0.59999999999999998 112.286 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.638 0.733 . . . . 1.0 110.332 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.759 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 110.162 -0.31 . . . . 1.46 110.162 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -38.54 -66.9 0.23 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.731 1.011 . . . . 0.83999999999999997 113.731 -171.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 49.49 1.49 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.131 -1.033 . . . . 0.32000000000000001 112.899 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.759 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 67.0 m-85 -125.03 118.66 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.735 0.779 . . . . 0.48999999999999999 112.369 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.777 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 24.5 mmt -82.69 172.26 13.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.716 -1.129 . . . . 2.3599999999999999 108.831 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -124.65 139.38 53.91 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.559 -0.457 . . . . 3.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.817 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 35.8 p -79.22 176.89 3.27 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.703 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.817 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.0 Cg_endo -52.7 -29.83 43.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.434 2.089 . . . . 0.79000000000000004 112.207 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 5.2 m-20 -79.74 -22.26 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.576 . . . . 1.95 110.921 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.33 13.74 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.363 -0.695 . . . . 0.38 111.363 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HD2' ' HB2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -78.59 132.13 37.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.727 -0.842 . . . . 3.79 108.727 174.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.89 102.93 11.99 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.598 -0.728 . . . . 0.69999999999999996 110.616 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -128.11 155.21 78.35 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 108.997 -0.742 . . . . 2.5 108.997 177.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 35.1 Cg_exo -31.48 144.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.813 3.675 . . . . 0.59999999999999998 113.751 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.777 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 3.5 p . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG23 ' CD2' ' A' ' 11' ' ' TYR . 16.0 m . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 120.866 0.365 . . . . 1.46 111.305 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.11 108.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.414 -0.812 . . . . 0.83999999999999997 112.421 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.26 34.33 26.49 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.767 -0.651 . . . . 0.32000000000000001 113.737 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 8' ' ' VAL . 85.9 m-85 -134.01 121.7 21.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.763 0.653 . . . . 0.48999999999999999 112.763 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -90.44 177.97 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.668 -1.234 . . . . 2.3599999999999999 107.668 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 13' ' ' ARG . 13.1 mtp180 -143.71 155.55 44.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.325 0.861 . . . . 3.0 113.325 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -95.54 166.57 14.38 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 114.318 -1.31 . . . . 0.5 110.039 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.07 -28.59 84.09 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.799 2.333 . . . . 0.79000000000000004 112.606 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.686 ' OD1' ' HD3' ' A' ' 18' ' ' ARG . 2.3 p30 -79.57 -14.17 59.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.519 -0.764 . . . . 1.95 111.921 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.63 11.65 37.49 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.72 -0.753 . . . . 0.38 113.868 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.686 ' HD3' ' OD1' ' A' ' 16' ' ' ASP . 11.4 mpt_? -79.89 142.42 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.355 0.577 . . . . 3.79 110.36 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.5 m -100.12 117.5 34.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.308 0.575 . . . . 0.69999999999999996 110.933 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -113.06 153.58 45.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.748 -1.204 . . . . 2.5 107.748 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.69 163.53 6.98 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 121.691 1.594 . . . . 0.59999999999999998 112.305 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 20.3 t . . . . . 0 C--O 1.235 0.331 0 CA-C-O 120.666 0.269 . . . . 1.46 110.512 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.45 126.24 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.83999999999999997 110.947 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.08 3.5 48.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.793 -0.717 . . . . 0.32000000000000001 111.986 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.8 m-85 -118.27 119.64 35.25 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.288 0.566 . . . . 0.48999999999999999 111.95 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.59 158.88 15.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.058 -1.46 . . . . 2.3599999999999999 107.058 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm-85 -123.3 150.32 43.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.716 1.006 . . . . 3.0 113.716 -164.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 25.4 p -89.79 170.24 10.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 114.356 -1.293 . . . . 0.5 111.204 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 16.5 Cg_exo -66.57 -13.84 41.55 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.008 2.472 . . . . 0.79000000000000004 110.951 173.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.32 -25.05 42.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.577 -1.192 . . . . 1.95 110.13 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.82 28.57 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.613 -0.721 . . . . 0.38 112.079 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -95.41 143.51 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.114 0.483 . . . . 3.79 112.152 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -80.79 118.33 22.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.971 -1.013 . . . . 0.69999999999999996 109.935 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -132.53 159.77 71.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.741 -0.837 . . . . 2.5 108.741 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.29 160.31 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.208 1.939 . . . . 0.59999999999999998 112.025 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.35 0.595 . . . . 1.0 110.859 172.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 9' ' ' ALA . 4.1 p . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.98 0.419 . . . . 1.46 111.151 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 8' ' ' VAL . . . -57.15 134.52 55.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.09 0.471 . . . . 0.83999999999999997 111.264 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 22' ' ' THR . . . 93.88 6.89 61.7 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 111.77 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -128.92 118.08 22.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.385 0.513 . . . . 0.48999999999999999 112.385 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.3 ptm -89.56 164.04 14.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.164 -1.05 . . . . 2.3599999999999999 108.164 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.82 147.9 43.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.139 -0.624 . . . . 3.0 111.39 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.4 p -79.46 173.24 8.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.419 -0.81 . . . . 0.5 108.89 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.8 Cg_exo -61.3 -14.28 33.41 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.057 1.838 . . . . 0.79000000000000004 111.19 170.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.95 -10.27 43.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 1.95 110.196 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.94 28.42 58.8 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.154 -0.778 . . . . 0.38 111.154 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -79.7 127.03 31.69 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.41 -0.959 . . . . 3.79 108.41 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 m -80.18 101.57 8.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.379 0.609 . . . . 0.69999999999999996 110.849 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HE3' ' HG3' ' A' ' 12' ' ' MET . 54.3 pttt -114.74 159.89 35.49 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 108.108 -1.071 . . . . 2.5 108.108 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.3 Cg_exo -54.46 172.95 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.259 1.972 . . . . 0.59999999999999998 113.034 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.528 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.9 p . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 121.322 0.582 . . . . 1.0 111.293 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.657 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 4.1 t . . . . . 0 C--O 1.233 0.207 0 N-CA-C 108.497 -0.927 . . . . 1.46 108.497 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.76 106.13 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.057 0.456 . . . . 0.83999999999999997 110.823 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.16 26.68 9.99 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.962 -0.637 . . . . 0.32000000000000001 112.52 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.657 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 58.1 m-85 -128.03 130.82 48.9 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.48999999999999999 111.917 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.4 ptp -96.78 174.62 6.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.946 -1.025 . . . . 2.3599999999999999 108.778 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.6 mtp180 -133.5 143.43 48.78 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.989 0.424 . . . . 3.0 110.42 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 21.9 p -79.78 170.32 16.43 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.728 -0.669 . . . . 0.5 109.244 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 21.4 Cg_endo -62.82 -7.09 10.42 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.547 2.164 . . . . 0.79000000000000004 111.312 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.18 -18.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.475 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 19.52 39.79 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.562 . . . . 0.38 112.606 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 79.7 ttt180 -93.83 130.08 39.98 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.353 -0.24 . . . . 3.79 110.353 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -83.58 121.42 27.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.262 0.553 . . . . 0.69999999999999996 111.267 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 14' ' ' THR . 48.8 mtmt -124.08 160.63 51.28 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.111 -1.07 . . . . 2.5 108.111 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.78 169.06 1.41 Allowed 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.179 1.919 . . . . 0.59999999999999998 111.262 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.5 0.667 . . . . 1.0 110.107 174.55 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.2 t . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 109.638 -0.504 . . . . 1.46 109.638 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.97 118.92 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.83999999999999997 111.087 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.65 39.55 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.593 -0.813 . . . . 0.32000000000000001 112.132 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 72.8 m-85 -119.98 128.62 53.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 0.48999999999999999 112.148 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.1 ptm -104.92 166.03 10.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.566 -1.272 . . . . 2.3599999999999999 107.566 175.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 14.1 mtp180 -135.75 160.78 37.49 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.04 -0.664 . . . . 3.0 112.124 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 57.7 p -104.38 172.68 3.92 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.171 -0.922 . . . . 0.5 109.56 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 33.5 Cg_exo -59.32 -18.92 47.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.704 2.269 . . . . 0.79000000000000004 112.888 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 3.9 m-20 -79.24 -10.07 59.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.753 -0.462 . . . . 1.95 109.753 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.16 22.47 54.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.157 -0.544 . . . . 0.38 111.81 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 98.8 mtt180 -85.66 126.61 34.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.714 -0.243 . . . . 3.79 110.738 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.6 m -93.19 117.19 29.78 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.723 0.64 . . . . 0.69999999999999996 111.044 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 31.7 pttt -130.28 167.42 20.94 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.182 -1.044 . . . . 2.5 108.182 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' A' ' 12' ' ' MET . 77.4 Cg_exo -50.89 163.06 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.019 1.813 . . . . 0.59999999999999998 111.783 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 177.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 40.5 t . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.154 -0.684 . . . . 1.46 109.154 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.74 117.13 4.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.931 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 18.47 20.56 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.963 -0.637 . . . . 0.32000000000000001 111.85 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 69.0 m-85 -128.92 124.46 35.22 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.806 0.813 . . . . 0.48999999999999999 112.079 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.418 ' C ' ' HD3' ' A' ' 13' ' ' ARG . 26.1 ptm -90.73 164.3 14.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.652 -1.158 . . . . 2.3599999999999999 108.832 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -125.32 141.0 52.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.336 -0.546 . . . . 3.0 110.935 -176.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 p -79.32 176.73 3.43 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.379 -0.828 . . . . 0.5 110.332 175.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 14.7 Cg_endo -57.1 -19.15 31.99 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 113.169 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 24.0 p30 -104.7 3.34 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.861 0.363 . . . . 1.95 111.082 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.78 37.35 34.31 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.38 113.556 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 24.4 mmt180 -90.12 136.66 32.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.366 -0.605 . . . . 3.79 109.366 171.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.7 m -91.87 129.29 37.86 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.989 -0.55 . . . . 0.69999999999999996 111.487 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 11.8 ptpt -147.27 156.56 46.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.503 -0.925 . . . . 2.5 108.503 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -38.5 145.86 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.623 2.882 . . . . 0.59999999999999998 113.32 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.635 0.731 . . . . 1.0 111.106 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 15.3 t . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 109.946 -0.39 . . . . 1.46 109.946 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 113.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.942 0.401 . . . . 0.83999999999999997 111.456 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.95 12.83 19.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.03 -0.605 . . . . 0.32000000000000001 111.659 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.428 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.6 m-85 -129.75 143.15 50.68 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.406 0.622 . . . . 0.48999999999999999 112.376 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -122.35 165.61 16.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.486 -1.234 . . . . 2.3599999999999999 107.758 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 12.8 mtp85 -131.37 151.84 51.16 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.833 0.679 . . . . 3.0 112.833 -171.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.9 p -79.78 176.62 3.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.93 -1.032 . . . . 0.5 110.045 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.1 Cg_endo -54.21 -22.33 25.61 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.707 2.272 . . . . 0.79000000000000004 112.161 172.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 -35.11 46.47 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.926 -0.579 . . . . 1.95 109.824 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.78 15.93 15.41 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.54 -0.754 . . . . 0.38 111.504 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 72.0 mtp180 -79.55 130.24 35.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.957 -0.386 . . . . 3.79 109.957 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.83 107.41 18.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.291 0.567 . . . . 0.69999999999999996 111.934 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -104.33 157.06 34.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.444 -0.947 . . . . 2.5 108.444 171.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -57.08 150.42 56.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 121.789 1.659 . . . . 0.59999999999999998 111.964 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.557 176.472 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CD1' ' A' ' 11' ' ' TYR . 14.7 m . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 110.304 -0.258 . . . . 1.46 110.304 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.77 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.202 0.525 . . . . 0.83999999999999997 111.909 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.99 36.2 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.326 -0.852 . . . . 0.32000000000000001 112.211 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CD1' HG23 ' A' ' 8' ' ' VAL . 18.8 m-85 -127.24 146.54 50.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.536 0.684 . . . . 0.48999999999999999 112.765 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.4 ppp? -114.48 168.65 9.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.864 -1.062 . . . . 2.3599999999999999 108.927 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -133.91 146.13 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.402 -0.519 . . . . 3.0 110.932 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.832 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.3 p -79.87 178.73 2.17 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.9 -0.591 . . . . 0.5 109.477 173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.832 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 19.4 Cg_endo -58.42 -19.52 44.12 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.016 1.811 . . . . 0.79000000000000004 111.948 173.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.787 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -79.23 -22.24 45.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.072 177.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.18 33.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.807 -0.711 . . . . 0.38 111.488 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.787 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 81.1 mtp180 -86.03 125.16 33.21 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.361 -0.607 . . . . 3.79 109.361 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.47 115.65 25.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 112.063 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HE2' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -113.13 157.53 40.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.659 -1.237 . . . . 2.5 107.659 167.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.02 173.91 1.59 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.866 1.711 . . . . 0.59999999999999998 111.891 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 1.0 111.03 178.024 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 109.234 -0.654 . . . . 1.46 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.35 133.68 55.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.311 . . . . 0.83999999999999997 111.301 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 1.41 63.36 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.769 -0.729 . . . . 0.32000000000000001 111.302 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.97 123.02 39.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.414 0.626 . . . . 0.48999999999999999 111.743 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -108.72 165.02 11.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.188 -1.041 . . . . 2.3599999999999999 108.188 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -112.54 148.49 34.4 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.392 -0.523 . . . . 3.0 111.774 -171.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.7 p -79.46 174.02 6.78 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.5 108.875 170.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 53.1 Cg_exo -55.81 -21.31 32.27 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.12 1.88 . . . . 0.79000000000000004 112.405 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -22.3 37.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 1.95 110.421 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.76 26.94 11.97 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.38 112.022 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 77.1 mtp180 -79.07 127.32 31.85 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.094 -0.335 . . . . 3.79 110.094 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -79.17 95.13 5.52 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 123.824 0.702 . . . . 0.69999999999999996 110.154 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.49 165.38 14.53 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.041 -1.096 . . . . 2.5 108.041 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 161.29 2.94 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.926 1.751 . . . . 0.59999999999999998 111.791 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.572 0.701 . . . . 1.0 110.155 173.393 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.1 t . . . . . 0 C--O 1.238 0.495 0 CA-C-O 120.67 0.271 . . . . 1.46 110.494 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.07 130.28 45.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 110.031 -0.359 . . . . 0.83999999999999997 110.031 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.51 7.91 44.53 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.023 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -122.27 131.85 54.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.187 0.81 . . . . 0.48999999999999999 113.187 176.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 85.5 mmm -83.51 148.9 26.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.776 -1.194 . . . . 2.3599999999999999 107.776 166.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -129.67 139.87 51.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.524 0.678 . . . . 3.0 111.551 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 p -92.58 168.46 12.53 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.101 -0.954 . . . . 0.5 110.042 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 54.2 Cg_exo -53.95 -28.21 48.36 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.798 2.332 . . . . 0.79000000000000004 113.251 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -82.21 -10.1 59.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.759 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.74 55.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.77 -0.729 . . . . 0.38 112.609 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -79.71 149.55 31.15 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.761 0.315 . . . . 3.79 110.632 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -105.38 135.61 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.69999999999999996 111.735 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -139.7 143.85 36.71 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 108.237 -1.023 . . . . 2.5 108.237 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -49.7 145.38 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.135 1.89 . . . . 0.59999999999999998 111.879 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.811 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.4 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.816 . . . . 1.0 109.991 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 11.4 t . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.697 0.284 . . . . 1.46 110.643 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.29 55.96 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.875 0.369 . . . . 0.83999999999999997 110.664 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.31 12.04 61.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.721 -0.752 . . . . 0.32000000000000001 111.722 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.457 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.6 m-85 -124.81 135.24 52.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.445 0.641 . . . . 0.48999999999999999 112.193 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.955 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 91.1 mmm -101.65 -179.66 4.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.686 -1.143 . . . . 2.3599999999999999 108.639 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -129.69 143.89 51.03 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.807 -0.357 . . . . 3.0 110.24 174.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.6 p -79.48 176.18 4.0 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.29 -0.868 . . . . 0.5 109.633 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.1 Cg_endo -55.5 -25.98 51.88 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.757 2.304 . . . . 0.79000000000000004 112.833 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 7.7 p-10 -95.6 -3.59 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.242 -0.435 . . . . 1.95 111.127 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 32.52 12.61 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.072 -0.585 . . . . 0.38 113.863 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.6 mtp180 -82.73 130.43 35.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.182 0.491 . . . . 3.79 109.777 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -79.03 86.6 4.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.313 0.578 . . . . 0.69999999999999996 110.298 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -95.45 163.01 22.61 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 108.901 -0.777 . . . . 2.5 108.901 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -40.52 151.43 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.843 2.362 . . . . 0.59999999999999998 112.274 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.955 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 5.9 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.812 0.815 . . . . 1.0 109.336 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.5 t . . . . . 0 C--O 1.237 0.418 0 N-CA-C 110.063 -0.347 . . . . 1.46 110.063 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.53 113.95 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.462 . . . . 0.83999999999999997 111.375 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.19 18.6 19.03 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 0.32000000000000001 112.38 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 92.0 m-85 -127.82 130.69 49.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.48999999999999999 112.37 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -103.34 162.81 12.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.689 -1.141 . . . . 2.3599999999999999 108.215 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -126.91 154.14 44.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.483 -0.487 . . . . 3.0 112.188 -169.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.617 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.2 p -85.59 176.54 3.55 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.346 -0.843 . . . . 0.5 109.824 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 50.6 Cg_exo -55.55 -31.04 77.09 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.364 2.043 . . . . 0.79000000000000004 111.893 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 -31.4 39.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.692 -0.686 . . . . 1.95 110.622 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.73 22.16 6.46 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.526 -0.845 . . . . 0.38 112.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 56.0 mtp180 -79.76 129.93 34.9 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.513 -0.551 . . . . 3.79 109.513 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -91.52 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.416 0.627 . . . . 0.69999999999999996 111.993 -173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -111.01 147.12 35.89 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.034 -0.985 . . . . 2.5 108.912 173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -41.12 142.09 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.3 2.667 . . . . 0.59999999999999998 112.774 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.589 0.709 . . . . 1.0 110.405 175.607 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 11' ' ' TYR . 7.1 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 109.674 -0.491 . . . . 1.46 109.674 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.64 119.96 2.39 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.102 0.778 . . . . 0.83999999999999997 113.102 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.79 13.35 58.12 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.32000000000000001 113.004 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.525 ' CD1' HG13 ' A' ' 8' ' ' VAL . 15.9 m-85 -124.98 135.48 52.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.341 0.591 . . . . 0.48999999999999999 112.128 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.647 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 82.9 mtp -99.02 176.56 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.024 . . . . 2.3599999999999999 108.815 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.19 140.11 45.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 3.0 109.813 173.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.5 p -80.43 176.79 3.45 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.475 -0.784 . . . . 0.5 109.771 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.8 Cg_exo -50.52 -34.49 42.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.487 2.125 . . . . 0.79000000000000004 113.45 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -79.95 -5.48 55.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.339 0.59 . . . . 1.95 111.047 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.54 32.63 30.18 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.978 -0.556 . . . . 0.38 112.44 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 19.3 mmm180 -88.88 120.91 30.71 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.609 -0.348 . . . . 3.79 110.411 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' MET . 86.1 m -80.03 128.42 33.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.879 -0.601 . . . . 0.69999999999999996 111.122 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 14.6 ptpt -153.0 160.84 30.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 2.5 109.102 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 11.7 Cg_exo -39.17 149.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.621 2.88 . . . . 0.59999999999999998 113.267 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HG3' ' A' ' 12' ' ' MET . 11.4 p . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.111 0.481 . . . . 1.0 112.282 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.241 0.652 0 CA-C-O 121.249 0.547 . . . . 1.46 111.856 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.54 120.89 10.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.279 -0.873 . . . . 0.83999999999999997 111.847 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.08 32.46 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.016 -0.993 . . . . 0.32000000000000001 112.102 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 91.4 m-85 -127.97 114.62 17.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.525 0.935 . . . . 0.48999999999999999 113.525 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.407 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.0 ppp? -89.72 156.35 18.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.972 -1.122 . . . . 2.3599999999999999 107.972 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 4.4 mtm-85 -132.78 140.5 48.05 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.565 -0.454 . . . . 3.0 111.044 -171.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 45.6 p -86.58 168.97 16.32 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.919 -0.582 . . . . 0.5 109.952 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 44.9 Cg_exo -58.67 -19.7 47.04 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.558 2.172 . . . . 0.79000000000000004 112.941 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.48 -12.12 59.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 1.95 110.834 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.5 30.72 26.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.055 -0.593 . . . . 0.38 111.638 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 28.5 ttm180 -92.59 122.21 34.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 3.79 109.709 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.7 m -91.05 107.68 19.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.572 0.701 . . . . 0.69999999999999996 111.272 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HE3' ' SD ' ' A' ' 12' ' ' MET . 55.8 mtmt -108.84 163.47 16.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.79 -1.095 . . . . 2.5 108.525 174.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.99 161.7 1.37 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.265 1.977 . . . . 0.59999999999999998 111.519 171.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 121.307 0.575 . . . . 1.0 110.496 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.097 0.475 . . . . 12.08 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -92.62 96.87 10.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 9.5 110.983 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -118.94 -65.74 1.14 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.669 -0.696 . . . . 8.9900000000000002 109.609 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -88.71 12.27 15.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.435 0.636 . . . . 6.9900000000000002 110.041 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.08 -60.78 4.65 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.609 -0.723 . . . . 4.7800000000000002 111.552 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.38 -145.32 18.32 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.343 -0.703 . . . . 3.1000000000000001 111.343 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 1.9 t -142.91 -171.38 3.44 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.838 -0.801 . . . . 1.51 108.838 176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 22.0 t -59.68 151.16 5.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 109.642 -0.503 . . . . 1.46 109.642 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.58 117.0 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.83999999999999997 111.012 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 17.55 25.22 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.042 -0.599 . . . . 0.32000000000000001 112.859 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 78.7 m-85 -120.7 119.53 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.877 0.695 . . . . 0.48999999999999999 112.877 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.937 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 21.4 mmt -84.26 171.94 12.29 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.807 -1.088 . . . . 2.3599999999999999 108.414 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 20.4 mtp180 -147.2 148.08 31.13 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.293 0.568 . . . . 3.0 111.526 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 75.7 p -92.72 168.83 11.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.016 -0.993 . . . . 0.5 110.203 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.3 Cg_exo -59.28 -21.29 59.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.682 2.255 . . . . 0.79000000000000004 112.764 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.58 41.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.116 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.21 25.17 6.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.545 -0.836 . . . . 0.38 112.748 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 74.1 mtp180 -87.16 121.55 29.77 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.309 -0.156 . . . . 3.79 110.725 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HD2' ' A' ' 13' ' ' ARG . 62.4 m -88.0 134.74 33.67 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.09 0.471 . . . . 0.69999999999999996 110.206 174.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -160.57 160.24 25.75 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.891 -0.781 . . . . 2.5 108.891 174.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.933 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 23.5 Cg_exo -34.34 146.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.11 3.207 . . . . 0.59999999999999998 113.23 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.937 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p -59.04 -29.99 67.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.929 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -90.06 -155.86 0.39 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 1.3500000000000001 109.337 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' HB2' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -79.45 126.09 30.4 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.075 0.464 . . . . 4.3200000000000003 110.167 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.933 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -63.8 -63.41 1.17 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.384 0.611 . . . . 6.7199999999999998 109.382 -178.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -161.15 -55.65 0.05 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.899 -1.519 . . . . 3.8999999999999999 106.899 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 pt -93.09 55.87 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.465 -1.243 . . . . 6.8099999999999996 109.238 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.605 ' HA ' ' HB2' ' A' ' 24' ' ' TYR . 70.2 p . . . . . 0 C--O 1.244 0.806 0 CA-C-N 114.561 -1.2 . . . . 6.8300000000000001 112.446 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.801 0.334 . . . . 12.08 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -140.73 173.02 11.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.245 -0.65 . . . . 9.5 109.245 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -115.74 146.18 42.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.877 0.37 . . . . 8.9900000000000002 110.685 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.86 122.44 24.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.075 -0.511 . . . . 6.9900000000000002 111.036 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -115.69 54.41 0.58 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.965 -0.636 . . . . 4.7800000000000002 112.079 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.56 -28.49 67.39 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.921 -0.657 . . . . 3.1000000000000001 111.702 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 t -142.45 -92.3 0.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.366 -0.605 . . . . 1.51 109.366 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 17.6 t -92.5 162.69 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.34 -0.985 . . . . 1.46 108.34 169.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.45 109.46 1.02 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.79 0.328 . . . . 0.83999999999999997 110.616 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' C ' HG23 ' A' ' 22' ' ' THR . . . 106.18 4.64 38.24 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.835 -0.698 . . . . 0.32000000000000001 111.832 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.696 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.2 m-85 -124.28 121.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.097 0.475 . . . . 0.48999999999999999 111.043 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.4 ptp -100.07 -179.72 4.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.295 -1.002 . . . . 2.3599999999999999 108.295 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 21.0 mmm-85 -124.93 139.83 53.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.162 0.506 . . . . 3.0 111.403 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 p -79.18 168.47 26.58 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.089 -0.959 . . . . 0.5 109.644 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.38 -28.73 88.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.137 1.891 . . . . 0.79000000000000004 111.336 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 3.0 p-10 -83.82 -5.27 59.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.255 -0.884 . . . . 1.95 111.355 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 36.04 7.94 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.636 -0.792 . . . . 0.38 114.416 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.0 mtp180 -93.99 139.39 31.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.522 0.661 . . . . 3.79 111.397 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.7 m -87.52 96.14 10.29 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.877 -0.786 . . . . 0.69999999999999996 108.877 171.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -130.7 161.43 61.13 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.653 -0.499 . . . . 2.5 109.653 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.554 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 23.8 Cg_exo -33.87 147.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.619 3.546 . . . . 0.59999999999999998 114.257 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 10' ' ' GLY . 2.9 p -56.01 -32.48 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.629 0.728 . . . . 1.0 110.384 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 27.1 p90 -94.35 -170.12 2.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.029 -0.987 . . . . 1.3500000000000001 110.073 175.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' O ' ' HD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -78.36 148.99 33.49 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.042 -0.527 . . . . 4.3200000000000003 110.227 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -71.22 43.11 0.08 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.846 -0.616 . . . . 6.7199999999999998 112.013 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 24' ' ' TYR . 5.1 tt -112.41 97.02 6.33 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.209 -1.034 . . . . 3.8999999999999999 108.209 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.97 133.47 29.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.865 -0.607 . . . . 6.8099999999999996 110.907 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.581 -0.723 . . . . 6.8300000000000001 110.017 175.78 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.818 0.342 . . . . 12.08 111.31 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -101.78 115.0 29.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.639 -0.71 . . . . 9.5 109.183 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -84.12 153.33 23.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.421 . . . . 8.9900000000000002 111.541 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -90.51 20.32 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.782 -0.645 . . . . 6.9900000000000002 110.392 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.42 38.89 3.15 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.929 -0.653 . . . . 4.7800000000000002 113.004 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.65 -54.91 2.93 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.178 -0.534 . . . . 3.1000000000000001 113.278 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -131.23 -177.38 4.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 122.57 0.348 . . . . 1.51 110.627 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m -86.4 -175.68 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 121.318 0.58 . . . . 1.46 112.49 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.3 128.96 37.97 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.412 -0.813 . . . . 0.83999999999999997 111.666 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 96.88 6.15 58.21 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.063 -0.971 . . . . 0.32000000000000001 111.759 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 84.8 m-85 -121.52 139.66 53.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.515 0.674 . . . . 0.48999999999999999 112.732 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.605 ' HG2' HG22 ' A' ' 22' ' ' THR . 93.3 mmm -129.47 142.94 50.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.667 -1.151 . . . . 2.3599999999999999 108.682 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.639 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -97.36 138.62 34.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.002 0.429 . . . . 3.0 109.909 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.74 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.5 p -79.09 -175.93 0.64 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.675 -0.693 . . . . 0.5 110.208 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.74 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 63.9 Cg_exo -55.86 -15.88 14.35 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.317 2.011 . . . . 0.79000000000000004 112.915 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.81 4.64 40.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 1.95 110.738 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.45 24.38 75.13 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.143 -0.551 . . . . 0.38 113.022 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 92.5 mtt180 -91.68 116.24 28.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.618 -0.512 . . . . 3.79 109.618 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 30.6 p -88.31 100.5 13.06 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.239 1.019 . . . . 0.69999999999999996 111.398 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.731 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -108.41 175.07 2.12 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 113.678 -1.601 . . . . 2.5 107.246 171.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -43.03 152.78 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.248 2.632 . . . . 0.59999999999999998 113.307 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.605 HG22 ' HG2' ' A' ' 12' ' ' MET . 6.1 p -57.82 -37.95 74.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.489 0.662 . . . . 1.0 110.221 174.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 21.6 p90 -88.08 -159.35 0.53 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.865 -1.061 . . . . 1.3500000000000001 110.195 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.543 ' O ' ' HD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -77.54 147.43 35.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.357 -0.537 . . . . 4.3200000000000003 109.873 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 20' ' ' LYS . 47.7 mt-30 -59.58 112.15 1.68 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.932 0.396 . . . . 6.7199999999999998 110.883 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -107.71 106.43 16.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.857 -0.794 . . . . 3.8999999999999999 108.857 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -96.96 148.68 5.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.911 -0.586 . . . . 6.8099999999999996 110.102 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.391 -0.814 . . . . 6.8300000000000001 110.44 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.773 0.32 . . . . 12.08 110.584 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.29 153.44 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.305 -0.407 . . . . 9.5 110.524 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -129.42 176.78 7.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.804 -0.635 . . . . 8.9900000000000002 109.612 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -78.63 -36.12 44.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 6.9900000000000002 110.867 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.17 -39.27 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.663 -0.575 . . . . 4.7800000000000002 111.663 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.56 -44.82 1.92 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.865 -0.683 . . . . 3.1000000000000001 112.703 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.811 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 17.1 t -100.24 -156.05 0.54 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.695 -0.483 . . . . 1.51 109.695 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 24.8 t -64.75 154.66 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.62 -0.511 . . . . 1.46 109.62 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.06 127.65 19.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.462 . . . . 0.83999999999999997 111.116 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.21 7.27 60.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.32000000000000001 112.88 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.41 132.0 42.36 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.503 0.557 . . . . 0.48999999999999999 112.503 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptp -104.03 -170.35 1.76 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.427 -1.323 . . . . 2.3599999999999999 107.427 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.811 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 2.3 mtp85 -143.1 150.92 40.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.124 -0.63 . . . . 3.0 112.381 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 38.1 p -82.34 171.68 11.32 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.25 -0.886 . . . . 0.5 109.616 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -55.75 -26.11 54.93 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.903 2.402 . . . . 0.79000000000000004 112.491 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.54 -24.48 42.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 1.95 110.669 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.22 8.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.377 -0.916 . . . . 0.38 112.949 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.7 mpt_? -80.48 129.87 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.541 -0.388 . . . . 3.79 110.559 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.0 m -78.52 90.77 4.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.904 0.859 . . . . 0.69999999999999996 110.289 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.45 135.33 19.4 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 113.627 -1.624 . . . . 2.5 108.047 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -43.03 152.28 0.22 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.162 2.575 . . . . 0.59999999999999998 113.781 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -57.77 -31.31 66.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.511 0.672 . . . . 1.0 110.359 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -98.76 -177.6 3.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 1.3500000000000001 110.622 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.6 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 2.6 p90 -79.04 135.17 36.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.344 -0.389 . . . . 4.3200000000000003 110.158 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 25' ' ' GLN . 18.7 mt-30 -56.62 114.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.095 -0.502 . . . . 6.7199999999999998 110.427 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -126.91 149.7 49.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.173 -0.467 . . . . 3.8999999999999999 110.244 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.2 mt -115.73 -77.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.532 -0.914 . . . . 6.8099999999999996 108.532 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.245 0.848 0 N-CA-C 108.493 -0.929 . . . . 6.8300000000000001 108.493 170.52 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.608 -0.516 . . . . 12.08 109.608 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.41 -28.19 21.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.451 -0.944 . . . . 9.5 108.451 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -89.9 166.48 13.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.035 -0.984 . . . . 8.9900000000000002 109.004 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.1 p -74.17 -64.26 1.05 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.17 0.509 . . . . 6.9900000000000002 110.655 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.93 122.72 0.74 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.778 -0.725 . . . . 4.7800000000000002 111.851 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.77 -47.36 3.78 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.712 -0.756 . . . . 3.1000000000000001 111.602 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 58.2 m -126.15 164.29 21.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.064 -0.347 . . . . 1.51 110.064 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.15 156.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.825 0.345 . . . . 1.46 110.784 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.05 122.38 14.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.37 0.605 . . . . 0.83999999999999997 110.548 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.97 12.34 27.94 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.508 -0.769 . . . . 0.32000000000000001 111.401 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.35 125.13 42.98 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.346 0.593 . . . . 0.48999999999999999 111.794 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.0 ptp -90.62 171.91 9.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.963 -1.017 . . . . 2.3599999999999999 108.711 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -138.16 148.45 44.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.275 0.559 . . . . 3.0 112.1 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.793 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.7 p -84.76 173.66 6.87 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.068 -0.969 . . . . 0.5 109.896 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 22.3 Cg_endo -61.1 -12.29 22.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.571 2.181 . . . . 0.79000000000000004 112.311 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.35 -21.64 45.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.913 -0.585 . . . . 1.95 109.954 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.45 27.14 33.67 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.031 -0.828 . . . . 0.38 111.031 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.8 134.9 38.2 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.792 -0.448 . . . . 3.79 109.792 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.3 m -80.79 130.78 35.25 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.774 0.671 . . . . 0.69999999999999996 111.424 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.83 151.91 66.83 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.073 -1.084 . . . . 2.5 108.073 171.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.644 ' HD2' ' HG2' ' A' ' 25' ' ' GLN . 76.2 Cg_exo -53.26 152.89 18.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 121.929 1.753 . . . . 0.59999999999999998 112.286 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.39 -38.38 83.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.638 0.733 . . . . 1.0 110.332 175.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.744 ' HE2' ' HB2' ' A' ' 26' ' ' LEU . 30.1 p90 -93.16 -171.79 2.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.819 -1.082 . . . . 1.3500000000000001 108.749 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -78.71 130.54 35.93 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.92 -0.312 . . . . 4.3200000000000003 110.774 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.644 ' HG2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 mt-30 -43.14 113.01 0.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.922 0.764 . . . . 6.7199999999999998 111.106 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.744 ' HB2' ' HE2' ' A' ' 23' ' ' PHE . 0.2 OUTLIER -90.53 107.08 18.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.713 -0.676 . . . . 3.8999999999999999 111.278 -168.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.16 -68.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.841 -0.618 . . . . 6.8099999999999996 109.739 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.245 -0.884 . . . . 6.8300000000000001 109.536 177.911 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.706 0.289 . . . . 12.08 110.744 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -101.86 -52.58 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 9.5 110.681 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -79.21 12.27 2.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.906 0.384 . . . . 8.9900000000000002 111.163 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.6 t -89.93 -8.61 51.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 6.9900000000000002 109.923 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.35 64.43 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.838 -0.696 . . . . 4.7800000000000002 111.814 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.99 86.82 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.663 -0.779 . . . . 3.1000000000000001 112.199 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 13' ' ' ARG . 84.9 m -80.67 -179.24 7.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.948 0.404 . . . . 1.51 110.655 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.759 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 t -71.02 168.51 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.06 -0.518 . . . . 1.46 110.162 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -38.54 -66.9 0.23 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.731 1.011 . . . . 0.83999999999999997 113.731 -171.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 49.49 1.49 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.131 -1.033 . . . . 0.32000000000000001 112.899 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.759 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 67.0 m-85 -125.03 118.66 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.735 0.779 . . . . 0.48999999999999999 112.369 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.777 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 24.5 mmt -82.69 172.26 13.11 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.716 -1.129 . . . . 2.3599999999999999 108.831 171.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HG3' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -124.65 139.38 53.91 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.559 -0.457 . . . . 3.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.817 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 35.8 p -79.22 176.89 3.27 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.703 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.817 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.0 Cg_endo -52.7 -29.83 43.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.434 2.089 . . . . 0.79000000000000004 112.207 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 5.2 m-20 -79.74 -22.26 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.576 . . . . 1.95 110.921 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.33 13.74 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.363 -0.695 . . . . 0.38 111.363 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HD2' ' HB2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -78.59 132.13 37.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.727 -0.842 . . . . 3.79 108.727 174.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -82.89 102.93 11.99 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.598 -0.728 . . . . 0.69999999999999996 110.616 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -128.11 155.21 78.35 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 108.997 -0.742 . . . . 2.5 108.997 177.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 35.1 Cg_exo -31.48 144.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.813 3.675 . . . . 0.59999999999999998 113.751 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.777 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 3.5 p -56.33 -36.62 68.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' H ' ' A' ' 24' ' ' TYR . 25.7 p90 -85.46 -148.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.449 -1.25 . . . . 1.3500000000000001 109.923 170.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' H ' ' HB2' ' A' ' 23' ' ' PHE . 6.8 p90 -100.16 134.08 43.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.152 0.501 . . . . 4.3200000000000003 111.032 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 tp-100 -56.58 115.52 2.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.404 -0.817 . . . . 6.7199999999999998 110.778 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 pp -119.14 156.04 30.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.981 -0.554 . . . . 3.8999999999999999 110.379 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.89 138.14 34.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.456 -0.338 . . . . 6.8099999999999996 110.289 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.722 -0.656 . . . . 6.8300000000000001 110.331 178.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.146 -0.316 . . . . 12.08 110.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -114.14 152.58 30.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.448 -0.342 . . . . 9.5 110.147 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.28 157.63 28.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.24 -0.436 . . . . 8.9900000000000002 110.273 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 m -87.22 32.81 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.228 -0.442 . . . . 6.9900000000000002 111.738 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.49 -45.63 1.03 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 4.7800000000000002 112.038 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.66 -47.52 0.7 Allowed Glycine 0 C--O 1.226 -0.361 0 N-CA-C 111.489 -0.644 . . . . 3.1000000000000001 111.489 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 8.1 t -117.13 -161.34 0.81 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.673 -0.862 . . . . 1.51 108.673 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG23 ' CD2' ' A' ' 11' ' ' TYR . 16.0 m -77.25 -172.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.866 0.365 . . . . 1.46 111.305 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.11 108.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.414 -0.812 . . . . 0.83999999999999997 112.421 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.26 34.33 26.49 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.767 -0.651 . . . . 0.32000000000000001 113.737 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 85.9 m-85 -134.01 121.7 21.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.763 0.653 . . . . 0.48999999999999999 112.763 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -90.44 177.97 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.668 -1.234 . . . . 2.3599999999999999 107.668 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.546 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 13.1 mtp180 -143.71 155.55 44.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.325 0.861 . . . . 3.0 113.325 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -95.54 166.57 14.38 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-N 114.318 -1.31 . . . . 0.5 110.039 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.07 -28.59 84.09 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.799 2.333 . . . . 0.79000000000000004 112.606 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.686 ' OD1' ' HD3' ' A' ' 18' ' ' ARG . 2.3 p30 -79.57 -14.17 59.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.519 -0.764 . . . . 1.95 111.921 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.63 11.65 37.49 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.72 -0.753 . . . . 0.38 113.868 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.686 ' HD3' ' OD1' ' A' ' 16' ' ' ASP . 11.4 mpt_? -79.89 142.42 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.355 0.577 . . . . 3.79 110.36 175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.5 m -100.12 117.5 34.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.308 0.575 . . . . 0.69999999999999996 110.933 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -113.06 153.58 45.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.748 -1.204 . . . . 2.5 107.748 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.69 163.53 6.98 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 121.691 1.594 . . . . 0.59999999999999998 112.305 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.66 2.22 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.822 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' HD2' ' H ' ' A' ' 25' ' ' GLN . 49.6 p90 -153.93 166.2 33.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.513 -0.921 . . . . 1.3500000000000001 108.513 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -146.59 64.64 1.19 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.515 0.674 . . . . 4.3200000000000003 109.914 169.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.526 ' H ' ' HD2' ' A' ' 23' ' ' PHE . 38.3 mt-30 -90.63 103.18 15.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.447 -0.797 . . . . 6.7199999999999998 109.478 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.954 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -88.12 23.02 2.23 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.504 -0.771 . . . . 3.8999999999999999 110.316 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.15 112.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.223 -0.898 . . . . 6.8099999999999996 109.572 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.381 -0.819 . . . . 6.8300000000000001 110.755 -177.393 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.599 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 6.1 pt-20 . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.496 0.189 . . . . 12.08 110.952 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.599 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 48.0 t30 -93.66 121.79 35.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.045 -0.354 . . . . 9.5 110.045 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -159.91 144.95 15.14 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.599 -0.889 . . . . 8.9900000000000002 108.599 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -70.21 91.57 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.241 -0.652 . . . . 6.9900000000000002 109.241 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.5 -38.25 2.32 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.827 -0.702 . . . . 4.7800000000000002 111.866 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.78 -87.07 0.41 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.811 -0.709 . . . . 3.1000000000000001 112.09 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' SG ' ' HD3' ' A' ' 13' ' ' ARG . 75.5 m -92.03 173.48 7.82 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.162 -0.31 . . . . 1.51 110.162 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 20.3 t -71.21 158.43 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.331 -0.395 . . . . 1.46 110.512 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.45 126.24 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.83999999999999997 110.947 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.08 3.5 48.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.793 -0.717 . . . . 0.32000000000000001 111.986 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CD2' ' HB ' ' A' ' 8' ' ' VAL . 97.8 m-85 -118.27 119.64 35.25 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.288 0.566 . . . . 0.48999999999999999 111.95 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.59 158.88 15.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.058 -1.46 . . . . 2.3599999999999999 107.058 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HD3' ' SG ' ' A' ' 7' ' ' CYS . 55.2 mtm-85 -123.3 150.32 43.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.716 1.006 . . . . 3.0 113.716 -164.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 25.4 p -89.79 170.24 10.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 114.356 -1.293 . . . . 0.5 111.204 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 16.5 Cg_exo -66.57 -13.84 41.55 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.008 2.472 . . . . 0.79000000000000004 110.951 173.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.32 -25.05 42.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.577 -1.192 . . . . 1.95 110.13 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.82 28.57 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.613 -0.721 . . . . 0.38 112.079 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -95.41 143.51 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.114 0.483 . . . . 3.79 112.152 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -80.79 118.33 22.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.971 -1.013 . . . . 0.69999999999999996 109.935 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -132.53 159.77 71.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.741 -0.837 . . . . 2.5 108.741 170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.29 160.31 1.57 Allowed 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.208 1.939 . . . . 0.59999999999999998 112.025 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -51.94 -38.47 56.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.35 0.595 . . . . 1.0 110.859 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -92.11 -172.38 3.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.661 -0.699 . . . . 1.3500000000000001 110.468 174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 4.2 p90 -79.18 133.0 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 4.3200000000000003 110.826 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -65.3 110.78 2.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.488 -0.778 . . . . 6.7199999999999998 110.077 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.87 123.4 27.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 3.8999999999999999 109.849 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.75 25.54 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.417 0.627 . . . . 6.8099999999999996 110.837 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.494 -0.765 . . . . 6.8300000000000001 109.924 179.205 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.826 0.346 . . . . 12.08 110.624 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -85.07 116.39 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.416 -0.587 . . . . 9.5 109.416 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.69 159.99 20.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.931 0.396 . . . . 8.9900000000000002 111.438 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -74.17 83.29 1.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 6.9900000000000002 110.633 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.12 -114.4 1.47 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.025 -0.83 . . . . 4.7800000000000002 111.025 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.38 58.27 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.461 -0.876 . . . . 3.1000000000000001 112.753 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.76 127.48 32.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.311 -0.625 . . . . 1.51 109.311 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 9' ' ' ALA . 4.1 p -82.65 -179.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.151 -0.477 . . . . 1.46 111.151 -169.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 8' ' ' VAL . . . -57.15 134.52 55.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.09 0.471 . . . . 0.83999999999999997 111.264 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 22' ' ' THR . . . 93.88 6.89 61.7 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 111.77 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -128.92 118.08 22.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.385 0.513 . . . . 0.48999999999999999 112.385 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.3 ptm -89.56 164.04 14.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.164 -1.05 . . . . 2.3599999999999999 108.164 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.82 147.9 43.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.139 -0.624 . . . . 3.0 111.39 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.4 p -79.46 173.24 8.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.419 -0.81 . . . . 0.5 108.89 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.8 Cg_exo -61.3 -14.28 33.41 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.057 1.838 . . . . 0.79000000000000004 111.19 170.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.95 -10.27 43.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 1.95 110.196 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.94 28.42 58.8 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 111.154 -0.778 . . . . 0.38 111.154 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -79.7 127.03 31.69 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.41 -0.959 . . . . 3.79 108.41 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 m -80.18 101.57 8.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.379 0.609 . . . . 0.69999999999999996 110.849 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HE3' ' HG3' ' A' ' 12' ' ' MET . 54.3 pttt -114.74 159.89 35.49 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 108.108 -1.071 . . . . 2.5 108.108 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.3 Cg_exo -54.46 172.95 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.259 1.972 . . . . 0.59999999999999998 113.034 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.528 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.9 p -56.55 -18.68 12.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.322 0.582 . . . . 1.0 111.293 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -121.38 -171.89 2.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 1.3500000000000001 109.473 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.573 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 2.0 p90 -78.33 130.51 36.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.891 0.377 . . . . 4.3200000000000003 110.133 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.69 101.42 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.904 -0.589 . . . . 6.7199999999999998 110.799 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.24 115.85 21.5 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.21 -0.663 . . . . 3.8999999999999999 109.21 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.14 -62.27 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.307 -0.406 . . . . 6.8099999999999996 110.71 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.744 -0.646 . . . . 6.8300000000000001 110.157 179.754 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.795 0.331 . . . . 12.08 110.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -108.68 144.27 36.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 9.5 110.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -131.11 15.41 5.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 8.9900000000000002 110.597 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -62.68 -46.98 85.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.615 -0.72 . . . . 6.9900000000000002 111.232 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.59 66.21 0.49 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.95 -0.643 . . . . 4.7800000000000002 111.677 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.75 -93.97 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.801 -0.714 . . . . 3.1000000000000001 111.58 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.8 t -102.56 -104.21 0.27 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.228 -0.656 . . . . 1.51 109.228 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.657 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 4.1 t -91.58 170.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.497 -0.927 . . . . 1.46 108.497 170.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.76 106.13 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.057 0.456 . . . . 0.83999999999999997 110.823 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.16 26.68 9.99 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.962 -0.637 . . . . 0.32000000000000001 112.52 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.657 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 58.1 m-85 -128.03 130.82 48.9 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.48999999999999999 111.917 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.4 ptp -96.78 174.62 6.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.946 -1.025 . . . . 2.3599999999999999 108.778 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.6 mtp180 -133.5 143.43 48.78 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.989 0.424 . . . . 3.0 110.42 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 21.9 p -79.78 170.32 16.43 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.728 -0.669 . . . . 0.5 109.244 173.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 21.4 Cg_endo -62.82 -7.09 10.42 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.547 2.164 . . . . 0.79000000000000004 111.312 175.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.18 -18.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.475 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 19.52 39.79 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.562 . . . . 0.38 112.606 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 79.7 ttt180 -93.83 130.08 39.98 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.353 -0.24 . . . . 3.79 110.353 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -83.58 121.42 27.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.262 0.553 . . . . 0.69999999999999996 111.267 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 14' ' ' THR . 48.8 mtmt -124.08 160.63 51.28 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.111 -1.07 . . . . 2.5 108.111 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.78 169.06 1.41 Allowed 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.179 1.919 . . . . 0.59999999999999998 111.262 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -64.59 -17.5 64.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.5 0.667 . . . . 1.0 110.107 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 25' ' ' GLN . 23.5 p90 -117.65 178.01 4.55 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.776 -1.102 . . . . 1.3500000000000001 109.322 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -79.19 -26.99 42.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.96 0.726 . . . . 4.3200000000000003 112.96 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.68 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 28.6 mt-30 -50.88 107.9 0.2 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.658 0.742 . . . . 6.7199999999999998 112.14 -168.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.2 pp -87.12 146.8 25.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.471 -1.241 . . . . 3.8999999999999999 111.062 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.9 -52.52 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.187 0.518 . . . . 6.8099999999999996 109.699 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.598 -0.715 . . . . 6.8300000000000001 109.84 177.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.346 0.593 . . . . 12.08 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.0 -59.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.833 -0.622 . . . . 9.5 110.368 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.93 -26.4 40.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 8.9900000000000002 110.038 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.0 m -78.92 103.36 8.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.43 -0.805 . . . . 6.9900000000000002 110.768 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.41 -71.13 2.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.253 -0.498 . . . . 4.7800000000000002 112.636 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.08 -143.51 16.52 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.405 -0.678 . . . . 3.1000000000000001 111.405 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.814 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 2.8 t -114.78 -156.26 0.6 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.701 -0.481 . . . . 1.51 109.701 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.2 t -64.57 151.94 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.638 -0.504 . . . . 1.46 109.638 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.97 118.92 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.83999999999999997 111.087 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.65 39.55 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.593 -0.813 . . . . 0.32000000000000001 112.132 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 72.8 m-85 -119.98 128.62 53.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 0.48999999999999999 112.148 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 26.1 ptm -104.92 166.03 10.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.566 -1.272 . . . . 2.3599999999999999 107.566 175.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.814 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 14.1 mtp180 -135.75 160.78 37.49 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.04 -0.664 . . . . 3.0 112.124 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 57.7 p -104.38 172.68 3.92 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.171 -0.922 . . . . 0.5 109.56 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 33.5 Cg_exo -59.32 -18.92 47.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.704 2.269 . . . . 0.79000000000000004 112.888 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 3.9 m-20 -79.24 -10.07 59.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.753 -0.462 . . . . 1.95 109.753 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.16 22.47 54.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.157 -0.544 . . . . 0.38 111.81 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 98.8 mtt180 -85.66 126.61 34.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.714 -0.243 . . . . 3.79 110.738 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.6 m -93.19 117.19 29.78 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.723 0.64 . . . . 0.69999999999999996 111.044 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 31.7 pttt -130.28 167.42 20.94 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.182 -1.044 . . . . 2.5 108.182 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 23' ' ' PHE . 77.4 Cg_exo -50.89 163.06 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.019 1.813 . . . . 0.59999999999999998 111.783 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -67.71 27.98 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 21' ' ' PRO . 24.9 p90 -157.68 -155.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.939 -0.763 . . . . 1.3500000000000001 108.939 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' HD1' ' H ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -93.03 123.38 36.24 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.853 0.358 . . . . 4.3200000000000003 110.675 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 122.86 19.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.567 -0.531 . . . . 6.7199999999999998 109.567 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.7 tm? -79.0 102.27 8.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.456 -0.572 . . . . 3.8999999999999999 109.456 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.74 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.607 -0.516 . . . . 6.8099999999999996 109.607 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.416 -0.802 . . . . 6.8300000000000001 110.177 179.576 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.731 -0.47 . . . . 12.08 109.731 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -92.41 -62.77 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.41 . . . . 9.5 111.024 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -95.08 138.16 33.16 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.127 -0.488 . . . . 8.9900000000000002 110.021 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 p -82.29 -1.21 48.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 6.9900000000000002 111.608 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.48 -62.36 4.33 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.88 -0.676 . . . . 4.7800000000000002 112.114 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.25 -167.57 25.71 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.786 -0.721 . . . . 3.1000000000000001 112.162 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.631 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 8.9 t -106.11 -155.11 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.06 -0.718 . . . . 1.51 109.06 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 40.5 t -60.61 145.32 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.154 -0.684 . . . . 1.46 109.154 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.74 117.13 4.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.931 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 18.47 20.56 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.963 -0.637 . . . . 0.32000000000000001 111.85 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 69.0 m-85 -128.92 124.46 35.22 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.806 0.813 . . . . 0.48999999999999999 112.079 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.418 ' C ' ' HD3' ' A' ' 13' ' ' ARG . 26.1 ptm -90.73 164.3 14.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.652 -1.158 . . . . 2.3599999999999999 108.832 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.631 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -125.32 141.0 52.33 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.336 -0.546 . . . . 3.0 110.935 -176.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 p -79.32 176.73 3.43 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.379 -0.828 . . . . 0.5 110.332 175.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 14.7 Cg_endo -57.1 -19.15 31.99 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 113.169 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 24.0 p30 -104.7 3.34 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.861 0.363 . . . . 1.95 111.082 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.78 37.35 34.31 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.38 113.556 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 24.4 mmt180 -90.12 136.66 32.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.366 -0.605 . . . . 3.79 109.366 171.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.7 m -91.87 129.29 37.86 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.989 -0.55 . . . . 0.69999999999999996 111.487 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 11.8 ptpt -147.27 156.56 46.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 108.503 -0.925 . . . . 2.5 108.503 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.62 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 6.4 Cg_exo -38.5 145.86 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.623 2.882 . . . . 0.59999999999999998 113.32 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.64 6.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.635 0.731 . . . . 1.0 111.106 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 54.6 p90 -150.27 -179.52 7.26 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.771 -1.104 . . . . 1.3500000000000001 108.033 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -159.07 67.97 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.633 0.73 . . . . 4.3200000000000003 109.612 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.453 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 14.8 mm100 -85.85 -25.81 26.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.911 -1.041 . . . . 6.7199999999999998 109.814 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.5 pp -82.6 114.14 20.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.363 -0.835 . . . . 3.8999999999999999 110.945 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 pt -122.78 13.51 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.555 -0.748 . . . . 6.8099999999999996 109.659 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.246 0.903 0 CA-C-N 114.715 -1.13 . . . . 6.8300000000000001 109.593 -179.35 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.816 -0.438 . . . . 12.08 109.816 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -129.4 134.6 47.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 9.5 110.314 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -103.98 124.94 49.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.921 -0.581 . . . . 8.9900000000000002 110.594 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.7 m -65.35 -57.44 8.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 6.9900000000000002 110.083 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.84 20.06 4.12 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.683 -0.77 . . . . 4.7800000000000002 111.204 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.83 6.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.91 -0.662 . . . . 3.1000000000000001 111.782 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.886 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 7.7 t -125.0 -153.99 0.59 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.409 -0.589 . . . . 1.51 109.409 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 11' ' ' TYR . 15.3 t -64.52 158.2 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.946 -0.39 . . . . 1.46 109.946 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 113.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.942 0.401 . . . . 0.83999999999999997 111.456 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.95 12.83 19.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.03 -0.605 . . . . 0.32000000000000001 111.659 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 97.6 m-85 -129.75 143.15 50.68 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.406 0.622 . . . . 0.48999999999999999 112.376 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -122.35 165.61 16.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.486 -1.234 . . . . 2.3599999999999999 107.758 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.886 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 12.8 mtp85 -131.37 151.84 51.16 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.833 0.679 . . . . 3.0 112.833 -171.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.9 p -79.78 176.62 3.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.93 -1.032 . . . . 0.5 110.045 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 10.1 Cg_endo -54.21 -22.33 25.61 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.707 2.272 . . . . 0.79000000000000004 112.161 172.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 -35.11 46.47 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.926 -0.579 . . . . 1.95 109.824 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.78 15.93 15.41 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.54 -0.754 . . . . 0.38 111.504 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 72.0 mtp180 -79.55 130.24 35.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.957 -0.386 . . . . 3.79 109.957 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.83 107.41 18.66 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.291 0.567 . . . . 0.69999999999999996 111.934 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -104.33 157.06 34.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.444 -0.947 . . . . 2.5 108.444 171.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -57.08 150.42 56.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 121.789 1.659 . . . . 0.59999999999999998 111.964 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -52.18 -50.15 62.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.557 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 2.8 p90 -97.0 175.73 6.22 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.059 -0.973 . . . . 1.3500000000000001 109.399 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -79.61 120.32 23.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.654 -0.498 . . . . 4.3200000000000003 109.654 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -61.57 111.34 1.78 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 6.7199999999999998 110.969 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tt -83.7 102.66 12.41 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.862 -0.792 . . . . 3.8999999999999999 108.862 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.7 pt -95.08 -25.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.856 -0.611 . . . . 6.8099999999999996 111.738 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.442 -0.79 . . . . 6.8300000000000001 110.174 -179.762 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.764 0.316 . . . . 12.08 110.784 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -86.5 90.46 8.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.21 0.529 . . . . 9.5 110.722 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.418 ' HE1' ' H ' ' A' ' 13' ' ' ARG . 49.2 p90 -114.55 11.97 17.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.634 0.731 . . . . 8.9900000000000002 109.383 173.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.63 93.0 3.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.177 -0.92 . . . . 6.9900000000000002 109.904 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.19 -20.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.173 -0.922 . . . . 4.7800000000000002 111.412 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.26 78.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.093 -0.803 . . . . 3.1000000000000001 111.093 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -97.93 -162.16 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.522 -0.918 . . . . 1.51 108.522 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CD1' ' A' ' 11' ' ' TYR . 14.7 m -69.78 156.91 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.433 -0.507 . . . . 1.46 110.304 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.77 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.202 0.525 . . . . 0.83999999999999997 111.909 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.99 36.2 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.326 -0.852 . . . . 0.32000000000000001 112.211 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CD1' HG23 ' A' ' 8' ' ' VAL . 18.8 m-85 -127.24 146.54 50.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.536 0.684 . . . . 0.48999999999999999 112.765 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.4 ppp? -114.48 168.65 9.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.864 -1.062 . . . . 2.3599999999999999 108.927 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -133.91 146.13 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.402 -0.519 . . . . 3.0 110.932 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.832 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.3 p -79.87 178.73 2.17 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.9 -0.591 . . . . 0.5 109.477 173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.832 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 19.4 Cg_endo -58.42 -19.52 44.12 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.016 1.811 . . . . 0.79000000000000004 111.948 173.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.787 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -79.23 -22.24 45.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.072 177.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.18 33.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.807 -0.711 . . . . 0.38 111.488 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.787 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 81.1 mtp180 -86.03 125.16 33.21 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.361 -0.607 . . . . 3.79 109.361 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.47 115.65 25.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 112.063 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HE2' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -113.13 157.53 40.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 107.659 -1.237 . . . . 2.5 107.659 167.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.02 173.91 1.59 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.866 1.711 . . . . 0.59999999999999998 111.891 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -62.74 -12.67 25.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.196 0.522 . . . . 1.0 111.03 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 37.2 p90 -139.78 171.41 14.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.548 -0.751 . . . . 1.3500000000000001 109.04 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.75 41.32 0.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.801 0.81 . . . . 4.3200000000000003 109.37 167.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 15.4 mm100 -90.3 105.9 18.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.796 -1.093 . . . . 6.7199999999999998 110.104 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 pp -129.14 128.05 42.66 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.151 0.5 . . . . 3.8999999999999999 110.042 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.4 mt -106.91 -29.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.165 -0.68 . . . . 6.8099999999999996 109.165 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.243 0.732 0 CA-C-N 115.61 -0.723 . . . . 6.8300000000000001 109.815 176.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.849 0.357 . . . . 12.08 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -99.82 72.03 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 9.5 110.883 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -159.81 135.33 8.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.811 -0.811 . . . . 8.9900000000000002 108.811 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.2 t -88.7 -46.79 8.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 6.9900000000000002 111.14 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.88 -88.18 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.62 -0.8 . . . . 4.7800000000000002 112.241 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.7 -50.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.993 -0.622 . . . . 3.1000000000000001 111.885 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.4 m -128.42 -169.69 2.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.343 -0.614 . . . . 1.51 109.343 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.08 157.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.234 -0.654 . . . . 1.46 109.234 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.35 133.68 55.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.311 . . . . 0.83999999999999997 111.301 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 1.41 63.36 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.769 -0.729 . . . . 0.32000000000000001 111.302 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.97 123.02 39.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.414 0.626 . . . . 0.48999999999999999 111.743 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -108.72 165.02 11.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.188 -1.041 . . . . 2.3599999999999999 108.188 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -112.54 148.49 34.4 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.392 -0.523 . . . . 3.0 111.774 -171.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.7 p -79.46 174.02 6.78 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.5 108.875 170.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 53.1 Cg_exo -55.81 -21.31 32.27 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.12 1.88 . . . . 0.79000000000000004 112.405 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -22.3 37.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 1.95 110.421 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.76 26.94 11.97 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.38 112.022 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 77.1 mtp180 -79.07 127.32 31.85 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 110.094 -0.335 . . . . 3.79 110.094 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.0 m -79.17 95.13 5.52 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 123.824 0.702 . . . . 0.69999999999999996 110.154 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.49 165.38 14.53 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 108.041 -1.096 . . . . 2.5 108.041 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 161.29 2.94 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.926 1.751 . . . . 0.59999999999999998 111.791 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 p -54.56 -41.02 69.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.572 0.701 . . . . 1.0 110.155 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HD1' ' O ' ' A' ' 24' ' ' TYR . 34.0 p90 -92.18 -173.6 3.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.3 -0.863 . . . . 1.3500000000000001 109.868 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' O ' ' HD1' ' A' ' 23' ' ' PHE . 13.4 p90 -79.91 130.93 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.708 -0.478 . . . . 4.3200000000000003 109.708 178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -61.11 116.97 4.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.14 0.495 . . . . 6.7199999999999998 110.99 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 2.7 pp -81.5 135.45 35.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.58 -0.736 . . . . 3.8999999999999999 110.369 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.63 -54.34 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.14 -0.482 . . . . 6.8099999999999996 110.715 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.462 -0.78 . . . . 6.8300000000000001 109.886 177.287 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 110.096 -0.335 . . . . 12.08 110.096 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -114.85 -70.41 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.941 0.4 . . . . 9.5 110.487 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -102.23 -2.83 28.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.221 0.534 . . . . 8.9900000000000002 110.266 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -76.01 -13.23 60.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 6.9900000000000002 110.73 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 98.73 0.14 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.256 -0.973 . . . . 4.7800000000000002 112.579 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.14 -74.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.576 -1.01 . . . . 3.1000000000000001 110.576 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.642 ' SG ' ' HG2' ' A' ' 13' ' ' ARG . 3.4 m -127.53 126.47 42.26 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.199 -0.667 . . . . 1.51 109.199 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.1 t -83.4 -179.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 1.46 110.494 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.07 130.28 45.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 110.031 -0.359 . . . . 0.83999999999999997 110.031 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.51 7.91 44.53 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.619 -0.8 . . . . 0.32000000000000001 112.023 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -122.27 131.85 54.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.187 0.81 . . . . 0.48999999999999999 113.187 176.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 85.5 mmm -83.51 148.9 26.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.776 -1.194 . . . . 2.3599999999999999 107.776 166.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.642 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 18.6 mtm-85 -129.67 139.87 51.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.524 0.678 . . . . 3.0 111.551 -175.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 p -92.58 168.46 12.53 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.101 -0.954 . . . . 0.5 110.042 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 54.2 Cg_exo -53.95 -28.21 48.36 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.798 2.332 . . . . 0.79000000000000004 113.251 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -82.21 -10.1 59.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.759 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.08 14.74 55.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.77 -0.729 . . . . 0.38 112.609 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -79.71 149.55 31.15 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.761 0.315 . . . . 3.79 110.632 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -105.38 135.61 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.69999999999999996 111.735 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -139.7 143.85 36.71 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 108.237 -1.023 . . . . 2.5 108.237 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 3.2 Cg_endo -49.7 145.38 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.135 1.89 . . . . 0.59999999999999998 111.879 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.811 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 1.4 p -64.29 -19.87 65.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.816 . . . . 1.0 109.991 174.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 38.8 p90 -119.88 -169.77 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.596 -1.183 . . . . 1.3500000000000001 109.289 176.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -159.88 76.99 0.66 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.459 -0.571 . . . . 4.3200000000000003 109.459 163.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' H ' ' HD1' ' A' ' 23' ' ' PHE . 7.4 tt0 -90.8 85.47 6.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.581 -0.736 . . . . 6.7199999999999998 109.016 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -89.38 168.07 12.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.179 -0.464 . . . . 3.8999999999999999 109.77 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 27' ' ' ILE . 4.5 mp -119.83 142.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.101 -0.333 . . . . 6.8099999999999996 110.101 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.222 -0.894 . . . . 6.8300000000000001 110.82 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.59 0.233 . . . . 12.08 110.557 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -88.42 140.13 29.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 9.5 110.502 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 23.86 5.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 8.9900000000000002 110.515 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.1 p -60.06 -45.08 94.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 6.9900000000000002 111.634 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.66 40.96 0.59 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.323 -0.711 . . . . 4.7800000000000002 111.323 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.97 83.21 0.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.087 -0.577 . . . . 3.1000000000000001 112.354 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.81 177.04 9.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.053 -0.351 . . . . 1.51 110.053 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 11.4 t -72.53 158.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 1.46 110.643 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.29 55.96 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.875 0.369 . . . . 0.83999999999999997 110.664 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.31 12.04 61.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.721 -0.752 . . . . 0.32000000000000001 111.722 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.457 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 88.6 m-85 -124.81 135.24 52.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.445 0.641 . . . . 0.48999999999999999 112.193 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.955 ' HG2' ' HA ' ' A' ' 22' ' ' THR . 91.1 mmm -101.65 -179.66 4.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.686 -1.143 . . . . 2.3599999999999999 108.639 172.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -129.69 143.89 51.03 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.807 -0.357 . . . . 3.0 110.24 174.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.6 p -79.48 176.18 4.0 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.29 -0.868 . . . . 0.5 109.633 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.1 Cg_endo -55.5 -25.98 51.88 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.757 2.304 . . . . 0.79000000000000004 112.833 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 7.7 p-10 -95.6 -3.59 46.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.242 -0.435 . . . . 1.95 111.127 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 32.52 12.61 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.072 -0.585 . . . . 0.38 113.863 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 65.6 mtp180 -82.73 130.43 35.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.182 0.491 . . . . 3.79 109.777 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -79.03 86.6 4.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.313 0.578 . . . . 0.69999999999999996 110.298 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -95.45 163.01 22.61 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 108.901 -0.777 . . . . 2.5 108.901 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 14.9 Cg_exo -40.52 151.43 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.843 2.362 . . . . 0.59999999999999998 112.274 167.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.955 ' HA ' ' HG2' ' A' ' 12' ' ' MET . 5.9 t -64.1 -17.99 63.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.812 0.815 . . . . 1.0 109.336 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HE1' HD22 ' A' ' 26' ' ' LEU . 24.0 p90 -106.63 -163.42 0.92 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.677 -1.147 . . . . 1.3500000000000001 109.192 170.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -77.3 138.82 39.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.063 0.459 . . . . 4.3200000000000003 110.468 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.566 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 7.8 tt0 -66.72 102.07 0.88 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.563 -0.455 . . . . 6.7199999999999998 109.833 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD22 ' HE1' ' A' ' 23' ' ' PHE . 1.6 pt? -87.2 129.12 35.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.285 0.564 . . . . 3.8999999999999999 110.137 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -109.69 -50.39 6.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.088 -0.708 . . . . 6.8099999999999996 109.088 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.248 0.977 0 CA-C-N 115.232 -0.895 . . . . 6.8300000000000001 109.113 173.039 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.634 0.254 . . . . 12.08 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -143.18 -59.31 0.42 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.53 -0.305 . . . . 9.5 111.381 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -79.95 2.24 24.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.892 0.377 . . . . 8.9900000000000002 111.845 -174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.7 p -86.34 -22.55 26.64 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.184 0.516 . . . . 6.9900000000000002 109.726 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.98 95.64 0.14 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.38 -0.827 . . . . 4.7800000000000002 111.175 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.15 40.86 2.72 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.03 -0.605 . . . . 3.1000000000000001 113.166 -176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -153.29 -162.19 1.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.92 -0.77 . . . . 1.51 108.92 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 21.5 t -63.93 152.83 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.063 -0.347 . . . . 1.46 110.063 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.53 113.95 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.462 . . . . 0.83999999999999997 111.375 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.19 18.6 19.03 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 0.32000000000000001 112.38 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.517 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 92.0 m-85 -127.82 130.69 49.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.48999999999999999 112.37 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -103.34 162.81 12.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.689 -1.141 . . . . 2.3599999999999999 108.215 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -126.91 154.14 44.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.483 -0.487 . . . . 3.0 112.188 -169.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.617 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.2 p -85.59 176.54 3.55 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.346 -0.843 . . . . 0.5 109.824 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 50.6 Cg_exo -55.55 -31.04 77.09 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.364 2.043 . . . . 0.79000000000000004 111.893 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.02 -31.4 39.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.692 -0.686 . . . . 1.95 110.622 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.73 22.16 6.46 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.526 -0.845 . . . . 0.38 112.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 56.0 mtp180 -79.76 129.93 34.9 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.513 -0.551 . . . . 3.79 109.513 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -91.52 107.69 19.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.416 0.627 . . . . 0.69999999999999996 111.993 -173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -111.01 147.12 35.89 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.034 -0.985 . . . . 2.5 108.912 173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.574 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 7.1 Cg_exo -41.12 142.09 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.3 2.667 . . . . 0.59999999999999998 112.774 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -63.24 -22.66 67.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.589 0.709 . . . . 1.0 110.405 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 52.9 p90 -114.74 -177.63 3.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.872 -1.058 . . . . 1.3500000000000001 109.42 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -157.89 31.42 0.26 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 4.3200000000000003 110.038 170.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -73.22 76.54 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.447 -0.797 . . . . 6.7199999999999998 109.513 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.9 95.75 8.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 3.8999999999999999 110.055 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.506 HG13 ' N ' ' A' ' 28' ' ' THR . 28.3 pt -81.62 -49.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 6.8099999999999996 110.31 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.506 ' N ' HG13 ' A' ' 27' ' ' ILE . 50.7 m . . . . . 0 C--O 1.244 0.809 0 N-CA-C 108.737 -0.838 . . . . 6.8300000000000001 108.737 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 111.564 0.209 . . . . 12.08 111.564 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.54 100.63 10.9 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.547 -0.538 . . . . 9.5 109.547 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -83.56 -41.35 18.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.431 . . . . 8.9900000000000002 111.101 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.7 p -81.12 -15.26 56.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.269 0.557 . . . . 6.9900000000000002 110.819 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.59 73.33 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.418 -0.81 . . . . 4.7800000000000002 111.273 -175.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . -130.22 -131.28 3.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.096 -0.573 . . . . 3.1000000000000001 112.477 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.805 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 7.7 t -116.66 -151.81 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.569 -0.53 . . . . 1.51 109.569 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 11' ' ' TYR . 7.1 p -71.79 152.62 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.674 -0.491 . . . . 1.46 109.674 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.64 119.96 2.39 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.102 0.778 . . . . 0.83999999999999997 113.102 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.79 13.35 58.12 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.32000000000000001 113.004 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' CD1' HG13 ' A' ' 8' ' ' VAL . 15.9 m-85 -124.98 135.48 52.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.341 0.591 . . . . 0.48999999999999999 112.128 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.647 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 82.9 mtp -99.02 176.56 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.024 . . . . 2.3599999999999999 108.815 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.805 ' HD2' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -135.19 140.11 45.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 3.0 109.813 173.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 69.5 p -80.43 176.79 3.45 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.475 -0.784 . . . . 0.5 109.771 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.8 Cg_exo -50.52 -34.49 42.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.487 2.125 . . . . 0.79000000000000004 113.45 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -79.95 -5.48 55.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.339 0.59 . . . . 1.95 111.047 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.54 32.63 30.18 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.978 -0.556 . . . . 0.38 112.44 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 19.3 mmm180 -88.88 120.91 30.71 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.609 -0.348 . . . . 3.79 110.411 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' MET . 86.1 m -80.03 128.42 33.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.879 -0.601 . . . . 0.69999999999999996 111.122 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 14.6 ptpt -153.0 160.84 30.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 2.5 109.102 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 24' ' ' TYR . 11.7 Cg_exo -39.17 149.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.621 2.88 . . . . 0.59999999999999998 113.267 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HG3' ' A' ' 12' ' ' MET . 11.4 p -61.49 -6.37 2.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.111 0.481 . . . . 1.0 112.282 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.547 ' HE2' ' HA ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -113.3 -88.9 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.565 . . . . 1.3500000000000001 110.88 177.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.552 ' HD1' ' H ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -153.94 -89.68 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.014 0.435 . . . . 4.3200000000000003 110.967 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.552 ' H ' ' HD1' ' A' ' 24' ' ' TYR . 38.1 mt-30 -93.07 -79.3 0.4 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.776 -0.647 . . . . 6.7199999999999998 111.005 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.547 ' HA ' ' HE2' ' A' ' 23' ' ' PHE . 3.3 pp -154.58 163.61 39.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.533 -0.758 . . . . 3.8999999999999999 110.632 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 mm -127.09 -32.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 6.8099999999999996 109.982 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.194 -0.907 . . . . 6.8300000000000001 109.764 173.212 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.808 0.337 . . . . 12.08 110.201 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -133.94 102.4 5.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.177 -0.465 . . . . 9.5 110.392 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -80.54 -28.09 37.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 8.9900000000000002 109.245 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -77.61 -35.44 52.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.563 -0.744 . . . . 6.9900000000000002 110.992 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.07 2.04 38.98 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.862 -0.685 . . . . 4.7800000000000002 111.745 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.42 -38.08 1.97 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.684 -0.769 . . . . 3.1000000000000001 112.119 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.25 -179.19 6.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.242 -0.281 . . . . 1.51 110.242 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.7 m -87.85 -178.22 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 121.249 0.547 . . . . 1.46 111.856 -171.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.54 120.89 10.85 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.279 -0.873 . . . . 0.83999999999999997 111.847 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.08 32.46 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.016 -0.993 . . . . 0.32000000000000001 112.102 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 91.4 m-85 -127.97 114.62 17.37 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.525 0.935 . . . . 0.48999999999999999 113.525 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.407 ' SD ' ' HE3' ' A' ' 20' ' ' LYS . 5.0 ppp? -89.72 156.35 18.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.972 -1.122 . . . . 2.3599999999999999 107.972 172.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 4.4 mtm-85 -132.78 140.5 48.05 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.565 -0.454 . . . . 3.0 111.044 -171.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 45.6 p -86.58 168.97 16.32 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.919 -0.582 . . . . 0.5 109.952 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 44.9 Cg_exo -58.67 -19.7 47.04 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.558 2.172 . . . . 0.79000000000000004 112.941 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.48 -12.12 59.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 1.95 110.834 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.5 30.72 26.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.055 -0.593 . . . . 0.38 111.638 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 28.5 ttm180 -92.59 122.21 34.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 3.79 109.709 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.7 m -91.05 107.68 19.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.572 0.701 . . . . 0.69999999999999996 111.272 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HE3' ' SD ' ' A' ' 12' ' ' MET . 55.8 mtmt -108.84 163.47 16.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.79 -1.095 . . . . 2.5 108.525 174.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 87.1 Cg_exo -50.99 161.7 1.37 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.265 1.977 . . . . 0.59999999999999998 111.519 171.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -23.19 46.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.307 0.575 . . . . 1.0 110.496 175.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 36.1 p90 -115.44 169.09 9.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.08 -0.964 . . . . 1.3500000000000001 109.709 171.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -78.63 141.14 38.25 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.098 -0.501 . . . . 4.3200000000000003 110.782 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.09 92.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.521 -0.763 . . . . 6.7199999999999998 110.181 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tt -97.29 124.16 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 3.8999999999999999 110.26 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 54.3 mt -98.07 -52.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.785 -0.643 . . . . 6.8099999999999996 109.779 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.1 -0.955 . . . . 6.8300000000000001 109.642 -178.846 . . . . . . . . 0 0 . 1 stop_ save_